ChemBuyersGuide.com

+1-212-348-5610

Chemical Search


























Creative Enzymes




Country: USA

Creative Enzymes
45-1 Ramsey Road,
Shirley, New York 11967, USA


Phone: 631-619-7922
FAX: 631-938-8127
E-Mail:E-Mail this Supplier


http://www.creative-enzymes.com/

Description:Creative Enzymes uses its expertise in enzyme manufacturing to supply customers enzymes using for life science research and production of medicines, food, alcohol, beer, fruit juice, fabric, paper, leather goods, etc.

Our products are used worldwide in academic, commercial, and government laboratories in diverse applications, including basic research, drug discovery, cancer research, infectious disease research, microbiology, and personalized medicine. As a reliable supplier, Creative Enzymes supplies the products of high quality and competitive cost performance. We cooperate with a large number of satisfied customers in corresponding fields all over the world.

Creative Enzymes is customer-oriented. Our staff are always devoting themselves to provide quality products and considerate services to the customers. Some of our products are also unique in the field. Choosing our products means choosing high return.


Product List: 8,311

PON:Page:1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |


 


Others

(2S)-OMPT
CAS:799268-70-5
PHOZ-178
>99%
(2S)-1-(9Z-octadecenoyl)-2-O-methyl-glycero-3-phosphothionate (ammonium salt); 1-Oleoyl-2-methyl-sn-glycero-3-phosphothionate (ammonium salt); (2S)-OMPT; 799268-70-5
(R)-FTY720-OME
CAS:1382486-90-9
SPHZ-020
>99%
(R)-FTY720-methyl ether; ROME; (R)-FTY720-OMe; (R)-2-amino-2-(methoxymethyl)-4-(4-octylphenyl)butan-1-ol; 1382486-90-9
03:0 PC
CAS:66414-33-3
PHOZ-238
>99%
PC(3:0/3:0); 1,2-Dipropionyl-sn-glycero-3-phosphocholine; 03:0 PC; 66414-33-3
04:0 PYRENE COENZYME A
CAS:81923-89-9
FLBZ-143
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 04:0 Pyrene Coenzyme A; 81923-89-9; 1-Pyrenebutanoyl Coenzyme A (ammonium salt)
06:0 DIETHER PC
CAS:79645-39-9
PHOZ-041
>99%
PC(6:0e/6:0e); 6-O-PC; DoHPC; 1,2-Di-O-hexyl-sn-glycero-3-phosphocholine; 06:0 Diether PC; 79645-39-9
06:0 LYSO PA
CAS:384835-45-4
PHOZ-185
>99% LPA; may contain up to 10% of the 2-LPA isome
1-hexanoyl-sn-glycero-3-phosphate (ammonium salt); PA(6:0/0:0); 1-Hexanoyl-2-hydroxy-sn-glycero-3-phosphate (ammonium salt); 06:0 Lyso PA; 384835-45-4
06:0 PA
CAS:321883-53-8
PHOZ-199
>99%
1,2-dicaproyl-sn-glycero-3-phosphate (sodium salt); PA(6:0/6:0); 1,2-Dihexanoyl-sn-glycero-3-phosphate (sodium salt); 06:0 PA; 321883-53-8
06:0 PE
CAS:96893-06-0
PHOZ-160
>99%
PE(6:0/6:0); 1,2-Dihexanoyl-sn-glycero-3-phosphoethanolamine; 06:0 PE; 96893-06-0
06:0 PG
CAS:322647-18-7
PHOZ-130
>99%
1,2-dicaproyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); PG(6:0/6:0); 1,2-Dihexanoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); 06:0 PG; 322647-18-7
06:0 PI(3,4,5)P3
CAS:799268-62-5
PHOZ-069
>99%
PIP3[3',4',5'](6:0/6:0); 1,2-Dihexanoyl-sn-glycero-3-phospho-(1'-myo-inositol-3',4',5'-trisphosphate) (ammonium salt); 06:0 PI(3,4,5)P3; 799268-62-5
06:0 PI(3,5)P2
CAS:799268-61-4
PHOZ-070
>99%
PIP2[3',5'](6:0/6:0); 1,2-Dihexanoyl-sn-glycero-3-phospho-(1'-myo-inositol-3',5'-bisphosphate) (ammonium salt); 06:0 PI(3,5)P2; 799268-61-4
06:0 PS
CAS:321862-85-5
PHOZ-113
>99%
PS(6:0/6:0); 1,2-Dihexanoyl-sn-glycero-3-phospho-L-serine (sodium salt); 06:0 PS; 321862-85-5
06:0 SM (D18:1/6:0)
CAS:182493-45-4
SPHZ-091
>99%
Hexanoyl Sphingomyelin; N-(hexanoyl)-sphing-4-enine-1-phosphocholine; 06:0 SM (d18:1/6:0); N-hexanoyl-D-erythro-sphingosylphosphorylcholine; 182493-45-4
06:0-06:0 NBD PA
CAS:474942-99-9
FLBZ-236
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 06:0-06:0 NBD PA; 474942-99-9; 1-Hexanoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphate (ammonium salt)
06:0-06:0 NBD PC
CAS:328946-22-1
FLBZ-229
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 06:0-06:0 NBD PC; 328946-22-1; 1-Hexanoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphocholine
06:0-06:0 NBD PE
CAS:328946-20-9
FLBZ-233
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 06:0-06:0 NBD PE; 328946-20-9; 1-Hexanoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphoethanolamine
06:0-06:0 NBD PG
CAS:474942-89-7
FLBZ-228
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 06:0-06:0 NBD PG; 474942-89-7; 1-Hexanoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-[phospho-rac-(1-glycerol)] (ammonium salt)
06:0-12:0 NBD PA
CAS:384833-05-0
FLBZ-225
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 06:0-12:0 NBD PA; 384833-05-0; 1-Hexanoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-phosphate (ammonium salt)
06:0-12:0 NBD PC
CAS:328946-23-2
FLBZ-212
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 06:0-12:0 NBD PC; 328946-23-2; 1-Hexanoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-phosphocholine
06:0-12:0 NBD PG
CAS:474942-90-0
FLBZ-209
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 06:0-12:0 NBD PG; 474942-90-0; 1-Hexanoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-[phospho-rac-(1-glycerol)] (ammonium salt)
07:0 LYSO PC
CAS:160118-49-0
PHOZ-209
>99% LPC; may contain up to 10% of the 2-LPC isome
1-heptanoyl-sn-glycero-3-phosphocholine; PC(7:0/0:0); 1-Heptanoyl-2-hydroxy-sn-glycero-3-phosphocholine; 07:0 Lyso PC; 160118-49-0
08:0 DGPP
CAS:474943-13-0
FLBZ-039
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 08:0 DGPP; 474943-13-0; Dioctanoylglycerol pyrophosphate (ammonium salt)
08:0 LYSO PC
CAS:45287-18-1
PHOZ-210
>99% LPC; may contain up to 10% of the 2-LPC isome
1-Octanoyl-2-hydroxy-sn-glycero-3-phosphocholine; 08:0 Lyso PC; 45287-18-1
08:0 PA
CAS:321883-54-9
PHOZ-200
>99%
PA(8:0/8:0); 1,2-Dioctanoyl-sn-glycero-3-phosphate (sodium salt); 08:0 PA; 321883-54-9
08:0 PE
CAS:96760-44-0
PHOZ-161
>99%
PE(8:0/8:0); 1,2-Dioctanoyl-sn-glycero-3-phosphoethanolamine; 08:0 PE; 96760-44-0
08:0 PG
CAS:322647-21-2
PHOZ-129
>99%
1,2-Dioctanoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); 08:0 PG; 322647-21-2
08:0 PI(3)P
CAS:299216-98-1
PHOZ-062
>99%
1,2-dioctanoyl-sn-glycero-3-phospho-(1'-myo-inositol-3'-phosphate) (ammonium salt); PIP[3'](8:0/8:0); 1,2-Dioctanoyl-sn-glycero-3-(phosphoinositol-3-phosphate) (ammonium salt); 08:0 PI(3)P; 299216-98-1
08:0 PI(3,4)P2
CAS:852043-35-7
PHOZ-066
>99%
PIP2[3',4'](8:0/8:0); 1,2-Dioctanoyl-sn-glycero-3-phospho-(1'-myo-inositol-3',4'-bisphosphate) (ammonium salt); 08:0 PI(3,4)P2; 852043-35-7
08:0 PI(3,4,5)P3
CAS:852043-38-0
PHOZ-063
>99%
PIP3[3',4',5'](8:0/8:0); 1,2-Dioctanoyl-sn-glycero-3-phospho-(1'-myo-inositol-3',4',5'-trisphosphate) (ammonium salt); 08:0 PI(3,4,5)P3; 852043-38-0
08:0 PI(3,5)P2
CAS:852043-36-8
PHOZ-065
>99%
PIP2[3',5'](8:0/8:0); 1,2-Dioctanoyl-sn-glycero-3-phospho-(1'-myo-inositol-3',5'-bisphosphate) (ammonium salt); 08:0 PI(3,5)P2; 852043-36-8
08:0 PI(4)P
CAS:1246303-11-6
PHOZ-067
>99%
PIP[4'](8:0/8:0); 1,2-Dioctanoyl-sn-glycero-3-phospho-(1'-myo-inositol-4'-phosphate) (ammonium salt); 08:0 PI(4)P; 1246303-11-6
08:0 PI(4,5)P2
CAS:852043-37-9
PHOZ-064
>99%
PIP2[4',5'](8:0/8:0); 1,2-Dioctanoyl-sn-glycero-3-phospho-(1'-myo-inositol-4',5'-bisphosphate) (ammonium salt); 08:0 PI(4,5)P2; 852043-37-9
08:0 PS
CAS:321862-88-8
PHOZ-112
>99%
1,2-Dioctanoyl-sn-glycero-3-phospho-L-serine (sodium salt); 08:0 PS; 321862-88-8
09:0 LYSO PC
CAS:253678-66-9
PHOZ-211
>99% LPC; may contain up to 10% of the 2-LPC isome
1-nonanoyl-sn-glycero-3-phosphocholine; PC(9:0/0:0); 1-Nonanoyl-2-hydroxy-sn-glycero-3-phosphocholine; 09:0 Lyso PC; 253678-66-9
1-DEOXYSPHINGOSINE
CAS:193222-34-3
SPHZ-023
>99%
1-deoxy SO; 1-deoxySo; 1-deoxysphingosine; 1-deoxysphingosine (m18:1); 193222-34-3
1-DESOXYMETHYLSPHINGANINE
CAS:1219484-98-6
SPHZ-022
>99%
1-deoxymethylsphinganine; (2R)-1-amino-2-hydroxy-heptadecane; 1-deoxyMe SA; 1-desoxyMeSa; 1-desoxymethylsphinganine; 1-desoxymethylsphinganine (m17:0); 1219484-98-6
1-DESOXYMETHYLSPHINGOSINE
CAS:1246303-16-1
SPHZ-024
>99%
1-deoxyMe SO; 1-desoxyMeSo; 1-desoxymethylsphingosine; 1-desoxymethylsphingosine (m17:1); 1246303-16-1
1-O-ACYL-CERAMIDE
CAS:1246303-19-4
SPHZ-125
>99%
C17:0, d18:1 ceramide-1-O-18:1; 1-O-Acyl-Ceramide; 1-oleoyl-N-heptadecanoyl-D-erythro-sphingosine; 1246303-19-4
10:0 PA
CAS:321883-64-1
PHOZ-201
>99%
PA(10:0/10:0); 1,2-Didecanoyl-sn-glycero-3-phosphate (sodium salt); 10:0 PA; 321883-64-1
10:0 PE
CAS:253685-27-7
PHOZ-162
>99%
PE(10:0/10:0); 1,2-Didecanoyl-sn-glycero-3-phosphoethanolamine; 10:0 PE; 253685-27-7
10:0 PG
CAS:322647-25-6
PHOZ-128
>99%
1,2-Didecanoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); 10:0 PG; 322647-25-6
11:0 LYSO PC
CAS:27869-41-6
PHOZ-212
>99% LPC; may contain up to 10% of the 2-LPC isome
1-undecanoyl-sn-glycero-3-phosphocholine; PC(11:0/0:0); 1-Undecanoyl-2-hydroxy-sn-glycero-3-phosphocholine; 11:0 Lyso PC; 27869-41-6
12-NBD STEARATE
CAS:117056-67-4
FLBZ-245
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 12-NBD Stearate; 117056-67-4; 12-N-methyl-(7-nitrobenz-2-oxa-1,3-diazo)aminostearic acid
12:0 BIOTINYL LPA
CAS:799812-69-4
NSMZ-144
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 799812-69-4; 12:0 Biotinyl LPA; 1-[12-Biotinyl(aminododecanoyl)]-2-hydroxy-sn-glycero-3-phosphate (ammonium salt)
12:0 BIOTINYL MG
CAS:799812-64-9
NSMZ-146
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 799812-64-9; 12:0 Biotinyl MG; 1-(12-N-biotin)aminododecanoyl-rac-glycerol
12:0 DIETHER PC
CAS:72593-72-7
PHOZ-042
>99%
PC(12:0e/12:0e); 12-O-PC; DIODPC; 1,2-Di-O-dodecyl-sn-glycero-3-phosphocholine; 12:0 Diether PC; 72593-72-7
12:0 DIHYDRO SM (D18:0/12:0)
CAS:474923-31-4
SPHZ-093
>99%
Dodecanoyl Dihydrosphingomyelin; N-(dodecanoyl)-sphinganine-1-phosphocholine; 12:0 Dihydro SM (d18:0/12:0); N-lauroyl-D-erythro-sphinganylphosphorylcholine; 474923-31-4
12:0 EPC (CL SALT)
CAS:474945-22-7
PCNZ-062
>99%
12:0 EPC (Cl Salt) ; 1,2-dilauroyl-sn-glycero-3-ethylphosphocholine (chloride salt); 474945-22-7; 1,2-didodecanoyl-sn-glycero-3-ethylphosphocholine (chloride salt); Cationic Lipids; Transfection; lipid products; lipid
12:0 LYSO NBD PC
CAS:1246303-00-3
FLBZ-231
>99% LPC; may contain up to 10% of the 2-LPC isome
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 12:0 Lyso NBD PC; 1246303-00-3; 1-{12-[(7-Nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-2-hydroxy-sn-glycero-3-phosphocholine
12:0 PG
CAS:322647-27-8
PHOZ-127
>99%
1,2-Dilauroyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt)?; 12:0 PG; 322647-27-8
12:0 PS
CAS:208757-51-1
PHOZ-109
>99%
1,2-didodecanoyl-sn-glycero-3-phospho-L-serine (sodium salt); DLPS; PS(12:0/12:0); 1,2-Dilauroyl-sn-glycero-3-phospho-L-serine (sodium salt); 12:0 PS; 208757-51-1
12:0 SM (D18:1/12:0)
CAS:474923-21-2
SPHZ-092
>99%
Dodecanoyl Sphingomyelin; N-(dodecanoyl)-sphing-4-enine-1-phosphocholine; 12:0 SM (d18:1/12:0); N-lauroyl-D-erythro-sphingosylphosphorylcholine; 474923-21-2
12:0(2R-OH) CERAMIDE
CAS:1246298-44-1
SPHZ-100
>99%
12:0(2R-OH) Ceramide; N-(2-(R)-hydroxylauroyl)-D-erythro-sphingosine; 1246298-44-1
12:0(2S-OH) CERAMIDE
CAS:1246298-45-2
SPHZ-099
>99%
12:0(2S-OH) Ceramide; N-(2-(S)-hydroxylauroyl)-D-erythro-sphingosine; 1246298-45-2
13:0 DIETHER PC
CAS:328250-31-3
PHOZ-043
>99%
PC(13:0e/13:0e); 1,2-Di-O-tridecyl-sn-glycero-3-phosphocholine; 13:0 Diether PC; 328250-31-3
13:0 LYSO PC
CAS:20559-17-5
PHOZ-213
>99% LPC; may contain up to 10% of the 2-LPC isome
1-tridecanoyl-sn-glycero-3-phosphocholine; PC(13:0/0:0); 1-Tridecanoyl-2-hydroxy-sn-glycero-3-phosphocholine; 13:0 Lyso PC; 20559-17-5
13:0 LYSO PI
CAS:1223078-83-8
PHOZ-088
>99% LPI; may contain up to 10% of the 2-LPI isome
PI(13:0/0:0); 1-Tridecanoyl-2-hydroxy-sn-glycero-3-phospho-(1'-myo-inositol) (ammonium salt); 13:0 Lyso PI; 1223078-83-8
13:0 PC
CAS:71242-28-9
PHOZ-239
>99%
1,2-Ditridecanoyl-sn-glycero-3-phosphocholine; 13:0 PC; 71242-28-9
14-DEMETHYL-LANOSTEROL
CAS:7448-2-4
STEZ-052
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 14-demethyl-lanosterol; 4,4-dimethyl-cholest-8(9),24-dien-3?-ol; 14-norlanosterol4,4-dimethylzymosterolT-MAS; 7448-02-4
14-DEMETHYL-LANOSTEROL-D6
CAS:1246298-30-5
STEZ-037
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 14-demethyl-lanosterol-d6; (4,4-dimethyl-d6)cholest-8(9),24-dien-3?-ol; 1246298-30-5
14:0 BMP (S,R)
CAS:325466-03-3
PHOZ-020
>99% BMP (contains 30% positional isomers)
sn-(3-tetradecanoyl-2-hydroxy)-glycerol-1-phospho-sn-3'-(1'-tetradecanoyl-2'-hydroxy)-glycerol (ammonium salt); lysobisphosphatidic acid; LBPA; Bis(monomyristoylglycero)phosphate (S,R Isomer) (ammonium salt); 14:0 BMP (S,R); 325466-03-3
14:0 CARDIOLIPIN (AMMONIUM SALT)
CAS:63988-20-5
PHOZ-049
>99%
1,1',2,2'-tetramyristoyl cardiolipin (ammonium salt); 1,1',2,2'-tetratetradecanoyl cardiolipin (ammonium salt); CL(1'-[14:0/14:0],3'-[14:0/14:0]); 1',3'-Bis[1,2-dimyristoyl-sn-glycero-3-phospho]-sn-glycerol (ammonium salt); 14:0 Cardiolipin (ammonium salt); 63988-20-5
14:0 CARDIOLIPIN (SODIUM SALT)
CAS:63988-21-6
PHOZ-050
>99%
1,1',2,2'-tetratetradecanoyl cardiolipin (sodium salt); CL(1'-[14:0/14:0],3'-[14:0/14:0]); 1',3'-Bis[1,2-dimyristoyl-sn-glycero-3-phospho]-sn-glycerol (sodium salt); 14:0 Cardiolipin (sodium salt); 63988-21-6
14:0 DAP
CAS:72719-84-7
PCNZ-063
>99%
14:0 DAP; 1,2-dimyristoyl-3-dimethylammonium-propane; 72719-84-7; 1,2-ditetradecanoyl-3-dimethylammonium-propane; Cationic Lipids; Transfection; lipid products; lipid
14:0 DIETHER PC
CAS:36314-48-4
PHOZ-044
>99%
PC(14:0e/14:0e); 14-O-PC; 1,2-Di-O-tetradecyl-sn-glycero-3-phosphocholine; 14:0 Diether PC; 36314-48-4
14:0 DIETHER PG
CAS:384835-62-5
PHOZ-040
>99%
GPGro(14:0e/14:0e); 1,2-Di-O-tetradecyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); 14:0 Diether PG; 384835-62-5
14:0 EPC (CL SALT)
CAS:186492-53-5
PCNZ-061
>99%
14:0 EPC (Cl Salt); 1,2-dimyristoyl-sn-glycero-3-ethylphosphocholine (chloride salt); 186492-53-5; 1,2-ditetradecanoyl-sn-glycero-3-ethylphosphocholine (chloride salt); Cationic Lipids; Transfection; lipid products; lipid
14:0 HEMI BMP (S,R)
CAS:325466-04-4
PHOZ-021
>99%
sn-(3-myristoyl-2-hydroxy)-glycerol-1-phospho-sn-3'-(1',2'-dimyristoyl)-glycerol (ammonium salt); 14:0 Hemi BMP (S,R); 325466-04-4
14:0 LISS RHOD PE
CAS:474942-83-1
FLBZ-139
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 14:0 Liss Rhod PE; 474942-83-1; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt)
14:0 LYSO PA
CAS:325465-45-0
PHOZ-186
>99% LPA; may contain up to 10% of the 2-LPA isome
1-Myristoyl-2-hydroxy-sn-glycero-3-phosphate (sodium salt); 14:0 Lyso PA; 325465-45-0
14:0 LYSO PE
CAS:123060-40-2
PHOZ-143
>99% LPE; may contain up to 10% of the 2-LPE isome
1-tetradecanoyl-sn-glycero-3-phosphoethanolamine; PE(14:0/0:0); 1-Myristoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine; 14:0 Lyso PE; 123060-40-2
14:0 LYSO PG
CAS:326495-21-0
PHOZ-139
>99% LPG; may contain up to 10% of the 2-LPG isome
1-tetradecanoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); PG(14:0/0:0); 1-Myristoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); 14:0 Lyso PG; 326495-21-0
14:0 NBD PE
CAS:474942-82-0
FLBZ-184
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 14:0 NBD PE; 474942-82-0; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt)
14:0 NPS PC
CAS:273931-53-6
FLBZ-018
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 1-tetradecanoyl-2-(4-nitrophenylsuccinyl)-sn-glycero-3-phosphocholine; 14:0 NPS PC; 273931-53-6; 1-Myristoyl-2-(4-nitrophenylsuccinyl)-sn-glycero-3-phosphocholine
14:0 PE-DTPA
CAS:384832-89-7
NSMZ-060
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 384832-89-7; 14:0 PE-DTPA; 1,2-ditetradecanoyl-sn-glycero-3-phosphoethanolamine-N-diethylenetriaminepentaacetic acid; DMPE-DTPA; 1,2-Dimyristoyl-sn-gly
14:0 PE-DTPA (GD)
CAS:827020-81-5
NSMZ-056
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 827020-81-5; 14:0 PE-DTPA (Gd); 1,2-ditetradecanoyl-sn-glycero-3-phosphoethanolamine-N-diethylenetriaminepentaacetic acid (gadolinium salt); DMPE-DTPA
14:0 PEG1000 PE
CAS:474922-82-2
PCNZ-039
>99%
14:0 PEG1000 PE; 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] (ammonium salt); 474922-82-2; MPEG 1000; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
14:0 PEG2000 PE
CAS:474922-82-2
PCNZ-035
>99%
14:0 PEG2000 PE; 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt); 474922-82-2; MPEG 2000; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
14:0 PEG3000 PE
CAS:474922-82-2
PCNZ-032
>99%
14:0 PEG3000 PE; 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] (ammonium salt); 474922-82-2 ; MPEG 3000; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
14:0 PEG350 PE
CAS:474922-82-2
PCNZ-052
>99%
14:0 PEG350 PE; 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] (ammonium salt); 474922-82-2; MPEG 350; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
14:0 PEG5000 PE
CAS:474922-82-2
PCNZ-029
>99%
14:0 PEG5000 PE; 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] (ammonium salt); 474922-82-2; MPEG 5000; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
14:0 PEG550 PE
CAS:474922-82-2
PCNZ-048
>99%
14:0 PEG550 PE; 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] (ammonium salt); 474922-82-2; MPEG 550; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
14:0 PEG750 PE
CAS:474922-82-2
PCNZ-044
>99%
14:0 PEG750 PE; 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-750] (ammonium salt); 474922-82-2; MPEG 750; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
14:0 TAP
CAS:197974-74-6
PCNZ-068
>99%
14:0 TAP; 1,2-dimyristoyl-3-trimethylammonium-propane (chloride salt); 197974-74-6; 1,2-ditetradecanoyl-3-trimethylammonium-propane (chloride salt); DMTAP; Cationic Lipids; Transfection; lipid products; lipid
14:0-06:0 NBD PC
CAS:148533-26-0
FLBZ-203
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 14:0-06:0 NBD PC; 148533-26-0; 1-Myristoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphocholine
14:0-06:0 NBD PE
CAS:328946-24-3
FLBZ-217
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 14:0-06:0 NBD PE; 328946-24-3; 1-Myristoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]Hexanoyl}-sn-glycero-3-phosphoethanolamine
14:0-06:0 NBD PG
CAS:474942-84-2
FLBZ-201
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 14:0-06:0 NBD PG; 474942-84-2; 1-Myristoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-[phospho-rac-(1-glycerol)] (ammonium salt)
14:0-12:0 NBD PA
CAS:474942-93-3
FLBZ-198
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 14:0-12:0 NBD PA; 474942-93-3; 1-Myristoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-phosphate (ammonium salt)
14:0-12:0 NBD PC
CAS:153597-84-3
FLBZ-179
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 14:0-12:0 NBD PC; 153597-84-3; 1-Myristoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-sn-Glycero-3-Phosphocholine
14:0-12:0 NBD PE
CAS:328946-25-4
FLBZ-194
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 14:0-12:0 NBD PE; 328946-25-4; 1-Myristoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-phosphoethanolamine
14:0-12:0 NBD PG
CAS:384833-03-8
FLBZ-178
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 14:0-12:0 NBD PG; 384833-03-8; 1-Myristoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-[phospho-rac-(1-glycerol)] (ammonium salt)
14:0-14:0(COOH) PC
CAS:119766-79-9
PHOZ-027
>99%
DMPC-COOH; 1-Myristoyl-2-(14-carboxymyristoyl)-sn-glycero-3-phosphocholine; 14:0-14:0(COOH) PC; 119766-79-9
14:0-16:0 PC
CAS:69525-80-0
PHOZ-222
>99%
1-Myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine; 14:0-16:0 PC; 69525-80-0
14:0-18:0 PC
CAS:76343-22-1
PHOZ-223
>99%
1-Myristoyl-2-stearoyl-sn-glycero-3-phosphocholine; 14:0-18:0 PC; 76343-22-1
14:1 EPC (TF SALT)
CAS:1246304-44-8
PCNZ-056
>99%
14:1 EPC (Tf Salt); 1,2-dimyristoleoyl-sn-glycero-3-ethylphosphocholine (Tf salt); 1246304-44-8; 1,2-di-(9Z-tetradecenoyl)-sn-glycero-3-ethylphosphocholine (Tf salt); Cationic Lipids; Transfection; lipid products; lipid
15-KETOCHOLESTANE
CAS:55823-04-6
STEZ-065
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 15-ketocholestane; 3?-hydroxy-5a-cholestane-15-one; 55823-04-6
15:0 LYSO PC
CAS:108273-89-8
PHOZ-214
>99% LPC; may contain up to 10% of the 2-LPC isome
1-pentadecanoyl-sn-glycero-3-phosphocholine; PC(15:0/0:0); 1-Pentadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine; 15:0 Lyso PC; 108273-89-8
15:0 PE
CAS:109032-52-2
PHOZ-163
>99%
PE(15:0/15:0); 1,2-Dipentadecanoyl-sn-glycero-3-phosphoethanolamine; 15:0 PE; 109032-52-2
15:0 PG
CAS:322647-32-5
PHOZ-126
>99%
PG(15:0/15:0); 1,2-Dipentadecanoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); 15:0 PG; 322647-32-5
15?-HYDROXYCHOLESTANE
CAS:80656-42-4
STEZ-062
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 15?-hydroxycholestane; 5a-cholestane-3?,15?-diol; 3b,15b-diol-5a-cholestane; 80656-42-4
15?-HYDROXYCHOLESTENE
CAS:26660-51-5
STEZ-068
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 15?-hydroxycholestene; 5a-cholest-8(14)-ene-3?,15?,-diol; 3b,15b-diol-5a-cholest-8(14)-ene; 26660-51-5
15A-HYDROXYCHOLESTANE
CAS:73389-49-8
STEZ-063
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 15a-hydroxycholestane; 5a-cholestane-3?,15a-diol; 3b,15a-diol-5a-cholestane; 73389-49-8
15A-HYDROXYCHOLESTENE
CAS:26758-45-2
STEZ-067
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 15a-hydroxycholestene; 5a-cholest-8(14)-ene-3?,15a-diol; 3b,15a-diol-5a-cholest-8(14)-ene; 26758-45-2
16-NBD-16:0 COENZYME A
CAS:1367862-09-6
FLBZ-138
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 16-NBD-16:0 Coenzyme A; 1367862-09-6; {N-[(7-nitro-2-1,3-benzoxadiazol-4-yl)-methyl]amino} palmitoyl Coenzyme A (ammonium salt)
16:0 ALDEHYDE-D9
CAS:1246523-71-6
SPHZ-026
>90% (contains dimer, trimer, tetramer)
16:0 aldehyde-d9; hexadecanal(d9); 1246523-71-6
16:0 BIOTINYL CAP PE
CAS:384835-52-3
NSMZ-064
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 384835-52-3; 16:0 Biotinyl Cap PE; 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine-N-(cap biotinyl) (sodium salt); Solvent: chloroform/methanol/wat
16:0 BIOTINYL PE
CAS:384835-54-5
NSMZ-077
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 384835-54-5; 16:0 Biotinyl PE; 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine-N-(biotinyl) (sodium salt); Solvent: chloroform/methanol/water, 65:3
16:0 CAPROYLAMINE PE
CAS:115288-21-6
NSMZ-089
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 115288-21-6; 16:0 Caproylamine PE; 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine-N-(hexanoylamine); 1,2-Dipalmitoyl-sn-Glycero-3-Phosphoethanolam
16:0 CDP DG
CAS:384835-55-6
FLBZ-010
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; CDP-DAG Dihexadecanoyl; Cytidine Diacylglycerol; 16:0 CDP DG; 384835-55-6; 1,2-Dipalmitoyl-sn-glycero-3-(cytidine diphosphate) (ammonium salt)
16:0 CHOLESTERYL-D7 ESTER
CAS:1416275-32-5
STEZ-006
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 16:0 cholesteryl-d7 ester; cholesteryl-d7 palmitate; 1416275-32-5
16:0 CYANUR CAP PE
CAS:1246304-36-8
NSMZ-073
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 1246304-36-8; 16:0 Cyanur Cap PE; DPPE-Cyanur Cap; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-{6-[(cyanur)amino]hexanoyl} (sodium salt)
16:0 CYANUR PE
CAS:1246304-37-9
NSMZ-085
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 1246304-37-9; 16:0 Cyanur PE; DPPE-Cyanur; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(cyanur) (sodium salt)
16:0 CYCLIC LPA
CAS:799268-71-6
PHOZ-180
>99%
1-hexadecanoyl-sn-glycero-2,3-cyclic-phosphate (ammonium salt); cPA; cLPA; 1-Palmitoyl-sn-glycero-2,3-cyclic-phosphate (ammonium salt); 16:0 Cyclic LPA; 799268-71-6
16:0 DAP
CAS:96326-74-8
PCNZ-064
>99%
16:0 DAP; 1,2-dipalmitoyl-3-dimethylammonium-propane; 96326-74-8; 1,2-dihexadecanoyl-3-dimethylammonium-propane; Cationic Lipids; Transfection; lipid products; lipid
16:0 DG GALLOYL
CAS:799812-76-3
NSMZ-103
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 799812-76-3; 16:0 DG Galloyl; 1,2-Dipalmitoyl-sn-glycero-3-galloyl
16:0 DGS
CAS:108032-13-9
NSMZ-108
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 108032-13-9; 16:0 DGS; 1,2-dihexadecanoyl-sn-glycero-3-succinatedipalmitoylsuccinylglycerol; DPSG; 1,2-Dipalmitoyl-sn-glycero-3-succinate
16:0 DNP CAP PE
CAS:474943-10-7
NSMZ-070
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 474943-10-7; 16:0 DNP Cap PE; 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine-N-[6-[(2,4-dinitrophenyl)amino]caproyl] (ammonium salt); 1,2-Dipalmit
16:0 DNP PE
CAS:474943-09-4
NSMZ-083
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 474943-09-4; 16:0 DNP PE; 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine-N-(2,4-dinitrophenyl) (ammonium salt); 1,2-Dipalmitoyl-sn-glycero-3-phosp
16:0 DODECANOYL PE
CAS:474923-49-4
NSMZ-079
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 474923-49-4; 16:0 Dodecanoyl PE; 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine-N-(dodecanoyl) (sodium salt); 1,2-Dipalmitoyl-sn-glycero-3-phospho
16:0 DODECANYLAMINE PE
CAS:474944-08-6
NSMZ-081
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 474944-08-6; 16:0 Dodecanylamine PE; 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine-N-(dodecanoylamine); 1,2-Dipalmitoyl-sn-glycero-3-phosphoethan
16:0 EPC (CL SALT)
CAS:328250-18-6
PCNZ-060
>99%
16:0 EPC (Cl Salt); 1,2-dipalmitoyl-sn-glycero-3-ethylphosphocholine (chloride salt); 328250-18-6; 1,2-dihexadecanoyl-sn-glycero-3-ethylphosphocholine (chloride salt); Cationic Lipids; Transfection; lipid products; lipid
16:0 GLUTARYL PE
CAS:474923-45-0
NSMZ-088
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 474923-45-0; 16:0 Glutaryl PE; 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine-N-(glutaryl) (sodium salt); DPPE-GA; 1,2-Dipalmitoyl-sn-glycero-3-ph
16:0 LISS RHOD PE
CAS:384833-01-6
FLBZ-135
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 16:0 Liss Rhod PE; 384833-01-6; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt)
16:0 LYSO PA
CAS:17618-08-5
PHOZ-187
>99% LPA; may contain up to 10% of the 2-LPA isome
1-Palmitoyl-2-hydroxy-sn-glycero-3-phosphate (sodium salt); 16:0 Lyso PA; 17618-08-5
16:0 LYSO PG
CAS:326495-22-1
PHOZ-140
>99% LPG; may contain up to 10% of the 2-LPG isome
1-Palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); 16:0 Lyso PG; 326495-22-1
16:0 LYSO PI
CAS:141553-69-7
PHOZ-089
>99% LPI; may contain up to 10% of the 2-LPI isome
1-hexadecanoyl-2-hydroxy-sn-glycero-3-phospho-(1'-myo-inositol) (ammonium salt); PI(16:0/0:0); 1-Palmitoyl-2-hydroxy-sn-glycero-3-phosphoinositol (ammonium salt); 16:0 Lyso PI; 141553-69-7
16:0 LYSYL PG
CAS:1246303-06-9
FLBZ-012
>99% (up to 15% acyl migration on lysine)
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; Lysyl-DPPG; 16:0 Lysyl PG; 1246303-06-9; 1,2-Dipalmitoyl-sn-glycero-3-[phospho-rac-(3-lysyl(1-glycerol))] (chloride salt)
16:0 MPB PE
CAS:384835-50-1
NSMZ-075
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 384835-50-1; 16:0 MPB PE; 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine-N-[4-(p-maleimidophenyl)butyramide] (sodium salt); 1,2-Dipalmitoyl-sn-gly
16:0 NBD PE
CAS:384823-46-5
FLBZ-172
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 16:0 NBD PE; 384823-46-5; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxaDiazol-4-yl) (ammonium salt)
16:0 PDP PE
CAS:474944-16-6
NSMZ-080
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 474944-16-6; 16:0 PDP PE; 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine-N-[3-(2-pyridyldithio)propionate] (sodium salt); 1,2-Dipalmitoyl-sn-glyce
16:0 PE MCC
CAS:384832-87-5
NSMZ-078
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 384832-87-5; 16:0 PE MCC; 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine-N-[4-(p-maleimidomethyl)cyclohexane-carboxamide] (sodium salt); 1,2-Dipal
16:0 PE-DTPA (GD)
CAS:790172-80-4
NSMZ-054
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 790172-80-4; 16:0 PE-DTPA (Gd); 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine-N-diethylenetriaminepentaacetic acid (gadolinium salt); DPPE-DTPA (
16:0 PEG1000 PE
CAS:474922-84-4
PCNZ-038
>99%
16:0 PEG1000 PE; 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] (ammonium salt); 474922-84-4; MPEG 1000; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
16:0 PEG2000 PE
CAS:474922-84-4
PCNZ-034
>99%
16:0 PEG2000 PE; 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt); 474922-84-4; MPEG 2000; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
16:0 PEG3000 PE
CAS:474922-84-4
PCNZ-033
>99%
16:0 PEG3000 PE; 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] (ammonium salt); 474922-84-4; MPEG 3000; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
16:0 PEG350 PE
CAS:474922-84-4
PCNZ-053
>99%
16:0 PEG350 PE; 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] (ammonium salt); 474922-84-4; MPEG 350; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
16:0 PEG5000 PE
CAS:474922-84-4
PCNZ-028
>99%
16:0 PEG5000 PE; 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] (ammonium salt); 474922-84-4; MPEG 5000; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
16:0 PEG550 PE
CAS:474922-84-4
PCNZ-049
>99%
16:0 PEG550 PE; 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] (ammonium salt); 474922-84-4; MPEG 550; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
16:0 PEG750 PE
CAS:474922-84-4
PCNZ-045
>99%
16:0 PEG750 PE; 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-750] (ammonium salt); 474922-84-4; MPEG 750; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
16:0 PHOSPHATIDYLBUTANOL
CAS:92609-92-2
NSMZ-100
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 92609-92-2; 16:0 Phosphatidylbutanol; 1,2-dihexadecanoyl-sn-glycero-3-phosphobutanol (sodium salt); 1,2-Dipalmitoyl-sn-glycero-3-phosphobutanol (sodium
16:0 PHOSPHATIDYLETHANOL
CAS:92609-90-0
NSMZ-106
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 92609-90-0; 16:0 Phosphatidylethanol; 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanol (sodium salt); 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanol (sodium
16:0 PHOSPHATIDYLMETHANOL
CAS:92609-89-7
NSMZ-107
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 92609-89-7; 16:0 Phosphatidylmethanol; 1,2-dihexadecanoyl-sn-glycero-3-phosphomethanol (sodium salt); 1,2-Dipalmitoyl-sn-glycero-3-phosphomethanol (sod
16:0 PHOSPHATIDYLPROPANOL
CAS:92609-91-1
NSMZ-105
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 92609-91-1; 16:0 Phosphatidylpropanol; 1,2-dihexadecanoyl-sn-glycero-3-phosphopropanol (sodium salt); 1,2-Dipalmitoyl-sn-glycero-3-phosphopropanol (sod
16:0 PI
CAS:34290-57-8
PHOZ-085
>99%
1,2-dihexadecanoyl-sn-glycero-3-phospho-(1'-myo-inositol) (ammonium salt); PI(16:0/16:0); DPPI; 1,2-Dipalmitoyl-sn-glycero-3-phospho-(1'-myo-inositol) (ammonium salt); 16:0 PI; 34290-57-8
16:0 PS
CAS:145849-32-7
PHOZ-110
>99%
1,2-Dipalmitoyl-sn-glycero-3-phospho-L-serine (sodium salt); 16:0 PS; 145849-32-7
16:0 PTD ETHYLENE GLYCOL
CAS:148439-06-9
NSMZ-104
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 148439-06-9; 16:0 Ptd Ethylene Glycol; 1,2-dihexadecanoyl-sn-glycero-3-phospho(ethylene glycol) (sodium salt); 16:0 PtdEG; 1,2-Dipalmitoyl-sn-glycero-3
16:0 PTD THIOETHANOL
CAS:474923-39-2
NSMZ-099
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 474923-39-2; 16:0 Ptd Thioethanol; 1,2-dihexadecanoyl-sn-glycero-3-phosphothioethanol (sodium salt); 16:0 PTE; 1,2-Dipalmitoyl-sn-glycero-3-phosphothio
16:0 TAP
CAS:139984-36-4
PCNZ-069
>99%
16:0 TAP ; 1,2-dipalmitoyl-3-trimethylammonium-propane (chloride salt); 139984-36-4; 1,2-dihexadecanoyl-3-trimethylammonium-propane (chloride salt); Cationic Lipids; Transfection; lipid products; lipid
16:0(2R-OH) CERAMIDE
CAS:34839-02-6
SPHZ-102
>99%
16:0(2R-OH) Ceramide; N-(2-(R)-hydroxypalmitoyl)-D-erythro-sphingosine; 34839-02-6
16:0(2S-OH) CERAMIDE
CAS:890041-50-6
SPHZ-101
>99%
16:0(2S-OH) Ceramide; N-(2-(S)-hydroxypalmitoyl)-D-erythro-sphingosine; 890041-50-6
16:0-06:0 NBD PA
CAS:474942-95-5
FLBZ-215
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 16:0-06:0 NBD PA; 474942-95-5; 1-Palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphate (ammonium salt)
16:0-06:0 NBD PC
CAS:91992-01-7
FLBZ-196
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 16:0-06:0 NBD PC; 91992-01-7; 1-Palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphocholine
16:0-06:0 NBD PE
CAS:106918-69-8
FLBZ-208
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 16:0-06:0 NBD PE; 106918-69-8; 1-Palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphoethanolamine
16:0-06:0 NBD PG
CAS:474942-85-3
FLBZ-195
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 16:0-06:0 NBD PG; 474942-85-3; 1-Palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-[phospho-rac-(1-glycerol)] (ammonium salt)
16:0-06:0 NBD PS
CAS:384833-06-1
FLBZ-192
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 16:0-06:0 NBD PS; 384833-06-1; 1-Palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphoserine (ammonium salt)
16:0-09:0 (ALDO) PC
CAS:117746-89-1
PHOZ-013
>99%
1-Palmitoyl-2-(9'-oxo-nonanoyl)-sn-glycero-3-phosphocholine; 16:0-09:0 (ALDO) PC; 117746-89-1
16:0-12:0 NBD PA
CAS:474942-96-6
FLBZ-193
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 16:0-12:0 NBD PA; 474942-96-6; 1-Palmitoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-phosphate (ammonium salt)
16:0-12:0 NBD PC
CAS:105539-26-2
FLBZ-175
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 16:0-12:0 NBD PC; 105539-26-2; 1-Palmitoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-phosphocholine
16:0-12:0 NBD PE
CAS:328946-26-5
FLBZ-187
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 16:0-12:0 NBD PE; 328946-26-5; 1-Palmitoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-phosphoethanolamine
16:0-12:0 NBD PG
CAS:474942-86-4
FLBZ-174
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 16:0-12:0 NBD PG; 474942-86-4; 1-Palmitoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-[phospho-rac-(1-glycerol)] (ammonium salt)
16:0-12:0 NBD PS
CAS:384833-07-2
FLBZ-171
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 16:0-12:0 NBD PS; 384833-07-2; 1-palmitoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-phosphoserine (ammonium salt)
16:0-14:0 PC
CAS:69441-09-4
PHOZ-224
>99%
1-Palmitoyl-2-myristoyl-sn-glycero-3-phosphocholine; 16:0-14:0 PC; 69441-09-4
16:0-16:0 (16-F) PC
CAS:215362-14-4
NSMZ-139
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 215362-14-4; 16:0-16:0 (16-F) PC; 1-hexadecanoyl-2-(16-fluorohexadecanoyl)-sn-glycero-3-phosphocholine; 1-Palmitoyl-2-(16-fluoroPalmitoyl)-sn-glycero-3
16:0-16:0(ACRYLATE) PC
CAS:1246304-43-7
PHOZ-028
>99%
1-Palmitoyl-2-[16-(acryloyloxy)palmitoyl]-sn-glycero-3-phosphorylcholine; 16:0-16:0(acrylate) PC; 1246304-43-7
16:0-18:0 (11-12BR) PC
CAS:324054-54-8
NSMZ-120
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 324054-54-8; 16:0-18:0 (11-12BR) PC; 1-hexadecanoyl-2-(11,12-dibromooctadecanoyl)-sn-glycero-3-phosphocholine; 1-Palmitoyl-2-(11,12-dibromo)stearoyl-sn
16:0-18:0 (6-7BR) PC
CAS:324054-50-4
NSMZ-122
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 324054-50-4; 16:0-18:0 (6-7BR) PC; 1-hexadecanoyl-2-(6,7-dibromooctadecanoyl)-sn-glycero-3-phosphocholine; 1-Palmitoyl-2-(6,7-dibromo)stearoyl-sn-glyce
16:0-18:0 (9-10BR) PC
CAS:324054-52-6
NSMZ-121
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 324054-52-6; 16:0-18:0 (9-10BR) PC; 1-hexadecanoyl-2-(9,10-dibromooctadecanoyl)-sn-glycero-3-phosphocholine; 1-Palmitoyl-2-(9,10-dibromo)stearoyl-sn-gl
16:0-18:1 DG
CAS:29541-66-0
PCNZ-092
>99%
16:0-18:1 DG; 1-palmitoyl-2-oleoyl-sn-glycerol; 29541-66-0; 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycerol; DG(16:0/18:1(9Z)/0:0); neutral Lipids; lipid products; lipid
16:0-18:1 EPC (CL SALT)
CAS:328250-19-7
PCNZ-057
>99%
16:0-18:1 EPC (Cl Salt); 1-palmitoyl-2-oleoyl-sn-glycero-3-ethylphosphocholine (chloride salt); 328250-19-7; 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-ethylphosphocholine (chloride salt); Cationic Lipids; Transfection; lipid products; lipid
16:0-18:1 PHOSPHATIDYLETHANOL
CAS:322647-55-2
NSMZ-101
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 322647-55-2; 16:0-18:1 Phosphatidylethanol; 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanol (sodium salt)
16:0-18:1 PI
CAS:50730-13-7
PHOZ-084
>99%
1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1'-myo-inositol) (ammonium salt); POPI; PI(16:0/18:1); 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoinositol (ammonium salt); 16:0-18:1 PI; 50730-13-7
16:0-18:2 PC
CAS:159701-21-0
PHOZ-225
>99%
1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine; PC(16:0/18:2(9Z,12Z)); 1-Palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine; 16:0-18:2 PC; 159701-21-0
16:0-18:2 PG
CAS:322647-44-9
PHOZ-132
>99%
1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); PG(16:0/18:2(9Z,12Z)); 1-Palmitoyl-2-linoleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); 16:0-18:2 PG; 322647-44-9
16:0-18:2 PS
CAS:384833-20-9
PHOZ-101
>99%
1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-L-serine (sodium salt); PS(16:0/18:2(9Z,12Z)); 1-Palmitoyl-2-linoleoyl-sn-glycero-3-phospho-L-serine (sodium salt); 16:0-18:2 PS; 384833-20-9
16:0-20:4 PA
CAS:322647-60-9
PHOZ-195
>99%
1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphate (sodium salt); PAPA; PA(16:0/20:4(5Z,8Z,11Z,14Z)); 1-Palmitoyl-2-arachidonoyl-sn-glycero-3-phosphate (sodium salt); 16:0-20:4 PA; 322647-60-9
16:0-20:4 PE
CAS:70812-59-8
PHOZ-146
>99%
1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine; PAPE; PE(16:0/20:4(5Z,8Z,11Z,14Z)); 1-Palmitoyl-2-arachidonoyl-sn-glycero-3-phosphoethanolamine; 16:0-20:4 PE; 70812-59-8
16:0-20:4 PG
CAS:322647-47-2
PHOZ-133
>99%
1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); PAPG; PG(16:0/20:4(5Z,8Z,11Z,14Z)); 1-Palmitoyl-2-arachidonoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); 16:0-20:4 PG; 322647-47-2
16:0-20:4 PS
CAS:474943-16-3
PHOZ-102
>99%
1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-L-serine (sodium salt); PAPS; PS(16:0/20:4(5Z,8Z,11Z,14Z)); 1-Palmitoyl-2-arachidonoyl-sn-glycero-3-phospho-L-serine (sodium salt); 16:0-20:4 PS; 474943-16-3
16:0-22:6 PA
CAS:474943-28-7
PHOZ-196
>99%
1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphate (sodium salt); PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)); 1-Palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphate (sodium salt); 16:0-22:6 PA; 474943-28-7
16:0-22:6 PE
CAS:96998-00-4
PHOZ-147
>99%
1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine; PE(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)); 1-Palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphoethanolamine; 16:0-22:6 PE; 96998-00-4
16:0-22:6 PG
CAS:384833-22-1
PHOZ-134
>99%
1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); PG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)); 1-Palmitoyl-2-docosahexaenoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); 16:0-22:6 PG; 384833-22-1
16:0-22:6 PS
CAS:474943-17-4
PHOZ-103
>99%
1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phospho-L-serine (sodium salt); PS(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)); 1-Palmitoyl-2-docosahexaenoyl-sn-glycero-3-phospho-L-serine (sodium salt); 16:0-22:6 PS; 474943-17-4
16:0-23:2 DIYNE PC
CAS:84271-00-1
NSMZ-131
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 84271-00-1; 16:0-23:2 Diyne PC; PTPC; 1-Palmitoyl-2-(10,12-tricosadiynoyl)-sn-glycero-3-phosphocholine
16:0-23:2 DIYNE PE
CAS:328946-17-4
NSMZ-136
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 328946-17-4; 16:0-23:2 Diyne PE; PTPE; 1-Palmitoyl-2-(10,12-tricosadiynoyl)-sn-glycero-3-phosphoethanolamine
16:1 ALDEHYDE
CAS:3163-37-9
SPHZ-025
>99%
16:1 aldehyde; (2E)-hexadecenal; 3163-37-9
16:1 ALDEHYDE-D5
CAS:948862-50-8
SPHZ-027
>99%
16:1 aldehyde-d5; (2E)-hexadecenal(d5); 948862-50-8
16:1 PE
CAS:61599-23-3
PHOZ-152
>99%
1,2-di-(9Z-hexadecenoyl)-sn-glycero-3-phosphoethanolamine; PE(16:1(9Z)/16:1(9Z)); 1,2-Dipalmitoleoyl-sn-glycero-3-phosphoethanolamine; 16:1 PE; 61599-23-3
17:0 LYSO PA
CAS:799268-66-9
PHOZ-188
>99% LPA; may contain up to 10% of the 2-LPA isome
heptadecanoyl lysophosphatidic acid1-heptadecanoyl-sn-glycero-3-phosphate (sodium salt); PA(17:0/0:0)17:0 LPA; 1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphate (sodium salt); 17:0 Lyso PA; 799268-66-9
17:0 PE
CAS:140219-78-9
PHOZ-158
>99%
PE(17:0/17:0); 1,2-Diheptadecanoyl-sn-glycero-3-phosphoethanolamine; 17:0 PE; 140219-78-9
17:0 PG
CAS:799268-52-3
PHOZ-131
>99%
PG(17:0/17:0); 1,2-Diheptadecanoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); 17:0 PG; 799268-52-3
17:0 PS
CAS:799268-51-2
PHOZ-114
>99%
PS(17:0/17:0); 1,2-Diheptadecanoyl-sn-glycero-3-phospho-L-serine (sodium salt); 17:0 PS; 799268-51-2
17:0 SM (D18:1/17:0)
CAS:121999-64-2
SPHZ-096
>99%
Heptadecanoyl Sphingomyelin; N-(heptadecanoyl)-sphing-4-enine-1-phosphocholine; 17:0 SM (d18:1/17:0); N-heptadecanoyl-D-erythro-sphingosylphosphorylcholine; 121999-64-2
17:0(2R-OH) CERAMIDE
CAS:1246298-46-3
SPHZ-104
>99%
17:0(2R-OH) Ceramide; N-(2-(R)-hydroxyheptadecanoyl)-D-erythro-sphingosine; 1246298-46-3
17:0(2S-OH) CERAMIDE
CAS:1246298-47-4
SPHZ-103
>99%
17:0(2S-OH) Ceramide; N-(2-(S)-hydroxyheptadecanoyl)-D-erythro-sphingosine; 1246298-47-4
17:1 LYSO PI
CAS:1246353-39-8
PHOZ-090
>99% LPI; may contain up to 10% of the 2-LPI isome
PI(17:1(10Z)/0:0); 1-(10Z-heptadecenoyl)-2-hydroxy-sn-glycero-3-phospho-(1'-myo-inositol) (ammonium salt); 17:1 Lyso PI; 1246353-39-8
17:1 LYSO PS
CAS:1246298-15-6
PHOZ-098
>99% LPS; may contain up to 10% of the 2-LPS isome
1-(10Z-heptadecenoyl)-2-hydroxy-sn-glycero-3-[phospho-L-serine] (sodium salt); 17:1 Lyso PS; 1246298-15-6
18:0 (9,10DIBROMO) PC
CAS:217075-01-9
NSMZ-115
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 217075-01-9; 18:0 (9,10dibromo) PC; 1,2-di-(9,10-dibromooctadecanoyl)-sn-glycero-3-phosphocholine; 1,2-Di-(9,10-dibromo)stearoyl-sn-glycero-3-phosphoch
18:0 DAP
CAS:121315-93-3
PCNZ-065
>99%
18:0 DAP; 1,2-distearoyl-3-dimethylammonium-propane; 121315-93-3; 1,2-dioctadecanoyl-3-dimethylammonium-propane; Cationic Lipids; Transfection; lipid products; lipid
18:0 DIBROMO MG
CAS:1438282-43-9
NSMZ-145
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 1438282-43-9; 18:0 Dibromo MG; 1-(9,10-Dibromostearoyl)-rac-glycerol
18:0 DIETHER PC
CAS:1188-85-8
PHOZ-045
>99%
PC(18:0e/18:0e); 1,2-Di-O-octadecyl-sn-glycero-3-phosphocholine; 18:0 Diether PC; 1188-85-8
18:0 DIMETHYLACETAL
CAS:14620-55-4
PHOZ-010
>99%
1,1-Dimethoxyoctadecane; Octadecanal-dimethylacetal; 18:0 dimethylacetal; 14620-55-4
18:0 EPC (CL SALT)
CAS:328268-13-9
PCNZ-059
>99%
18:0 EPC (Cl Salt); 1,2-distearoyl-sn-glycero-3-ethylphosphocholine (chloride salt); 328268-13-9; 1,2-dioctadecanoyl-sn-glycero-3-ethylphosphocholine (chloride salt); Cationic Lipids; Transfection; lipid products; lipid
18:0 LYSO PA
CAS:325465-92-7
PHOZ-189
>99% LPA; may contain up to 10% of the 2-LPA isome
stearoyl lysophosphatidic acid1-octadecanoyl-sn-glycero-3-phosphate (sodium salt); PA(18:0/0:0); 18:0 LPA; s-LPA; 1-Stearoyl-2-hydroxy-sn-glycero-3-phosphate (sodium salt); 18:0 Lyso PA; 325465-92-7
18:0 LYSO PE
CAS:69747-55-3
PHOZ-144
>99% LPE; may contain up to 10% of the 2-LPE isome
1-octadecanoyl-sn-glycero-3-phosphoethanolamine; PE(18:0/0:0); 1-Stearoyl-2-Hydroxy-sn-Glycero-3-Phosphoethanolamine; 18:0 Lyso PE; 69747-55-3
18:0 LYSO PG
CAS:326495-23-2
PHOZ-141
>99% LPG; may contain up to 10% of the 2-LPG isome
1-octadecanoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); PG(18:0/0:0); 1-Stearoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); 18:0 Lyso PG; 326495-23-2
18:0 LYSO PI
CAS:849412-49-3
PHOZ-091
>99% LPI; may contain up to 10% of the 2-LPI isome
1-octadecanoyl-2-hydroxy-sn-glycero-3-phospho-(1'-myo-inositol) (ammonium salt); PI(18:0/0:0); 1-Stearoyl-2-hydroxy-sn-glycero-3-phosphoinositol (ammonium salt); 18:0 Lyso PI; 849412-49-3
18:0 LYSO PS
CAS:1246298-16-7
PHOZ-100
>99% LPS; may contain up to 10% of the 2-LPS isome
1-octadecanoyl-sn-glycero-3-phospho-L-serine (sodium salt); 18:0 LPS; C18 LPS; PS(18:0/0:0); 1-Stearoyl-2-hydroxy-sn-glycero-3-phospho-L-serine (sodium salt); 18:0 Lyso PS; 1246298-16-7
18:0 NBD PE (NBD-DSPE)
CAS:1246303-01-4
FLBZ-160
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; NBD-DSPE; 18:0 NBD PE (NBD-DSPE); 1246303-01-4; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt)
18:0 PE-DTPA
CAS:1585969-98-7
NSMZ-055
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 1585969-98-7; 18:0 PE-DTPA; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-diethylenetriaminepentaacetic acid (ammonium salt)
18:0 PEG2000 PE
CAS:474922-77-5
PCNZ-037
>99%
18:0 PEG2000 PE; 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt); 474922-77-5; DSPE-mPEG(2000); MPEG 2000; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
18:0 PEG2000 PE CF
CAS:1092697-61-4
FLBZ-129
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 18:0 PEG2000 PE CF; 1092697-61-4; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[poly(ethylene glycol)2000-N-carboxyfluorescein] (ammonium salt)
18:0 PEG3000 PE
CAS:474922-77-5
PCNZ-031
>99%
18:0 PEG3000 PE; 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] (ammonium salt); 474922-77-5; MPEG 3000; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
18:0 PEG350 PE
CAS:474922-77-5
PCNZ-050
>99%
18:0 PEG350 PE; 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] (ammonium salt); 474922-77-5; MPEG 350; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
18:0 PEG5000 PE
CAS:474922-77-5
PCNZ-027
>99%
18:0 PEG5000 PE; 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] (ammonium salt); 474922-77-5; MPEG 5000; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
18:0 PEG550 PE
CAS:474922-77-5
PCNZ-047
>99%
18:0 PEG550 PE; 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] (ammonium salt); 474922-77-5; MPEG 550; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
18:0 PEG750 PE
CAS:474922-77-5
PCNZ-042
>99%
18:0 PEG750 PE; 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-750] (ammonium salt); 474922-77-5; MPEG 750; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
18:0 PI
CAS:849412-67-5
PHOZ-083
>99%
1,2-dioctadecanoyl-sn-glycero-3-phospho-(1'-myo-inositol) (ammonium salt); DSPI; PI(18:0/18:0); 1,2-Distearoyl-sn-glycero-3-phosphoinositol (ammonium salt); 18:0 PI; 849412-67-5
18:0 TAP
CAS:220609-41-6
PCNZ-067
>99%
18:0 TAP; 1,2-stearoyl-3-trimethylammonium-propane (chloride salt); 220609-41-6; 1,2-dioctadecanoyl-3-trimethylammonium-propane (chloride salt); Cationic Lipids; Transfection; lipid products; lipid
18:0(2R-OH) CERAMIDE
CAS:34249-40-6
SPHZ-106
>99%
18:0(2R-OH) Ceramide; N-(2-(R)-hydroxystearoyl)-D-erythro-sphingosine; 34249-40-6
18:0(2S-OH) CERAMIDE
CAS:34839-04-8
SPHZ-105
>99%
18:0(2S-OH) Ceramide; N-(2-(S)-hydroxystearoyl)-D-erythro-sphingosine; 34839-04-8
18:0-14:0 PC
CAS:20664-02-2
PHOZ-226
>99%
1-Stearoyl-2-myristoyl-sn-glycero-3-phosphocholine; 18:0-14:0 PC; 20664-02-2
18:0-18:1 PE
CAS:6418-95-7
PHOZ-148
>99%
1-octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine; SOPE; PE(18:0/18:1(9Z)); 1-Stearoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine; 18:0-18:1 PE; 6418-95-7
18:0-18:1 PG
CAS:322647-48-3
PHOZ-135
>99%
1-octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); SOPG; PG(18:0/18:1(9Z)); 1-Stearoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); 18:0-18:1 PG; 322647-48-3
18:0-18:2 PE
CAS:7266-53-7
PHOZ-149
>99%
1-octadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphoethanolamine; PE(18:0/18:2(9Z,12Z)); 1-Stearoyl-2-linoleoyl-sn-glycero-3-phosphoethanolamine; 18:0-18:2 PE; 7266-53-7
18:0-18:2 PG
CAS:474943-26-5
PHOZ-136
>99%
1-octadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); PG(18:0/18:2(9Z,12Z)); 1-Stearoyl-2-linoleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); 18:0-18:2 PG; 474943-26-5
18:0-20:4 PA
CAS:322647-61-0
PHOZ-197
>99%
1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphate (sodium salt); SAPA; PA(18:0/20:4(5Z,8Z,11Z,14Z)); 1-Stearoyl-2-arachidonoyl-sn-glycero-3-phosphate (sodium salt); 18:0-20:4 PA; 322647-61-0
18:0-20:4 PE
CAS:61216-62-4
PHOZ-150
>99%
1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine; SAPE; PE(18:0/20:4(5Z,8Z,11Z,14Z)); 1-Stearoyl-2-arachidonoyl-sn-glycero-3-phosphoethanolamine; 18:0-20:4 PE; 61216-62-4
18:0-20:4 PG
CAS:322647-50-7
PHOZ-137
>99%
1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); SAPG; PG(18:0/20:4(5Z,8Z,11Z,14Z)); 1-Stearoyl-2-arachidonoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); 18:0-20:4 PG; 322647-50-7
18:0-20:4 PI
CAS:1331751-28-0
PHOZ-082
>99%
1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol) (ammonium salt); SAPI; PI(18:0/20:4(5Z,8Z,11Z,14Z)); 1-Stearoyl-2-arachidonoyl-sn-glycero-3-phosphoinositol (ammonium salt); 18:0-20:4 PI; 1331751-28-0
18:0-20:4 PI(3,4,5)P3
CAS:799268-60-3
PHOZ-071
>99%
1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-[phosphoinositol-3,4,5-trisphosphate] (ammonium salt); PIP3[3',4',5'](18:0/20:4(5Z,8Z,11Z,14Z)); 1-Stearoyl-2-arachidonoyl-sn-glycero-3-phospho-(1'-myo-inositol-3',4',5'-trisphosphate) (ammonium salt); 18:0-20:4 PI(3,4,5)P3; 799268-60-3
18:0-20:4 PI(3,5)P2
CAS:799268-58-9
PHOZ-073
>99%
1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-[phosphoinositol-3,5-bisphosphate] (ammonium salt); PIP2[3',5'](18:0/20:4(5Z,8Z,11Z,14Z)); 1-Stearoyl-2-arachidonoyl-sn-glycero-3-phospho-(1'-myo-inositol-3',5'-bisphosphate) (ammonium salt); 18:0-20:4 PI(3,5)P2; 799268-58-9
18:0-20:4 PI(4,5)P2
CAS:799268-59-0
PHOZ-072
>99%
1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-[phosphoinositol-4,5-bisphosphate] (ammonium salt); PIP2[4',5'](18:0/20:4(5Z,8Z,11Z,14Z)); 1-Stearoyl-2-arachidonoyl-sn-glycero-3-phospho-(1'-myo-inositol-4',5'-bisphosphate) (ammonium salt); 18:0-20:4 PI(4,5)P2; 799268-59-0
18:0-20:4 PS
CAS:474967-15-2
PHOZ-104
>99%
1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-L-serine (sodium salt); SAPS; PS(18:0/20:4(5Z,8Z,11Z,14Z)); 1-Stearoyl-2-arachidonoyl-sn-glycero-3-phospho-L-serine (sodium salt); 18:0-20:4 PS; 474967-15-2
18:0-22:6 DG
CAS:65886-80-8
PCNZ-093
>99%
18:0-22:6 DG; 1-stearoyl-2-docosahexaenoyl-sn-glycerol; 65886-80-8; 1-octadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycerol; DG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0); neutral Lipids; lipid products; lipid
18:0-22:6 PA
CAS:474943-30-1
PHOZ-198
>99%
1-octadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphate (sodium salt); PA(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)); 1-Stearoyl-2-docosahexaenoyl-sn-glycero-3-phosphate (sodium salt); 18:0-22:6 PA; 474943-30-1
18:0-22:6 PC
CAS:59403-52-0
PHOZ-227
>99%
1-octadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine; PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)); 1-Stearoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine; 18:0-22:6 PC; 59403-52-0
18:0-22:6 PE
CAS:96998-01-5
PHOZ-151
>99%
1-octadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine; PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)); 1-Stearoyl-2-docosahexaenoyl-sn-glycero-3-phosphoethanolamine; 18:0-22:6 PE; 96998-01-5
18:0-22:6 PG
CAS:474943-27-6
PHOZ-138
>99%
1-octadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); PG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)); 1-Stearoyl-2-docosahexaenoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); 18:0-22:6 PG; 474943-27-6
18:0-22:6 PS
CAS:474943-18-5
PHOZ-105
>99%
1-octadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phospho-L-serine (sodium salt); PS(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)); 1-Stearoyl-2-docosahexaenoyl-sn-glycero-3-phospho-L-serine (sodium salt); 18:0-22:6 PS; 474943-18-5
18:1 BDP (S,S)
CAS:1246298-28-1
PHOZ-026
>99%
sn-[2,3-dioleoyl]-glycerol-1-phospho-sn-1'-[2',3'-dioleoyl]-glycerol (ammonium salt); 18:1 BDP (S,S); 1246298-28-1
18:1 BIOTINYL CAP PE
CAS:384835-51-2
NSMZ-059
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 384835-51-2; 18:1 Biotinyl Cap PE; 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine-N-(cap biotinyl) (sodium salt); 1,2-Dioleoyl-sn-glycero-3-
18:1 BIOTINYL PE
CAS:384835-53-4
NSMZ-069
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 384835-53-4; 18:1 Biotinyl PE; 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine-N-(biotinyl) (sodium salt); 1,2-Dioleoyl-sn-glycero-3-phosphoe
18:1 BMP (R,R)
CAS:1246303-13-8
PHOZ-025
>99% BMP (contains 30% positional isomers)
lysobisphosphatidic acid; LBPA; sn-(1-oleoyl-2-hydroxy)-glycerol-3-phospho-sn-3'-(1'-oleoyl-2'-hydroxy)-glycerol (ammonium salt); 18:1 BMP (R,R); 1246303-13-8
18:1 BMP (S,R)
CAS:799268-67-0
PHOZ-022
>99% BMP (contains 30% positional isomers)
sn-(3-(9Z-octadecenoyl)-2-hydroxy)-glycerol-1-phospho-sn-3'-(1'-(9Z-octadecenoyl)-2'-hydroxy)-glycerol (ammonium salt); lysobisphosphatidic acid; LBPA; Bis(monooleoylglycero)phosphate (S,R Isomer) (ammonium salt); 18:1 BMP (S,R); 799268-67-0
18:1 BMP (S,S)
CAS:1246303-12-7
PHOZ-024
>99% BMP (contains 30% positional isomers)
lysobisphosphatidic acid; LBPA; sn-(3-oleoyl-2-hydroxy)-glycerol-1-phospho-sn-1'-(3'-oleoyl-2'-hydroxy)-glycerol (ammonium salt); 18:1 BMP (S,S); 1246303-12-7
18:1 CAPROYLAMINE PE
CAS:110796-31-1
NSMZ-086
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 110796-31-1; 18:1 Caproylamine PE; 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine-N-(hexanoylamine); 1,2-Dioleoyl-sn-glycero-3-phosphoethano
18:1 CARDIOLIPIN
CAS:115404-77-8
PHOZ-051
>99%
tetraoleoyl cardiolipin; 1,1',2,2'-tetra-(9Z-octadecenoyl) cardiolipin (sodium salt); CL(1'-[18:1(9Z)/18:1(9Z)],3'-[18:1(9Z)/18:1(9Z)]); 1',3'-Bis[1,2-dioleoyl-sn-glycero-3-phospho]-sn-glycerol (sodium salt); 18:1 Cardiolipin; 115404-77-8
18:1 CDP DG
CAS:799812-77-4
FLBZ-009
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; CDP-DAG Di-(9Z-octadecenoyl); Cytidine Diacylglycerol; 18:1 CDP DG; 799812-77-4; 1,2-Dioleoyl-sn-glycero-3-(cytidine diphosphate) (ammonium salt)
18:1 CYCLIC LPA
CAS:799268-72-7
PHOZ-182
>99%
1-(9Z-octadecenoyl)-sn-glycero-2,3-cyclic-phosphate (ammonium salt); 1-Oleoyl-sn-glycero-2,3-cyclic-phosphate (ammonium salt); 18:1 Cyclic LPA; 799268-72-7
18:1 DANSYL PE
CAS:474942-79-5
FLBZ-152
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 18:1 Dansyl PE; 474942-79-5; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-(5-dimethylamino-1-naphthalenesulfonyl) (ammonium salt)
18:1 DANSYL PS
CAS:474943-03-8
FLBZ-145
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 18:1 Dansyl PS; 474943-03-8; 1,2-Dioleoyl-sn-glycero-3-phospho-L-serine-N-(5-dimethylamino-1-naphthalenesulfonyl) (ammonium salt)
18:1 DGPP
CAS:474943-14-1
FLBZ-014
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 18:1 DGPP; 474943-14-1; Dioleoylglycerol pyrophosphate (ammonium salt)
18:1 DGS
CAS:127640-49-7
NSMZ-102
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 127640-49-7; 18:1 DGS; 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-succinate; dioleoylglycerolsuccinate; DOGS; dioleoylsuccinylglycerol; DOSG; 1,2-Dioleoyl-s
18:1 DGS-NTA
CAS:474942-78-4
NSMZ-067
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 474942-78-4; 18:1 DGS-NTA; 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-[(N-(5-amino-1-carboxypentyl)iminodiacetic acid)succinyl] (ammonium salt); DOGS NTA; 1
18:1 DGS-NTA(NI)
CAS:231615-77-3
NSMZ-062
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 231615-77-3; 18:1 DGS-NTA(Ni); 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-[(N-(5-amino-1-carboxypentyl)iminodiacetic acid)succinyl] (nickel salt); DOGS NTA;
18:1 DIETHER PC
CAS:105370-99-8
PHOZ-046
>99%
PC(18:1(9Z)e/18:1(9Z)e); 1,2-Di-O-(9Z-octadecenyl)-sn-glycero-3-phosphocholine; 18:1 Diether PC; 105370-99-8
18:1 DIMETHYL PE
CAS:96687-22-8
NSMZ-093
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 96687-22-8; 18:1 Dimethyl PE; 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine-N,N-dimethyl; phosphatidyldimethylethanolamine; PDME; 1,2-Dileo
18:1 DIMETHYLACETAL
CAS:15677-71-1
PHOZ-011
>99%
1,1-dimethoxy-(9Z)octadecene; 9Z-octadecenal-dimethylacetal; 18:1 dimethylacetal; 15677-71-1
18:1 DODECANYL PE
CAS:474923-47-2
NSMZ-072
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 474923-47-2; 18:1 Dodecanyl PE; 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine-N-(dodecanoyl) (sodium salt); 1,2-Dioleoyl-sn-glycero-3-phosp
18:1 DODECANYLAMINE PE
CAS:474944-10-0
NSMZ-076
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 474944-10-0; 18:1 Dodecanylamine PE; 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine-N-(dodecanoylamine); 1,2-Dioleoyl-sn-glycero-3-phosphoet
18:1 EPC (CL SALT)
CAS:474945-24-9
PCNZ-058
>99%
18:1 EPC (Cl Salt); 1,2-dioleoyl-sn-glycero-3-ethylphosphocholine (chloride salt); 474945-24-9; 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-ethylphosphocholine (chloride salt); EDOPC; DOPC+; Cationic Lipids; Transfection; lipid products; lipid
18:1 ETHYLENE GLYCOL
CAS:928-24-5
PCNZ-091
18:1 Ethylene Glycol; 1-2-dioleoyl ethylene glycol; 928-24-5; 1,2-di-(9Z-octadecenoyl) ethylene glycol DEG(18:1(9Z)/18:1(9Z)); neutral Lipids; lipid products; lipid
18:1 GLUTARYL PE
CAS:111516-02-0
NSMZ-082
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 111516-02-0; 18:1 Glutaryl PE; 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine-N-(glutaryl) (sodium salt); DOPE-GA; 1,2-Dioleoyl-sn-glycero-3
18:1 HEMI BMP (S,R)
CAS:474943-36-7
PHOZ-023
>99%
sn-(3-oleoyl-2-hydroxy)-glycerol-1-phospho-sn-3'-(1',2'-dioleoyl)-glycerol (ammonium salt); 18:1 Hemi BMP (S,R); 474943-36-7
18:1 LACTOSYL PE
CAS:474943-47-0
NSMZ-061
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 474943-47-0; 18:1 Lactosyl PE; 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine-N-lactosyl (ammonium salt); 1,2-Dioleoyl-sn-glycero-3-phosphoe
18:1 LISS RHOD PE
CAS:384833-00-5
FLBZ-133
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 18:1 Liss Rhod PE; 384833-00-5; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt)
18:1 LYSO PE
CAS:89576-29-4
PHOZ-145
>99% LPE; may contain up to 10% of the 2-LPE isome
1-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine; PE(18:1(9Z)/0:0); 1-Oleoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine; 18:1 Lyso PE; 89576-29-4
18:1 LYSO PG
CAS:326495-24-3
PHOZ-142
>99% LPG; may contain up to 10% of the 2-LPG isome
1-oleoy-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); PG(18:1(9Z)/0:0); 1-Oleoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); 18:1 Lyso PG; 326495-24-3
18:1 LYSO PI
CAS:1246298-13-4
PHOZ-087
>99% LPI; may contain up to 10% of the 2-LPI isome
1-(9Z-octadecenoyl)-2-hydroxy-sn-glycero-3-phosphoinositol (ammonium salt); PI(18:1(9Z)/0:0); 1-Oleoyl-2-hydroxy-sn-glycero-3-phospho-(1'-myo-inositol) (ammonium salt); 18:1 Lyso PI; 1246298-13-4
18:1 LYSO PS
CAS:326589-90-6
PHOZ-099
>99% LPS; may contain up to 10% of the 2-LPS isome
1-(9Z-octadecenoyl)-sn-glycero-3-phospho-L-serine (sodium salt); PS(18:1(9Z)/0:0); 18:1 LPS; C18:1 LPS; 1-Oleoyl-2-hydroxy-sn-glycero-3-phospho-L-serine (sodium salt); 18:1 Lyso PS; 326589-90-6
18:1 LYSYL PG
CAS:1246303-07-0
FLBZ-011
>99% (up to 15% acyl migration on lysine)
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; Lysyl-DOPG; 18:1 Lysyl PG; 1246303-07-0; 1,2-Dioleoyl-sn-glycero-3-[phospho-rac-(3-lysyl(1-glycerol))] (chloride salt)
18:1 MONOMETHYL PE
CAS:96687-23-9
NSMZ-096
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 96687-23-9; 18:1 Monomethyl PE; 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine-N-methyl; 1,2-Dileoyl-sn-glycero-3-phosphoethanolamine-N-meth
18:1 MPB PE
CAS:384835-49-8
NSMZ-068
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 384835-49-8; 18:1 MPB PE; 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine-N-[4-(p-maleimidophenyl)butyramide] (sodium salt); 1,2-Dioleoyl-sn-
18:1 NBD PE
CAS:384832-99-9
FLBZ-161
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 18:1 NBD PE; 384832-99-9; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt)
18:1 NBD PS
CAS:474943-02-7
FLBZ-153
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 18:1 NBD PS; 474943-02-7; 1,2-Dioleoyl-sn-glycero-3-phospho-L-serine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt)
18:1 PDP PE
CAS:474944-13-3
NSMZ-074
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 474944-13-3; 18:1 PDP PE; 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine-N-[3-(2-pyridyldithio)propionate] (sodium salt); 1,2-Dioleoyl-sn-gl
18:1 PE CF
CAS:799268-49-8
FLBZ-141
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 18:1 PE CF; 799268-49-8; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-(carboxyfluorescein) (ammonium salt)
18:1 PE MCC
CAS:384847-49-8
NSMZ-071
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 384847-49-8; 18:1 PE MCC; 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine-N-[4-(p-maleimidomethyl)cyclohexane-carboxamide] (sodium salt); 1,2
18:1 PE-N-20:4
CAS:1246304-42-6
FLBZ-007
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 18:1 PE-N-20:4; 1246304-42-6; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-arachidonoyl (ammonium salt)
18:1 PEG1000 PE
CAS:474922-90-2
PCNZ-040
>99%
18:1 PEG1000 PE; 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] (ammonium salt); 474922-90-2 ; MPEG 1000; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
18:1 PEG2000 PE
CAS:474922-90-2
PCNZ-036
>99%
18:1 PEG2000 PE; 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt); 474922-90-2 ; MPEG 2000; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
18:1 PEG3000 PE
CAS:474922-90-2
PCNZ-030
>99%
18:1 PEG3000 PE; 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] (ammonium salt); 474922-90-2; MPEG 3000; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
18:1 PEG350 PE
CAS:474922-90-2
PCNZ-051
>99%
18:1 PEG350 PE; 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] (ammonium salt); 474922-90-2; MPEG 350; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
18:1 PEG5000 PE
CAS:474922-90-2
PCNZ-026
>99%
18:1 PEG5000 PE; 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] (ammonium salt); 474922-90-2; MPEG 5000; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
18:1 PEG550 PE
CAS:474922-90-2
PCNZ-046
>99%
18:1 PEG550 PE; 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] (ammonium salt); 474922-90-2; MPEG 550; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
18:1 PEG750 PE
CAS:474922-90-2
PCNZ-043
>99%
18:1 PEG750 PE; 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-750] (ammonium salt); 474922-90-2; MPEG 750; click reagents; Polymers; Polymerizable Lipids; lipid products; lipid
18:1 PHOSPHATIDYLBUTANOL
CAS:384835-47-6
NSMZ-092
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 384835-47-6; 18:1 Phosphatidylbutanol; 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphobutanol (sodium salt); 1,2-Dileoyl-sn-glycero-3-phosphobutanol (sod
18:1 PHOSPHATIDYLETHANOL
CAS:322647-53-0
NSMZ-097
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 322647-53-0; 18:1 Phosphatidylethanol; 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanol (sodium salt); 1,2-Dileoyl-sn-glycero-3-phosphoethanol (sod
18:1 PHOSPHATIDYLMETHANOL
CAS:151379-99-6
NSMZ-098
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 151379-99-6; 18:1 Phosphatidylmethanol; 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphomethanol (sodium salt); 1,2-Dileoyl-sn-glycero-3-phosphomethanol (
18:1 PHOSPHATIDYLPROPANOL
CAS:384835-46-5
NSMZ-095
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 384835-46-5; 18:1 Phosphatidylpropanol; 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphopropanol (sodium salt); 1,2-Dileoyl-sn-glycero-3-phosphopropanol (
18:1 PI
CAS:799268-53-4
PHOZ-081
>99%
1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphoinositol (ammonium salt); DOPI; PI(18:1(9Z)/18:1(9Z)); 1,2-Dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol) (ammonium salt); 18:1 PI; 799268-53-4
18:1 PI(3)P
CAS:1246303-09-2
PHOZ-080
>99%
PIP[3'](18:1/18:1); 1,2-Dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol-3'-phosphate) (ammonium salt); 18:1 PI(3)P; 1246303-09-2
18:1 PI(3,4)P2
CAS:799268-54-5
PHOZ-077
>99%
1,2-di-(9Z-octadecenoyl)-sn-glycero-3-[phosphoinositol-3,4-bisphosphate] (ammonium salt); PIP2[3',4'](18:1(9Z)/18:1(9Z)); 1,2-Dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol-3',4'-bisphosphate) (ammonium salt); 18:1 PI(3,4)P2; 799268-54-5
18:1 PI(3,4,5)P3
CAS:799268-57-8
PHOZ-074
>99%
1,2-di-(9Z-octadecenoyl)-sn-glycero-3-[phosphoinositol-3,4,5-trisphosphate] (ammonium salt); PIP3[3',4',5'](18:1(9Z)/18:1(9Z)); 1,2-Dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol-3',4',5'-trisphosphate) (ammonium salt); 18:1 PI(3,4,5)P3; 799268-57-8
18:1 PI(3,5)P2
CAS:799268-55-6
PHOZ-076
>99%
1,2-di-(9Z-octadecenoyl)-sn-glycero-3-[phosphoinositol-3,5-bisphosphate] (ammonium salt); PIP2[3',5'](18:1(9Z)/18:1(9Z)); 1,2-Dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol-3',5'-bisphosphate) (ammonium salt); 18:1 PI(3,5)P2; 799268-55-6
18:1 PI(4)P
CAS:1803104-55-3
PHOZ-079
>99%
1,2-Dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol-4'-phosphate) (ammonium salt); 18:1 PI(4)P; 1803104-55-3
18:1 PI(4,5)P2
CAS:799268-56-7
PHOZ-075
>99%
1,2-di-(9Z-octadecenoyl)-sn-glycero-3-[phosphoinositol-4,5-bisphosphate] (ammonium salt); PIP2[4',5'](18:1(9Z)/18:1(9Z)); 1,2-Dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol-4',5'-bisphosphate) (ammonium salt); 18:1 PI(4,5)P2; 799268-56-7
18:1 PI(5)P
CAS:1246303-10-5
PHOZ-078
>99%
PIP[5'](18:1/18:1); 1,2-Dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol-5'-phosphate) (ammonium salt); 18:1 PI(5)P; 1246303-10-5
18:1 PS (DOPS)
CAS:90693-88-2
PHOZ-111
>99%
1,2-Dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt); 18:1 PS (DOPS); 90693-88-2
18:1 PTD ETHYLENE GLYCOL
CAS:474923-51-8
NSMZ-094
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 474923-51-8; 18:1 Ptd Ethylene Glycol; 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phospho(ethylene glycol) (sodium salt); 1,2-Dioleoyl-sn-Glycero-3-Phospho(
18:1 PYRENE PE
CAS:384832-93-3
FLBZ-150
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 18:1 Pyrene PE; 384832-93-3; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-(1-pyrenesulfonyl) (ammonium salt)
18:1 SUCCINYL PE
CAS:111613-33-3
NSMZ-084
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 111613-33-3; 18:1 Succinyl PE; 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine-N-(succinyl) (sodium salt); 1,2-Dioleoyl-sn-glycero-3-phosphoe
18:1(2R-OH) CERAMIDE
CAS:1246298-52-1
SPHZ-108
>99%
18:1(2R-OH) Ceramide; N-(2-(R)-hydroxyoleoyl)-D-erythro-sphingosine; 1246298-52-1
18:1(2S-OH) CERAMIDE
CAS:1246298-53-2
SPHZ-107
>99%
18:1(2S-OH) Ceramide; N-(2-(S)-hydroxyoleoyl)-D-erythro-sphingosine; 1246298-53-2
18:1-06:0 NBD PA
CAS:474942-97-7
FLBZ-207
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 18:1-06:0 NBD PA; 474942-97-7; 1-Oleoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphate (ammonium salt)
18:1-06:0 NBD PC
CAS:106974-05-4
FLBZ-191
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 18:1-06:0 NBD PC; 106974-05-4; 1-Oleoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphocholine
18:1-06:0 NBD PE
CAS:106918-68-7
FLBZ-200
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 18:1-06:0 NBD PE; 106918-68-7; 1-Oleoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphoethanolamine
18:1-06:0 NBD PG
CAS:474942-87-5
FLBZ-190
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 18:1-06:0 NBD PG; 474942-87-5; 1-Oleoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-[phospho-rac-(1-glycerol)] (ammonium salt)
18:1-06:0 NBD PS
CAS:384833-08-3
FLBZ-183
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 18:1-06:0 NBD PS; 384833-08-3; 1-Oleoyl-2-{6-[(7-nitro-2-1,3-benzoxaDiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphoserine (ammonium salt)
18:1-12:0 BIOTIN DG
CAS:799812-65-0
NSMZ-137
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 799812-65-0; 18:1-12:0 Biotin DG; 1-Oleoyl-2-[12-biotinyl(aminododecanoyl)]-sn-glycerol
18:1-12:0 BIOTIN PE
CAS:799812-67-2
NSMZ-125
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 799812-67-2; 18:1-12:0 Biotin PE; 1-Oleoyl-2-(12-biotinyl(aminododecanoyl))-sn-glycero-3-phosphoethanolamine
18:1-12:0 BIOTIN PIP3
CAS:799812-70-7
NSMZ-110
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 799812-70-7; 18:1-12:0 Biotin PIP3; 1-Oleoyl-2-[12-biotinyl(aminododecanoyl)]-sn-glycero-3-phosphoinositol-3,4,5-trisphosphate (sodium salt)
18:1-12:0 BIOTIN PS
CAS:799812-66-1
NSMZ-117
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 799812-66-1; 18:1-12:0 Biotin PS; 1-Oleoyl-2-(12-biotinyl(aminododecanoyl))-sn-glycero-3-phospho-L-serine (ammonium salt)
18:1-12:0 NBD PA
CAS:384833-04-9
FLBZ-186
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 18:1-12:0 NBD PA; 384833-04-9; 1-Oleoyl-2-{12-[(7-nitro-2-1,3-benzoxaDiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-phosphate (ammonium salt)
18:1-12:0 NBD PC
CAS:190792-36-0
FLBZ-167
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 18:1-12:0 NBD PC; 190792-36-0; 1-Oleoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-sn-Glycero-3-Phosphocholine
18:1-12:0 NBD PE
CAS:321594-90-5
FLBZ-176
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 18:1-12:0 NBD PE; 321594-90-5; 1-Oleoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-phosphoethanolamine
18:1-12:0 NBD PG
CAS:474942-88-6
FLBZ-166
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 18:1-12:0 NBD PG; 474942-88-6; 1-Oleoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-[phospho-rac-(1-glycerol)] (ammonium salt)
18:1-12:0 NBD PS
CAS:474943-00-5
FLBZ-164
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 18:1-12:0 NBD PS; 474943-00-5; 1-Oleoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-phosphoserine (ammonium salt)
18:1-14:0 PC
CAS:95896-56-3
PHOZ-228
>99%
1-(9Z-octadecenoyl)-2-tetradecanoyl-sn-glycero-3-phosphocholine; OMPC; PC(18:1(9Z)/14:0); 1-Oleoyl-2-myristoyl-sn-glycero-3-phosphocholine; 18:1-14:0 PC; 95896-56-3
18:2 LYSO PA
CAS:65528-85-0
PHOZ-190
>99% LPA; may contain up to 10% of the 2-LPA isome
1-(9Z,12Z-octadecadienoyl)-2-hydroxy-sn-glycero-3-phosphate (sodium salt); PA(18:2(9Z,12Z)/0:0); 1-Linoleoyl-2-hydroxy-sn-glycero-3-phosphate (sodium salt); 18:2 Lyso PA; 65528-85-0
18:2 PA
CAS:322647-62-1
PHOZ-203
>99%
1,2-di-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphate (sodium salt); PA(18:2(9Z,12Z)/18:2(9Z,12Z))?; 1,2-Dilinoleoyl-sn-glycero-3-phosphate (sodium salt); 18:2 PA; 322647-62-1
18:2 PE
CAS:20707-71-5
PHOZ-154
>99%
1,2-Dilinoleoyl-sn-glycero-3-phosphoethanolamine; 18:2 PE; 20707-71-5
18:2 PG
CAS:322729-38-4
PHOZ-124
>99%
1,2-di-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); PG(18:2(9Z,12Z)/18:2(9Z,12Z)); 1,2-Dilinoleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); 18:2 PG; 322729-38-4
18:2 PS
CAS:321883-39-0
PHOZ-108
>99%
1,2-di-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-L-serine (sodium salt); PS(18:2(9Z,12Z)/18:2(9Z,12Z)); 1,2-Dilinoleoyl-sn-glycero-3-phospho-L-serine (sodium salt); 18:2 PS; 321883-39-0
18:3 (CIS) PC
CAS:2701-19-1
PHOZ-234
>99%
1,2-Dilinolenoyl-sn-glycero-3-phosphocholine; 18:3 (Cis) PC; 2701-19-1
18:3 PE
CAS:34813-40-6
PHOZ-155
>99%
1,2-Dilinolenoyl-sn-glycero-3-phosphoethanolamine; 18:3 PE; 34813-40-6
18:3 PG
CAS:474943-20-9
PHOZ-123
>99%
1,2-di-(9Z,12Z,15Z-octadecatrienoyl)-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); PG(18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)); 1,2-Dilinolenoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); 18:3 PG; 474943-20-9
19:0 LYSO PC
CAS:108273-88-7
PHOZ-217
>99% LPC; may contain up to 10% of the 2-LPC isome
1-Nonadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine; 19:0 Lyso PC; 108273-88-7
19:0 PC
CAS:95416-27-6
PHOZ-241
>99%
1,2-Dinonadecanoyl-sn-glycero-3-phosphocholine; 19:0 PC; 95416-27-6
2-OHOA
CAS:1229114-68-4
FLBZ-107
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; Minerval; NaCHOleate; 2OHOA; 2-OHOA; 1229114-68-4; 2-Hydroxyoleic acid (sodium salt)
20:0 LYSO PC
CAS:108341-80-6
PHOZ-218
>99% LPC; may contain up to 10% of the 2-LPC isome
1-eicosanoyl-sn-glycero-3-phosphocholine; PC(20:0/0:0); 1-Arachidoyl-2-hydroxy-sn-glycero-3-phosphocholine; 20:0 Lyso PC; 108341-80-6
20:0(2R-OH) CERAMIDE
CAS:943147-54-4
SPHZ-110
>99%
20:0(2R-OH) Ceramide; N-(2-(R)-hydroxyarachidoyl)-D-erythro-sphingosine; 943147-54-4
20:0(2S-OH) CERAMIDE
CAS:1246298-48-5
SPHZ-109
>99%
20:0(2S-OH) Ceramide; N-(2-(S)-hydroxyarachidoyl)-D-erythro-sphingosine; 1246298-48-5
20:1 (CIS) PC
CAS:61596-54-1
PHOZ-235
>99%
1,2-Dieicosenoyl-sn-glycero-3-phosphocholine; 20:1 (Cis) PC; 61596-54-1
20:4 (CIS) PC
CAS:17688-29-8
PHOZ-236
>99%
1,2-Diarachidonoyl-sn-glycero-3-phosphocholine; 20:4 (Cis) PC; 17688-29-8
20:4 LYSO PA
CAS:799268-65-8
PHOZ-191
>99% LPA; may contain up to 10% of the 2-LPA isome
arachidonoyl lysophosphatidic acid1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphate (ammonium salt); PA(20:4(5Z,8Z,11Z,14Z)/0:0); 20:4 LPA; 1-Arachidonoyl-2-hydroxy-sn-glycero-3-phosphate (ammonium salt); 20:4 Lyso PA; 799268-65-8
20:4 LYSO PI
CAS:1246430-04-5
PHOZ-092
>99% LPI; may contain up to 10% of the 2-LPI isome
1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-2-hydroxy-sn-glycero-3-phospho-(1'-myo-inositol) (ammonium salt); PI(20:4(5Z,8Z,11Z,14Z)/0:0);; 1-Arachidonoyl-2-hydroxy-sn-glycero-3-phosphoinositol (ammonium salt); 20:4 Lyso PI; 1246430-04-5
20:4 PA
CAS:474943-33-4
PHOZ-204
>99%
1,2-di-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphate (sodium salt); DAPA; PA(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)); 1,2-Diarachidonoyl-sn-glycero-3-phosphate (sodium salt); 20:4 PA; 474943-33-4
20:4 PE
CAS:5634-86-6
PHOZ-157
>99%
1,2-di-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine; DAPE; PE(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)); 1,2-Diarachidonoyl-sn-glycero-3-phosphoethanolamine; 20:4 PE; 5634-86-6
20:4 PG
CAS:474943-21-0
PHOZ-122
>99%
1,2-Diarachidonoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (sodium salt); 20:4 PG; 474943-21-0
20:4 PS
CAS:474967-17-4
PHOZ-107
>99%
1,2-di-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-L-serine (sodium salt); DAPS; PS(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)); 1,2-Diarachidonoyl-sn-glycero-3-phospho-L-serine (sodium salt); 20:4 PS; 474967-17-4
21:0 PC
CAS:253685-28-8
PHOZ-242
>99%
1,2-Dihenarachidoyl-sn-glycero-3-phosphocholine; 21:0 PC; 253685-28-8
22(R)-HYDROXYCHOLESTEROL-D7
CAS:1246302-93-1
STEZ-057
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 22(R)-hydroxycholesterol-d7; cholest-5-ene-3?,22(R)-diol-d7; 25,26,26,26,27,27,27-heptadeuterocholest-5-ene-3?,22R-diol; 1246302-93-1
22(S)-HYDROXYCHOLESTEROL-D7
CAS:1246302-91-9
STEZ-058
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 22(S)-hydroxycholesterol-d7; cholest-5-ene-3?,22(S)-diol-d7; 25,26,26,26,27,27,27-heptadeuterocholest-5-ene-3?,22S-diol; 1246302-91-9
22:0 LYSO PC
CAS:125146-65-8
PHOZ-219
>99% LPC; may contain up to 10% of the 2-LPC isome
1-docosanoyl-sn-glycero-3-phosphocholine; PC(22:0/0:0); 1-Behenoyl-2-hydroxy-sn-glycero-3-phosphocholine; 22:0 Lyso PC; 125146-65-8
22:0(2R-OH) CERAMIDE
CAS:31417-10-4
SPHZ-112
>99%
22:0(2R-OH) Ceramide; N-(2-(R)-hydroxybehenoyl)-D-erythro-sphingosine; 31417-10-4
22:0(2S-OH) CERAMIDE
CAS:1246298-49-6
SPHZ-111
>99%
22:0(2S-OH) Ceramide; N-(2-(S)-hydroxybehenoyl)-D-erythro-sphingosine; 1246298-49-6
22:6 PA
CAS:474943-34-5
PHOZ-205
>99%
1,2-di-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphate (sodium salt); PA(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)); 1,2-Didocosahexaenoyl-sn-glycero-3-phosphate (sodium salt); 22:6 PA; 474943-34-5
22:6 PE
CAS:123284-81-1
PHOZ-156
>99%
1,2-di-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine; PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)); 1,2-Didocosahexaenoyl-sn-glycero-3-phosphoethanolamine; 22:6 PE; 123284-81-1
22:6 PG
CAS:474943-23-2
PHOZ-121
>99%
1,2-Didocosahexaenoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (sodium salt); 22:6 PG; 474943-23-2
22:6 PS
CAS:474943-19-6
PHOZ-106
>99%
1,2-di-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phospho-L-serine (sodium salt); PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)); 1,2-Didocosahexaenoyl-sn-glycero-3-phospho-L-serine (sodium salt); 22:6 PS; 474943-19-6
23:0 PC
CAS:112241-60-8
PHOZ-243
>99%
1,2-Ditricosanoyl-sn-glycero-3-phosphocholine; 23:0 PC; 112241-60-8
23:2 DIYNE PC [DC(8,9)PC]
CAS:76078-28-9
NSMZ-124
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 76078-28-9; 23:2 Diyne PC [DC(8,9)PC]; DC(8,9)PC; DC8,9PC; 1,2-Bis(10,12-tricosadiynoyl)-sn-glycero-3-phosphocholine
23:2 DIYNE PE [DC(8,9)PE]
CAS:144750-73-2
NSMZ-128
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 144750-73-2; 23:2 Diyne PE [DC(8,9)PE]; DC(8,9)PE; DC8,9PEDTPE; 1,2-Bis(10,12-tricosadiynoyl)-sn-glycero-3-phosphoethanolamine
24(R)-HYDROXYCHOLESTEROL
CAS:27460-26-0
STEZ-066
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 24(R)-hydroxycholesterol; cholest-5-ene-3?,24(R)-diol; 5-cholestene-3?,24-diol24-hydroxycholest-5-en-3-ol; 27460-26-0
24(R/S),25-EPOXYCHOLESTEROL
CAS:72542-49-5
STEZ-071
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 24(R/S),25-epoxycholesterol; 24(R/S),25-epoxycholesterol; 72542-49-5
24(R/S),25-EPOXYCHOLESTEROL-D6
CAS:1246302-86-2
STEZ-061
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 24(R/S),25-epoxycholesterol-d6; 24(R/S),25-epoxycholesterol-d6; 26,26,26,27,27,27-hexadeutero-24,25-epoxycholesterol; 1246302-86-2
24:0 LYSO PC
CAS:325171-59-3
PHOZ-220
>99% LPC; may contain up to 10% of the 2-LPC isome
1-tetracosanoyl-sn-glycero-3-phosphocholine; PC(24:0/0:0); 1-Lignoceroyl-2-hydroxy-sn-glycero-3-phosphocholine; 24:0 Lyso PC; 325171-59-3
24:0 PC
CAS:91742-11-9
PHOZ-244
>99%
1,2-Dilignoceroyl-sn-glycero-3-phosphocholine; 24:0 PC; 91742-11-9
24:0 SM
CAS:60037-60-7
SPHZ-097
>99%
24:0 SM (d18:1/24:0); C24 sphingomyelin; Lignoceroyl Sphingomyelin; N-(tetracosanoyl)-sphing-4-enine-1-phosphocholine; 24:0 SM; N-lignoceroyl-D-erythro-sphingosylphosphorylcholine; 60037-60-7
24:0(2R-OH) CERAMIDE
CAS:64655-47-6
SPHZ-114
>99%
24:0(2R-OH) Ceramide; N-(2-(R)-hydroxylignoceroyl)-D-erythro-sphingosine; 64655-47-6
24:0(2S-OH) CERAMIDE
CAS:112317-53-0
SPHZ-113
>99%
24:0(2S-OH) Ceramide; N-(2-(S)-hydroxylignoceroyl)-D-erythro-sphingosine; 112317-53-0
24:1 (CIS) PC
CAS:51779-96-5
PHOZ-237
>99%
1,2-Dinervonoyl-sn-glycero-3-phosphocholine; 24:1 (Cis) PC; 51779-96-5
24:1 SM
CAS:94359-13-4
SPHZ-098
>99%
24:1 SM (d18:1/24:1(15Z)); C24:1 sphingomyelin; Nervonoyl Sphingomyelin; N-(15Z-tetracosenoyl)-sphing-4-enine-1-phosphocholine; 24:1 SM; N-nervonoyl-D-erythro-sphingosylphosphorylcholine; 94359-13-4
24:1(2R-OH) CERAMIDE
CAS:1246298-50-9
SPHZ-116
>99%
24:1(2R-OH) Ceramide; N-(2-(R)-hydroxynervonoyl)-D-erythro-sphingosine; 1246298-50-9
24:1(2S-OH) CERAMIDE
CAS:1246298-51-0
SPHZ-115
>99%
24:1(2S-OH) Ceramide; N-(2-(S)-hydroxynervonoyl)-D-erythro-sphingosine; 1246298-51-0
24S,27-DIHYDROXYCHOLESTEROL
CAS:642093-75-2
STEZ-040
>90%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 24S,27-dihydroxycholesterol; (25S)-cholest-5-en-3b,24S,27-triol; 642093-75-2
25-HYDROXYCHOLESTEROL-3-SULFATE
CAS:884905-07-1
STEZ-017
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 25-hydroxycholesterol-3-sulfate; 25-hydroxycholesterol-3-sulfate (sodium salt); 5-cholesten-3beta, 25-diol 3-sulfate25HC3S; 884905-07-1
25-NBD CHOLESTEROL
CAS:105539-27-3
STEZ-010
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 25-NBD Cholesterol; 25-[N-[(7-nitro-2-1,3-benzoxadiazol-4-yl)methyl]amino]-27-norcholesterol; 105539-27-3
26:0 LYSO PC
CAS:1213783-80-2
PHOZ-221
>99% LPC; may contain up to 10% of the 2-LPC isome
1-hexacosanoyl-sn-glycero-3-phosphocholine; PC(26:0/0:0); 1-Hexacosanoyl-2-hydroxy-sn-glycero-3-phosphocholine; 26:0 Lyso PC; 1213783-80-2
27-HYDROXY CHOLESTENONE
CAS:56792-59-7
STEZ-072
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 27-hydroxy cholestenone; 27-hydroxy-4-cholesten-3-one; (25R)-cholest-4-ene, 26-hydroxy-3-oxo; 56792-59-7
3-DEOXY SPHINGOSINE
CAS:126624-36-0
SPHZ-168
>99%
3-deoxy sphingosine; (R,E)-2-aminooctadec-4-en-1-ol; 126624-36-0
3-OXO-4-CHOLESTENOIC ACID
CAS:309762-85-4
STEZ-051
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 3-oxo-4-cholestenoic acid; (25R)-cholest-4-en-26-oic acid, 3-oxo; cholest-4-en-3-one-27-oic acid; 309762-85-4
3?,7?-DIHYDROXY-5-CHOLESTENOIC ACID
CAS:1246298-66-7
STEZ-024
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 3?,7?-dihydroxy-5-cholestenoic acid; (25R)-cholest-5-en-26-oic acid, 3?,7?-hydroxy; 1246298-66-7
3?,7A-DIHYDROXY-5-CHOLESTENOIC ACID
CAS:115538-84-6
STEZ-025
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 3?,7a-dihydroxy-5-cholestenoic acid; (25R)-cholest-5-en-26-oic acid, 3?,7a-hydroxy; 115538-84-6
3?-HYDROXY-5-CHOLESTENOIC ACID
CAS:56845-87-5
STEZ-047
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 3?-hydroxy-5-cholestenoic acid; (25R)-cholest-5-en-26-oic acid, 3?-hydroxy; 27-cholestenoic acid; 56845-87-5
3?-HYDROXY-7-OXO-5-CHOLESTENOIC ACID
CAS:1246298-64-5
STEZ-028
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 3?-hydroxy-7-oxo-5-cholestenoic acid; (25R)-cholest-5-en-26-oic acid, 3?-hydroxy-7-oxo; 1246298-64-5
4-HNE-DIMETHYLACETAL
CAS:119009-01-7
FLBZ-116
>95% (Each vial contains 6.8mg which yields ~5.2mg
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 4R-HNE-DA; 4-HNE-Dimethylacetal; 119009-01-7; (E)-4R-hydroxynonenal-dimethylacetal
4E,14Z-SPHINGADIENE
CAS:25696-03-1
SPHZ-171
>99% sphingadiene; contains ~10% (4E,14E) isomer
Sphinga-4,14-diene; D-erythro-sphinga-4,14-diene; 4E,14Z-Sphingadiene; (2S,3R,4E,14Z)-2-aminooctadec-4,14-diene-1,3-diol; 25696-03-1
4ME 16:0 COENZYME A
CAS:146622-45-9
NSMZ-114
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 146622-45-9; 4ME 16:0 Coenzyme A; 1-(3,7,11,15-tetramethylhexadecanoyl) Coenzyme A; Diphytanoyl Coenzyme A (ammonium salt)
4ME 16:0 DIETHER DG
CAS:99341-19-2
PHOZ-038
>99%
archaeol; 1,2-di-(3,7,11,15-tetramethylhexadecyl)-sn-glycerol; DG(16:0(3me,7me,11me,15me)e/16:0(3me,7me,11me,15me)e)/0:0); 1,2-Di-O-phytanyl-sn-glycerol; 4ME 16:0 Diether DG; 99341-19-2
4ME 16:0 DIETHER PC
CAS:200715-69-1
PHOZ-047
>99%
1,2-di-(3,7,11,15-tetramethylhexadecyl)-sn-glycero-3-phosphocholine; GPCho(16:0(3me,7me,11me,15me)e/16:0(3me,7me,11me,15me)e); 1,2-Di-O-phytanyl-sn-glycero-3-phosphocholine; 4ME 16:0 Diether PC; 200715-69-1
4ME 16:0 DIETHER PE
CAS:150135-14-1
PHOZ-039
>99%
1,2-di-(3,7,11,15-tetramethylhexadecyl)-sn-glycero-3-phosphoethanolamine; GPEtn(16:0(3me,7me,11me,15me)e/16:0(3me,7me,11me,15me)e); 1,2-Di-O-phytanyl-sn-glycero-3-phosphoethanolamine; 4ME 16:0 Diether PE; 150135-14-1
4ME 16:0 NBD PE (NBD-DPHPE)
CAS:1246355-56-5
NSMZ-116
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 1246355-56-5; 4ME 16:0 NBD PE (NBD-DPhPE); NBD-DPhPE; 1,2-Diphytanoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium s
4ME 16:0 PA
CAS:474967-75-4
PHOZ-202
>99%
1,2-di-(3,7,11,15-tetramethylhexadecanoyl)-sn-glycero-3-phosphate (sodium salt); PA(16:0(3me,7me,11me,15me)/16:0(3me,7me,11me,15me)); 1,2-Diphytanoyl-sn-glycero-3-phosphate (sodium salt); 4ME 16:0 PA; 474967-75-4
4ME 16:0 PC
CAS:207131-40-6
PHOZ-240
>99%
1,2-di-(3,7,11,15-tetramethylhexadecanoyl)-sn-glycero-3-phosphocholine; PC(16:0(3me,7me,11me,15me)/16:0(3me,7me,11me,15me)); 1,2-Diphytanoyl-sn-glycero-3-phosphocholine; 4ME 16:0 PC; 207131-40-6
4ME 16:0 PE
CAS:201036-16-0
PHOZ-159
>99%
1,2-di-(3,7,11,15-tetramethylhexadecanoyl)-sn-glycero-3-phosphoethanolamine; PE(16:0(3me,7me,11me,15me)/16:0(3me,7me,11me,15me)); 1,2-Diphytanoyl-sn-glycero-3-phosphoethanolamine; 4ME 16:0 PE; 201036-16-0
4ME 16:0 PG
CAS:474967-73-2
PHOZ-120
>99%
1,2-di-(3,7,11,15-tetramethylhexadecanoyl)-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); PG(16:0(3me,7me,11me,15me)/16:0(3me,7me,11me,15me)); 1,2-Diphytanoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt); 4ME 16:0 PG; 474967-73-2
5-PAHSA
CAS:1481636-41-2
FLBZ-037
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 5-PAHSA; 1481636-41-2; 5-(Palmitoyloxy)octadecanoic acid
5-PAHSA-D9
CAS:1809226-17-2
FLBZ-035
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 5-PAHSA-d9; 1809226-17-2; 5-[((13,13,14,14,15,15,16,16,16-d9)Palmitoyl)hydroxy]-stearic acid
5?,6?-EPOXYCHOLESTANOL-D7
CAS:127684-06-4
STEZ-056
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 5?,6?-epoxycholestanol-d7; cholestanol, 5?,6?-epoxy-d7; 127684-06-4
5A,6?-DIHYDROXYCHOLESTANOL-D7
CAS:127684-07-5
STEZ-030
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 5a,6?-dihydroxycholestanol-d7; cholestane-3?,5a,6?-triol-d7; 3?,5a,6?-trihydroxycholestane (d7); 127684-07-5
5A,6A-EPOXYCHOLESTANOL-D7
CAS:127685-38-5
STEZ-055
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 5a,6a-epoxycholestanol-d7; cholestanol, 5a,6a-epoxy-d7; 127685-38-5
5A-7,24-CHOLESTADIENE
CAS:651-54-7
STEZ-080
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 5a-7,24-cholestadiene; 5a-cholesta-7,24-dien-3?-ol; 651-54-7
6A-HYDROXY-5A-CHOLESTANOL
CAS:41083-73-2
STEZ-064
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 6a-hydroxy-5a-cholestanol; 6a-hydroxy-5a-cholestane; 41083-73-2
6A-HYDROXY-5A-CHOLESTANOL-D7
CAS:1246302-83-9
STEZ-053
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 6a-hydroxy-5a-cholestanol-d7; 6a-hydroxy-5a-cholestane-d7; 1246302-83-9
7-DEHYDROCHOLESTEROL-D7
CAS:388622-58-0
STEZ-076
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 7-dehydrocholesterol-d7; 7-dehydrocholesterol-d7; 388622-58-0
7-KETO-25-HYDROXYCHOLESTEROL
CAS:64907-23-9
STEZ-046
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 7-keto-25-hydroxycholesterol; 3?,25-dihydroxy-5-cholesten-7-one; cholest-5-ene-7-one-3?,25-diol; 64907-23-9
7-KETO-27-HYDROXYCHOLESTEROL
CAS:240129-30-0
STEZ-048
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 7-keto-27-hydroxycholesterol; 3?,27-dihydroxy-5-cholesten-7-one; 240129-30-0
7?,27-DIHYDROXYCHOLESTEROL
CAS:240129-43-5
STEZ-043
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 7?,27-dihydroxycholesterol; 7?,27-dihydroxycholesterol; 240129-43-5
7A,24(S)-DIHYDROXYCHOLESTEROL
CAS:245523-67-5
STEZ-042
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 7a,24(S)-dihydroxycholesterol; 7a,24(S)-dihydroxycholesterol; cholest-5-ene-3?,7a,24(S)-triol; 245523-67-5
7A,25-DIHYDROXYCHOLESTEROL
CAS:64907-22-8
STEZ-038
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 7a,25-dihydroxycholesterol; 7a,25-dihydroxycholesterol; cholest-5-ene-3,7a,25-triol; 64907-22-8
7A,27-DIHYDROXY-4-CHOLESTEN-3-ONE
CAS:192187-67-0
STEZ-049
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 7a,27-dihydroxy-4-cholesten-3-one; 7a,27-dihydroxy-4-cholesten-3-one; 192187-67-0
7A,27-DIHYDROXYCHOLESTEROL
CAS:4725-24-0
STEZ-041
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 7a,27-dihydroxycholesterol; 7a,27-dihydroxycholesterol; 4725-24-0
7A-HYDROXY-3-OXO-4-CHOLESTENOIC ACID
CAS:1246298-65-6
STEZ-027
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 7a-hydroxy-3-oxo-4-cholestenoic acid; (25R)-cholest-4-en-26-oic acid, 7a-hydroxy-3-oxo; 1246298-65-6
7SS,25-DIHYDROXYCHOLESTEROL
CAS:64907-21-7
STEZ-039
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 7,25-dihydroxycholesterol; 7,25-dihydroxycholesterol; cholest-5-ene-3,7,25-triol; 64907-21-7
8(14)-DEHYDROCHOLESTEROL
CAS:177962-82-2
STEZ-081
>95%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; 8(14)-dehydrocholesterol; cholesta-5,8(14)-dien-3?-ol; 177962-82-2
9-PAHSA
CAS:1481636-31-0
FLBZ-038
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 9-PAHSA; 1481636-31-0; 9-(Palmitoyloxy)octadecanoic acid
9-PAHSA-D9
CAS:1809222-43-2
FLBZ-036
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 9-PAHSA-d9; 1809222-43-2; 9-[((13,13,14,14,15,15,16,16,16-d9)Palmitoyl)hydroxy]-stearic acid
A-MYCOLIC ACID (C80)
CAS:23040-84-8
FLBZ-006
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; a-mycolic acid (C80); 23040-84-8; a-Mycolic acid (C80)
A-MYCOLIC ACID, METHOXY CIS
CAS:23599-54-4
FLBZ-005
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; a-Mycolic acid, Methoxy cis; 23599-54-4; a-Mycolic acid, Methoxy cis
ACYL 06:0 NBD PA
CAS:477235-69-1
FLBZ-127
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; Acyl 06:0 NBD PA; 477235-69-1; 1-Acyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphate (ammonium salt)
ACYL 06:0 NBD PC
CAS:477226-30-5
FLBZ-125
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; Acyl 06:0 NBD PC; 477226-30-5; 1-Acyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphocholine
ACYL 06:0 NBD PE
CAS:477228-64-1
FLBZ-126
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; Acyl 06:0 NBD PE; 477228-64-1; 1-Acyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphoethanolamine
ACYL 06:0 NBD PG
CAS:477232-03-4
FLBZ-124
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; Acyl 06:0 NBD PG; 477232-03-4; 1-Acyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-[phospho-rac-(1-glycerol)] (ammonium salt)
ACYL 12:0 NBD PA
CAS:477238-25-8
FLBZ-123
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; Acyl 12:0 NBD PA; 477238-25-8; 1-Acyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-phosphate (ammonium salt)
ACYL 12:0 NBD PC
CAS:477227-33-1
FLBZ-121
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; Acyl 12:0 NBD PC; 477227-33-1; 1-Acyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-phosphocholine
ACYL 12:0 NBD PE
CAS:477229-86-0
FLBZ-122
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; Acyl 12:0 NBD PE; 477229-86-0; 1-Acyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-phosphoethanolamine
ACYL 12:0 NBD PG
CAS:477233-37-7
FLBZ-120
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; Acyl 12:0 NBD PG; 477233-37-7; 1-Acyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-[phospho-rac-(1-glycerol)] (ammonium salt)
ADAMANTANYL GLCCER
CAS:853992-70-8
SPHZ-004
>99%
AdaGlcCer; Adamantanyl GlcCer; N-(1-adamantaneacetyl)glucosylceramide; 853992-70-8
ADENOSINE 5'-TRIPHOSPHATE (ATP) DISODIUM SALT (USP GRADE)
CAS:56-65-5
ATPU-0100
>= 99%
ATP; ATP-Na2; ATP-II; ATP-2; Adenosine 5'-triphosphate (ATP) Disodium Salt
AFRICAN MANGO SEED EXTRACT
CAS:9005-80-5
EXTW-103
20% Phytoprotein By KJELDAHL, 10:1 By TLC
African Mango Seed Extract; 9005-80-5; Irvingia GabonensisSeed; plant extract
ANDROGRAPHIS EXTRACT (STANDARD)
CAS:5508-58-7
EXTW-013
50.0% Andrographolide HPLC
Andrographis Extract (Standard); 5508-58-7; C20H30O5
ANNATTO EXTRACT
CAS:542-40-5
EXTW-113
30%-70% Norbixin By HPLC
Annatto Extract; 542-40-5; Bixa orellana L.; plant extract
ARACHIDONIC ACID-ALKYNE
CAS:1219038-32-0
FLBZ-111
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; Arachidonic acid-alkyne; 1219038-32-0; 5Z,8Z,11Z,14Z-eicosatetraen-19-ynoic acid
ARACHIDONIC ACID-D11
CAS:1287387-84-1
FLBZ-108
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; Arachidonic acid-d11; 1287387-84-1; 5Z,8Z,11Z,14Z-eicosatetraenoic-16,16,17,17,18,18,19,19,20,20,20-d11 acid
AZELAOYL-PAF
CAS:354583-69-0
PHOZ-014
>99%
C16-09:0 (COOH) PC; 1-Hexadecyl-2-azelaoyl-sn-glycero-3-phosphocholine; Azelaoyl-PAF; 354583-69-0
BARBERRY EXTRACT
CAS:117-74-8
EXTW-127
60% Berberine by HPLC
Barberry Extract; 117-74-8; Berberis vulgaris L.; plant extract
BAYBERRY EXTRACT
CAS:529-44-2
EXTW-128
50%-98% Myricitrin by HPLC, 5-10:1 by TLC
Bayberry Extract; 529-44-2; Myrica rubra sieb. Et Zucc; plant extract
BEARBERRY EXTRACT
CAS:497-76-7
EXTW-178
6%-98% arbutin
Bearberry Extract; 497-76-7; Arctostaphylos Uva Ursi; plant extract
BIOTIN S1P
CAS:799812-63-8
FLBZ-250
>99%
BLACK SESAME SEED EXTRACT
CAS:607-80-7
EXTW-137
10%-98% Sesamin by HPLC, 5-10:1 by TLC
Black Sesame Seed Extract; 607-80-7; Sesamum indicum L.; plant extract
BRAIN EXTRACT POLAR
CAS:86088-88-2
NSMZ-044
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 86088-88-2; Brain Extract Polar; Brain Polar Lipid Extract (Porcine)
BRAIN LYSO PE
CAS:475995-55-2
PHOZ-165
>99% LPE; may contain up to 10% of the 2-LPE isome
L-a-lysophosphatidylethanolamine plasmalogen (Brain, Porcine); Brain Lyso PE; 475995-55-2
BRAIN LYSO PS
CAS:383907-66-2
PHOZ-097
>99% LPS; may contain up to 10% of the 2-LPS isome
L-a-lysophosphatidylserine (Brain, Porcine) (sodium salt); Brain Lyso PS; 383907-66-2
BRAIN PE
CAS:383907-18-4
PHOZ-167
>99%
L-a-phosphatidylethanolamine (Brain, Porcine); Brain PE; 383907-18-4
BRAIN PI(4)P
CAS:475995-51-8
PHOZ-056
>99%
L-a-phosphatidylinositol-4-phosphate (Brain, Porcine) (ammonium Salt); Brain PI(4)P; 475995-51-8
BRAIN PI(4,5)P2
CAS:383907-42-4
PHOZ-057
>99%
Brain PI(4,5)P2; L-a-phosphatidylinositol-4,5-bisphosphate (Brain, Porcine) (ammonium salt); Brain PI(4,5)P2; 383907-42-4
BRAIN PS
CAS:383907-32-2
PHOZ-116
>99%
L-a-phosphatidylserine (Brain, Porcine) (sodium salt); Brain PS; 383907-32-2
BRAIN SM
CAS:383907-91-3
SPHZ-086
>99%
18:0 SM; Octadecanoyl Sphingomyelin; N-octadecanoyl-D-erythro-sphingosylphosphorylcholine; N-(octadecanoyl)-sphing-4-enine-1-phosphocholine; Brain SM; Sphingomyelin (Brain, Porcine); 383907-91-3
BRAIN SPHINGOSINE
CAS:477243-03-1
SPHZ-173
>99%
Sphingosine 2S, 3R; D-erythro-Sphingosine; (2S,3R,4E)-2-aminooctadec-4-ene-1,3-diol; (2S,3R,4E)-2-amino-1,3-octadec-4-enediol; Brain Sphingosine; D-erythro-Sphingosine (Brain, Porcine); 477243-03-1
BURDOCK EXTRACT
CAS:20362-31-6
EXTW-181
10%-40% Arctiin, 10:1
Burdock Extract; 20362-31-6; Arctium lappal; plant extract
BURDOCK ROOT EXTRACT
CAS:20362-31-6
EXTW-084
10% Arctiin by HPLC, 10:1 by TLC
Burdock Root Extract; 20362-31-6; Arctium lappa L.; plant extract
BUTTERBUR EXTRACT
CAS:26577-85-5
EXTW-129
8% Petasins by HPLC
Butterbur Extract; 26577-85-5; Petasites Hybridus L.; plant extract
C10 BISPHOSPHONATE
CAS:15049-93-1
SPHZ-016
>99%
C10 bisphosphonate; 1-aminodecane-1,1-bisphosphonic acid; 15049-93-1
C11 CERAMIDE
CAS:1246355-58-7
FLBZ-213
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; N-[11-undecanoyl]-D-erythro-sphingosine; C11 Ceramide; 1246355-58-7; N-[11-(Dipyrrometheneboron difluoride)undecanoyl]-D-erythro-sphingosine
C11 DIHYDROCERAMIDE
CAS:1246355-59-8
FLBZ-211
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; N-[11-undecanoyl]-D-erythro-sphinganine; C11 Dihydroceramide; 1246355-59-8; N-[11-(Dipyrrometheneboron difluoride)undecanoyl]-D-erythro-sphinganine
C11 GALACTOSYL CERAMIDE
CAS:1246355-61-2
FLBZ-170
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; N-[11-undecanoyl]-D-galactosyl-?1-1-D-erythro-sphingosine; C11 Galactosyl Ceramide; 1246355-61-2; N-[11-(Dipyrrometheneboron difluoride)undecanoyl]-D-galactosyl-?1-1-D-erythro-sphingosine
C11 GLUCOSYL CERAMIDE
CAS:1246355-70-3
FLBZ-169
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; C11 Glucosyl Ceramide; 1246355-70-3; N-[11-(Dipyrrometheneboron difluoride)undecanoyl]-D-glucosyl-?1-1-D-erythro-sphingosine
C11 PHYTOSPHINGOSINE
CAS:1246355-60-1
FLBZ-206
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; N-[11-undecanoyl]-phytosphingosine; C11 Phytosphingosine; 1246355-60-1; N-[11-(dipyrrometheneboron difluoride)undecanoyl]-phytosphingosine
C11 SPHINGOMYELIN
CAS:886209-09-2
FLBZ-168
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; N-[11-undecanoyl]-D-erythro-sphingosine-1-phosphocholine; C11 Sphingomyelin; 886209-09-2; N-[11-(Dipyrrometheneboron difluoride)undecanoyl]-D-erythro-sphingosylphosphorylcholine
C12 CARNITINE
CAS:25518-54-1
FLBZ-103
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; C12 Carnitine; 25518-54-1; Lauroyl L-carnitine
C12 CERAMIDE-1-PHOSPHATE (D18:1/12:0)
CAS:799812-62-7
SPHZ-130
>99%
N-(dodecanoyl)-sphing-4-enine-1-phosphate; CerP(d18:1/12:0); C12 Ceramide-1-Phosphate (d18:1/12:0); N-lauroyl-ceramide-1-phosphate (ammonium salt); 799812-62-7
C12 DIHYDROCERAMIDE (D18:0/12:0)
CAS:197302-96-8
SPHZ-120
>99%
N-12:0 Sphinganine; C12 Sphinganine; C12 dihydrosphingosine; N-(dodecanoyl)-sphinganine; C12 Dihydroceramide (d18:0/12:0); N-lauroyl-D-erythro-sphinganine; 197302-96-8
C12 SPHINGOSYL PE (D17:1/12:0)
CAS:1246303-21-8
SPHZ-049
>99%
N-C12 Sphingosylphosphoethanolamine (C17 base); 2-ammonioethyl (2R,3S,E)-2-dodecanamido-3-hydroxyheptadec-4-enyl phosphate; C12 Sphingosyl PE (d17:1/12:0); N-lauroyl-D-erythro-sphingosyl phosphoethanolamine (C17 base); 1246303-21-8
C12-NBD GALACTOSYL CERAMIDE
CAS:474942-98-8
FLBZ-182
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; C12-NBD Galactosyl Ceramide; 474942-98-8; N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-galactosyl-?1-1-sphingosine
C12-NBD GLUCOSYL CERAMIDE
CAS:474943-01-6
FLBZ-181
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; C12-NBD Glucosyl Ceramide; 474943-01-6; N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-glucosyl-?1-1-sphingosine
C12-NBD L-THREO-SPHINGOSINE
CAS:474943-08-3
FLBZ-223
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; C12-NBD L-threo-Sphingosine; 474943-08-3; N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-L-threo-sphingosine
C12-NBD LACTOSYL CERAMIDE
CAS:474943-06-1
FLBZ-154
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; C12-NBD Lactosyl Ceramide; 474943-06-1; N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-lactosyl-?1-1-sphingosine
C12-NBD PHYTOSPHINGOSINE
CAS:388566-94-7
FLBZ-218
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; C12-NBD Phytosphingosine; 388566-94-7; N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-phytosphingosine
C12-NBD SPHINGANINE
CAS:474943-05-0
FLBZ-222
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; C12-NBD Sphinganine; 474943-05-0; N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-sphinganine
C12-NBD SPHINGOMYELIN
CAS:254117-01-6
FLBZ-180
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; C12-NBD Sphingomyelin; 254117-01-6; N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-sphingosine-1-phosphocholine
C12-NBD SPHINGOSINE (C17)
CAS:474942-94-4
FLBZ-226
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; C12-NBD Sphingosine (C17); 474942-94-4; N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-(C17)-sphingosine
C14 CERAMIDE (D18:1/14:0)
CAS:123408-74-2
SPHZ-138
>99%
N-(tetradecanoyl)-sphing-4-enine; C14 Ceramide (d18:1/14:0); N-myristoyl-D-erythro-sphingosine; 123408-74-2
C16 CERAMIDE-1-PHOSPHATE (D18:1/16:0)
CAS:1246303-22-9
SPHZ-131
>99%
N-(hexadecanoyl)-sphing-4-enine-1-phosphate; CerP(d18:1/16:0); C16 Ceramide-1-Phosphate (d18:1/16:0); N-palmitoyl-ceramide-1-phosphate (ammonium salt); 1246303-22-9
C16 CYCLIC LPA
CAS:799268-68-1
PHOZ-183
>99%
1-hexadecyl-sn-glycero-2,3-cyclic-phosphate (ammonium salt); 1-O-hexadecyl-sn-glycero-2,3-cyclic-phosphate (ammonium salt); C16 Cyclic LPA; 799268-68-1
C16 DIHYDROCERAMIDE (D18:0/16:0)
CAS:5966-29-0
SPHZ-121
>99%
N-16:0 Sphinganine; C16 Sphinganine; C16 dihydrosphingosine; N-(hexadecanoyl)-sphinganine; C16 Dihydroceramide (d18:0/16:0); N-palmitoyl-D-erythro-sphinganine; 5966-29-0
C16 DIHYDROCERAMIDE-1-PHOSPHATE (D18:0/16:0)
CAS:1246303-17-2
SPHZ-117
>99%
16:0 Sphinganine-1-phosphate (ammonium salt); CerP(d18:0/16:0); C16 Dihydroceramide-1-Phosphate (d18:0/16:0); N-palmitoyl-D-erythro-dihydroceramide-1-phosphate (ammonium salt); 1246303-17-2
C16 LPA
CAS:799279-66-6
PHOZ-192
>99% LPA; may contain up to 10% of the 2-LPA isome
1-hexadecyl-sn-glycero-3-phosphate (ammonium salt); PA(16:0e/0:0); 1-O-hexadecyl-2-hydroxy-sn-glycero-3-phosphate (ammonium salt); C16 LPA; 799279-66-6
C16 PEG2000 CERAMIDE
CAS:212116-78-4
PCNZ-023
>99%
C16 PEG2000 Ceramide; N-palmitoyl-sphingosine-1-{succinyl[methoxy(polyethylene glycol)2000]}; 212116-78-4; Polymers; Polymerizable Lipids; lipid products; lipid
C16 PEG5000 CERAMIDE
CAS:212116-78-4
PCNZ-020
C16 PEG5000 Ceramide; N-palmitoyl-sphingosine-1-{succinyl[methoxy(polyethylene glycol)5000]}; 212116-78-4; Polymers; Polymerizable Lipids; lipid products; lipid
C16 PEG750 CERAMIDE
CAS:212116-78-4
PCNZ-018
>99%
C16 PEG750 Ceramide ; N-palmitoyl-sphingosine-1-{succinyl[methoxy(polyethylene glycol)750]}; 212116-78-4; Polymers; Polymerizable Lipids; lipid products; lipid
C16(PLASM) LPC
CAS:97802-53-4
PHOZ-001
>99%
1-O-1'-(Z)-hexadecenyl-2-hydroxy-sn-glycero-3-phosphocholine; PC(O-16:1(1Z)/0:0); PC(16:0p/0:0); 1-(1Z-hexadecenyl)-sn-glycero-3-phosphocholine; C16(Plasm) LPC; 97802-53-4
C16-04:0 PC
CAS:85405-03-4
FLBZ-034
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; PC(16:0e/4:0); C16:0-04:0 PAF; C16-04:0 PC; 85405-03-4; 1-O-hexadecyl-2-butyryl-sn-glycero-3-phosphocholine
C16-18:1 PC
CAS:95403-34-2
FLBZ-015
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 1-O-hexadecyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine; PC(16:0e/18:1(9Z)); C16:0-18:1 PAF; C16-18:1 PC; 95403-34-2; 1-O-hexadecyl-2-oleoyl-sn-glycero-3-phosphocholine
C16-UREA-CERAMIDE
CAS:361450-27-3
SPHZ-002
>99%
D-erythro-C16-urea-ceramide; C16-Urea-Ceramide; D-erythro-N-[2-(1,3-dihydroxy-4E-octadecene)]-N'-hexadecane-urea; 361450-27-3
C17 LYSO PAF
CAS:111858-52-7
FLBZ-049
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 1-O-heptadecyl-2-hydroxy-sn-glycero-3-phosphocholine; PC(17:0e/0:0); C17 Lyso PAF; 111858-52-7; 1-O-heptadecyl-2-hydroxy-sn-glycero-3-phosphocholine
C17:1 ANANDAMIDE
CAS:1094209-17-2
FLBZ-110
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 17:1 ethanolamide; C17:1 Anandamide; 1094209-17-2; 10Z-heptadecenoylethanolamide
C18 CERAMIDE (D17:1/18:0)
CAS:123065-42-9
SPHZ-140
>99%
N-(octadecanoyl)-sphing-4-enine (C17 base); C18 Ceramide (d17:1/18:0); N-stearoyl-D-erythro-sphingosine (C17 base); 123065-42-9
C18 LPA
CAS:799279-67-7
PHOZ-193
>99% LPA; may contain up to 10% of the 2-LPA isome
1-octadecyl-sn-glycero-3-phosphate (ammonium salt); PA(18:0e/0:0); 1-O-octadecyl-2-hydroxy-sn-glycero-3-phosphate (ammonium salt); C18 LPA; 799279-67-7
C18(PLASM) LPC
CAS:97802-55-6
PHOZ-002
>99%
PC(18:1p/0:0); 1-O-1'-(Z)-octadecenyl-2-hydroxy-sn-glycero-3-phosphocholine; C18(Plasm) LPC; 97802-55-6
C18(PLASM) LPE
CAS:174062-73-8
PHOZ-005
>99%
PE(18:1p/0:0); 1-O-1'-(Z)-octadecenyl-2-hydroxy-sn-glycero-3-phosphoethanolamine; C18(Plasm) LPE; 174062-73-8
C18(PLASM)-18:1 PC
CAS:799268-63-6
PHOZ-003
>99%
1-O-1'-(Z)-octadecenyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine; GPCho(18:0p/18:1(9Z)); 1-(1Z-octadecenyl)-2-oleoyl-sn-glycero-3-phosphocholine; C18(Plasm)-18:1 PC; 799268-63-6
C18(PLASM)-18:1 PE
CAS:144371-68-6
PHOZ-007
>99%
1-O-1'-(Z)-octadecenyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine; GPEtn(18:0p/18:1(9Z)); 1-(1Z-octadecenyl)-2-oleoyl-sn-glycero-3-phosphoethanolamine; C18(Plasm)-18:1 PE; 144371-68-6
C18(PLASM)-20:4 PC
CAS:97802-56-7
PHOZ-004
>99%
1-O-1'-(Z)-octadecenyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphocholine; GPCho(18:0p/20:4(5Z,8Z,11Z,14Z)); 1-(1Z-octadecenyl)-2-arachidonoyl-sn-glycero-3-phosphocholine; C18(Plasm)-20:4 PC; 97802-56-7
C18(PLASM)-20:4 PE
CAS:144371-69-7
PHOZ-008
>99%
1-O-1'-(Z)-octadecenyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine; GPEtn(18:0p/20:4(5Z,8Z,11Z,14Z)); 1-(1Z-octadecenyl)-2-arachidonoyl-sn-glycero-3-phosphoethanolamine; C18(Plasm)-20:4 PE; 144371-69-7
C18(PLASM)-22:6 PC
CAS:799268-64-7
PHOZ-006
>99%
1-O-1'-(Z)-octadecenyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine; GPCho(18:0p/22:6(4Z,7Z,10Z,13Z,16Z,19Z)); 1-(1Z-octadecenyl)-2-docosahexaenoyl-sn-glycero-3-phosphocholine; C18(Plasm)-22:6 PC; 799268-64-7
C18(PLASM)-22:6 PE
CAS:206059-98-5
PHOZ-009
>99%
1-O-1'-(Z)-octadecenyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine; GPEtn(18:0p/22:6(4Z,7Z,10Z,13Z,16Z,19Z)); 1-(1Z-octadecenyl)-2-docosahexaenoyl-sn-glycero-3-phosphoethanolamine; C18(Plasm)-22:6 PE; 206059-98-5
C18-04:0 PC
CAS:83526-67-4
FLBZ-030
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; PC(18:0e/4:0)C18:0-04:0 PAF; C18-04:0 PC; 83526-67-4; 1-O-octadecyl-2-butyryl-sn-glycero-3-phosphocholine
C18:1 ANANDAMIDE
CAS:7545-20-2
FLBZ-105
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; oleoylethanolamide; (9Z-octadecenoyl)ethanolamide; 9-cis-octadecenoylethanolamide; N-?(2-?hydroxyethyl)-?9Z-?octadecenamide; OEA; C18:1 Anandamide; 7545-20-2; 9Z-octadecenoylethanolamide
C18:1 ANANDAMIDE PHOSPHATE
CAS:211184-88-2
FLBZ-072
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; C18:1 anandamide phosphate; 211184-88-2; Oleoyl ethanolamide phosphate (sodium salt)
C18:1 CERAMIDE (D17:1/18:1(9Z))
CAS:352518-73-1
SPHZ-141
>99%
N-(9Z-octadecenoyl)-sphing-4-enine (C17 base); C18:1 Ceramide (d17:1/18:1(9Z)); N-oleoyl-D-erythro-sphingosine (C17 base); 352518-73-1
C18:1 CERAMIDE-1-PHOSPHATE (D18:1/18:1(9Z))
CAS:1246304-33-5
SPHZ-133
>99%
C18:1 Ceramide-1-Phosphate (d18:1/18:1(9Z)); N-oleoyl-ceramide-1-phosphate (ammonium salt); 1246304-33-5
C18:1 CYCLIC LPA
CAS:799268-69-2
PHOZ-184
>99%
1-O-octadecenyl-sn-glycero-2,3-cyclic-phosphate (ammonium salt); AGP 18:1; 1-O-(9Z-octadecenyl)-sn-glycero-2,3-cyclic-phosphate (ammonium salt); C18:1 Cyclic LPA; 799268-69-2
C18:1 DIHYDROCERAMIDE (D18:0/18:1(9Z))
CAS:34227-83-3
SPHZ-122
>99%
N-18:1 Sphinganine; C18:1 Sphinganine; C18:1 dihydrosphingosine; N-(9Z-octadecenoyl)-sphinganine; C18:1 Dihydroceramide (d18:0/18:1(9Z)); N-oleoyl-D-erythro-sphinganine; 34227-83-3
C18:1 LPA
CAS:799279-68-8
PHOZ-194
>99% LPA; may contain up to 10% of the 2-LPA isome
1-O-9-(Z)-octadecenyl-sn-glycero-3-phosphate (ammonium salt); PA(18:1(9Z)e/0:0); 1-(9Z-octadecenyl)-2-hydroxy-sn-glycero-3-phosphate (ammonium salt); C18:1 LPA; 799279-68-8
C18:1 LYSO PAF
CAS:87907-66-2
FLBZ-047
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 1-O-oleyl-sn-glycero-3-phosphocholine; PC(18:1(9Z)e/0:0); C18:1 Lyso PAF; 87907-66-2; 1-O-(9Z)octadecenyl-2-hydroxy-sn-glycero-3-phosphocholine
C2 CERAMIDE (D17:1/2:0)
CAS:474943-96-9
SPHZ-136
>99%
N-(acetoyl)-sphing-4-enine (C17 base); C2 Ceramide (d17:1/2:0); N-acetoyl-D-erythro-sphingosine (C17 base); 474943-96-9
C2 CERAMIDE (D18:1/2:0)
CAS:195194-58-2
SPHZ-135
>99%
N-(acetoyl)-sphing-4-enine; C2 Ceramide (d18:1/2:0); N-acetoyl-D-erythro-sphingosine; 195194-58-2
C2 CERAMIDE-1-PHOSPHATE (D17:1/2:0)
CAS:474944-02-0
SPHZ-127
>99%
CerP(d17:1/2:0); C2 Ceramide-1-Phosphate (d17:1/2:0); N-acetoyl-ceramide-1-phosphate (C17 base) (ammonium salt); 474944-02-0
C2 CERAMIDE-1-PHOSPHATE (D18:1/2:0)
CAS:474943-68-5
SPHZ-126
>99%
N-(acetoyl)-sphing-4-enine-1-phosphate; CerP(d18:1/2:0); C2 Ceramide-1-Phosphate (d18:1/2:0); N-acetoyl-ceramide-1-phosphate (ammonium salt); 474943-68-5
C2 DIHYDROCERAMIDE (D18:0/2:0)
CAS:13031-64-6
SPHZ-119
>99%
N-02:0 Sphinganine; C2 Sphinganine; C2 dihydrosphingosine; N-(acetoyl)-sphinganine; C2 Dihydroceramide (d18:0/2:0); N-acetoyl-D-erythro-sphinganine; 13031-64-6
C20 CERAMIDE (D17:1/20:0)
CAS:474944-00-8
SPHZ-143
>99%
N-(eicosanoyl)-sphing-4-enine (C17 base); C20 Ceramide (d17:1/20:0); N-arachidoyl-D-erythro-sphingosine (C17 base); 474944-00-8
C20 CERAMIDE (D18:1/20:0)
CAS:123482-93-9
SPHZ-142
>99%
N-(eicosanoyl)-sphing-4-enine; C20 Ceramide (d18:1/20:0); N-arachidoyl-D-erythro-sphingosine; 123482-93-9
C20:4 ANANDAMIDE (AEA)
CAS:913692-69-0
FLBZ-102
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 20:4 ethanolamide; N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)ethanolamine; 5,8,11,14-cis-eicosatetraenoylethanolamide; AEA; C20:4 Anandamide (AEA); 913692-69-0; 5Z,8Z,11Z,14Z-eicosatetraenoylethanolamide
C22 CERAMIDE (D18:1/22:0)
CAS:27888-44-4
SPHZ-144
>99%
C22 Ceramide (d18:1/22:0); N-behenoyl-D-erythro-sphingosine; 27888-44-4
C24 CERAMIDE (D17:1/24:0)
CAS:123065-50-9
SPHZ-147
>99%
N-(tetracosanoyl)-sphing-4-enine (C17 base); C24 Ceramide (d17:1/24:0); N-lignoceroyl-D-erythro-sphingosine (C17 base); 123065-50-9
C24 CERAMIDE (D18:1/24:0)
CAS:102917-80-6
SPHZ-146
>99%
N-(tetracosanoyl)-sphingosine; N-(tetracosanoyl)-sphing-4-enine; CER(NS); CER2(C24); C24 Ceramide (d18:1/24:0); N-lignoceroyl-D-erythro-sphingosine; 102917-80-6
C24 CERAMIDE-1-PHOSPHATE (D18:1/24:0)
CAS:1246303-20-7
SPHZ-134
>99%
N-(tetracosanoyl)-sphing-4-enine-1-phosphate CerP(d18:1/24:0); C24 Ceramide-1-Phosphate (d18:1/24:0); N-lignoceroyl-ceramide-1-phosphate (ammonium salt); 1246303-20-7
C24 DIHYDROCERAMIDE (D18:0/24:0)
CAS:6063-36-1
SPHZ-123
>99%
N-24:0 Sphinganine; C24 Sphinganine; C24 dihydrosphingosine; N-(tetracosanoyl)-sphinganine; C24 Dihydroceramide (d18:0/24:0); N-lignoceroyl-D-erythro-sphinganine; 6063-36-1
C24 DIHYDROCERAMIDE-1-PHOSPHATE (D18:0/24:0)
CAS:1246303-18-3
SPHZ-118
>99%
24:0 Sphinganine-1-phosphate (ammonium salt); CerP(d18:0/24:0); C24 Dihydroceramide-1-Phosphate (d18:0/24:0); N-lignoceroyl-D-erythro-dihydroceramide-1-phosphate (ammonium salt); 1246303-18-3
C24:1 CERAMIDE (D17:1/24:1(15Z))
CAS:352518-77-5
SPHZ-148
>99%
N-(15Z-tetracosenoyl)-sphing-4-enine (C17 base); C24:1 Ceramide (d17:1/24:1(15Z)); N-nervonoyl-D-erythro-sphingosine (C17 base); 352518-77-5
C24:1 DIHYDROCERAMIDE (D18:0/24:1(15Z))
CAS:352518-80-0
SPHZ-124
>99%
N-24:1 Sphinganine; C24:1 Sphinganine; C24:1 dihydrosphingosine; N-(15Z-tetracosenoyl)-sphinganine; C24:1 Dihydroceramide (d18:0/24:1(15Z)); N-nervonoyl-D-erythro-sphinganine; 352518-80-0
C6-NBD GALACTOSYL CERAMIDE
CAS:170212-26-7
FLBZ-205
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; C6-NBD Galactosyl Ceramide; 170212-26-7; N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-galactosyl-?1-1-sphingosine
C6-NBD GLUCOSYL CERAMIDE
CAS:94885-03-7
FLBZ-204
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; C6-NBD Glucosyl Ceramide; 94885-03-7; N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-glucosyl-?1-1-sphingosine
C6-NBD LACTOSYL CERAMIDE
CAS:474943-04-9
FLBZ-165
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; C6-NBD Lactosyl Ceramide; 474943-04-9; N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-lactosyl-?1-1-sphingosine
C6-NBD PHYTOSPHINGOSINE
CAS:477239-93-3
FLBZ-232
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; C6-NBD Phytosphingosine; 477239-93-3; N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]Hexanoyl]-phytosphingosine
C6-NBD SAFINGOL
CAS:114301-98-3
FLBZ-234
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; C6-NBD Safingol; 114301-98-3; N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-L-threo-sphinganine
C6-NBD SPHINGANINE
CAS:114301-97-2
FLBZ-235
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; C6-NBD Sphinganine; 114301-97-2; N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-sphinganine
C6-NBD SPHINGOSINE (C17)
CAS:474942-92-2
FLBZ-237
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; C6-NBD Sphingosine (C17); 474942-92-2; N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-(C17)-sphingosine
C6-PYRIDINIUM-CERAMIDE
CAS:853992-70-8
SPHZ-003
>99%
D-erythro-C6-pyridinium-ceramide; LCL29; C6-Pyridinium-Ceramide; D-erythro-2-N-[6'-(1 -pyridinium)-hexanoyl]-sphingosine bromide; 853992-70-8
C6-UREA-CERAMIDE
CAS:486991-52-0
SPHZ-001
>99%
D-erythro-C6-urea-ceramide; C6-Urea-Ceramide; D-erythro-N-[2-(1,3-dihydroxy-4E-octadecene)]-N'-hexane-urea-sphingosine; 486991-52-0
C8 CERAMIDE (D17:1/8:0)
CAS:474943-98-1
SPHZ-137
>99%
N-(octanoyl)-sphing-4-enine (C17 base); C8 Ceramide (d17:1/8:0); N-octanoyl-D-erythro-sphingosine (C17 base); 474943-98-1
C8 CERAMIDE-1-PHOSPHATE (D17:1/8:0)
CAS:474944-04-2
SPHZ-129
>99%
CerP(d17:1/8:0); C8 Ceramide-1-Phosphate (d17:1/8:0); N-octanoyl-ceramide-1-phosphate (C17 base) (ammonium salt); 474944-04-2
C8 CERAMIDE-1-PHOSPHATE (D18:1/8:0)
CAS:474943-70-9
SPHZ-128
>99%
N-(octanoyl)-sphing-4-enine-1-phosphate; CerP(d18:1/8:0); C8 Ceramide-1-Phosphate (d18:1/8:0); N-octanoyl-ceramide-1-phosphate (ammonium salt); 474943-70-9
C8 PEG2000 CERAMIDE
CAS:212116-76-2
PCNZ-022
>99%
C8 PEG2000 Ceramide; N-octanoyl-sphingosine-1-{succinyl[methoxy(polyethylene glycol)2000]}; 212116-76-2; Polymers; Polymerizable Lipids; lipid products; lipid
C8 PEG5000 CERAMIDE
CAS:212116-76-2
PCNZ-021
>99%
C8 PEG5000 Ceramide; N-octanoyl-sphingosine-1-{succinyl[methoxy(polyethylene glycol)5000]}; 212116-76-2; Polymers; Polymerizable Lipids; lipid products; lipid
C8 PEG750 CERAMIDE
CAS:212116-76-2
PCNZ-019
>99%
C8 PEG750 Ceramide; N-octanoyl-sphingosine-1-{succinyl[methoxy(polyethylene glycol)750]}; 212116-76-2; Polymers; Polymerizable Lipids; lipid products; lipid
CALENDULA EXTRACT
CAS:144-68-3
EXTW-121
5% Zeaxanthin By HPLC
Calendula Extract; 144-68-3; Calendula officinalis L.; plant extract
CERAMIDE (BRAIN)
CAS:497156-25-9
SPHZ-150
>99%
C18; CeramideN-octadecanoyl-D-erythro-sphingosine; N-(octadecanoyl)-sphing-4-enine; Ceramide (Brain); Ceramide (Brain, Porcine); 497156-25-9
CERAMIDE (EGG)
CAS:477243-06-4
SPHZ-149
>99%
C16 Ceramide; N-hexadecanoyl-D-erythro-sphingosine; N-(hexadecanoyl)-sphing-4-enine; Ceramide (Egg); Ceramide (Egg, Chicken); 477243-06-4
CEREBROSIDES (BRAIN)
CAS:383906-25-0
SPHZ-083
>99%
Cerebrosides (Brain); Total Cerebrosides (Brain, Porcine); 383906-25-0
CHITIN FROM CRAB SHELL
CAS:1398-61-4
CHIT-001
0.99
Poly-(1?4)--N-acetyl-D-glucosamine; 1398-61-4; Chitin
CHOL-C10-PC
CAS:1389265-82-0
STEZ-005
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; Chol-C10-PC; 10-cholesteryloxy decylphosphocholine; 1389265-82-0
CHOL-PEG600
CAS:27321-96-6
PCNZ-002
>99%
Chol-PEG600; Cholesterol-(polyethylene glycol-600); 27321-96-6; Polymers; Polymerizable Lipids; lipid products; lipid
CHOLESTEROL
CAS:878557-19-8
FLBZ-249
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; Bodipy CholesterolBdp-Chol; Cholesterol; 878557-19-8; 23-(Dipyrrometheneboron difluoride)-24-norcholesterol
CHOLESTEROL LINOLEATE
CAS:604-33-1
CHL-0100
>97.0%
3-Hydroxy-5-cholestene 3-linoleate; 5-Cholesten-3-ol 3-linoleate; Cholesteryl 9,12-octadecadienoate; Cholesteryl octadecadienoate; Linoleic Acid Cholesterol Ester
CIS-4-METHYLSPHINGOSINE
CAS:1407154-31-7
SPHZ-032
>99%
cis-4M-Sph; cis-4-methylsphingosine; cis-4-methylsphingosine; 1407154-31-7
CNIDIUM MONNIERI EXTRACT (STANDARD)
CAS:484-12-8
EXTW-022
10.0% Osthole HPLC
Cnidium Monnieri Extract (Standard); 484-12-8; C15H16O3
CONCANAVALIN A FROM THE JACK BEAN
CAS:11028-71-0
CONA-0100
Con A; Concanavalin A
COQ8
CAS:2394-68-5
PCNZ-081
>99%
CoQ8; Coenzyme Q8 (E. coli); 2394-68-5; Ubiquinone-40; Ubiquinone-Q8; Ubiquinone-8; neutral Lipids; lipid products; lipid
CORN SYRUP
CAS:8029-43-4
CSYC-001
Syrups; hydrolyzed starch; Corn sugar syrup; Corn syrup
D(+)-GLUCOSE
CAS:50-99-7
DGLC-001
Dextrose; D(+)-Glucose; Glucose
D-GLUCOSAMINE HYDROCHLORIDE
CAS:66-84-2
GLU-001
D-(+)-Glucosamine hydrochloride; 2-Amino-2-deoxy-D-glucose hydrochloride; Chitosamine hydrochloride; 66-84-2; C6H13NO5HCl
D-GLUCOSAMINE SULFATE POTASSIUM CHLORIDE
CAS:31284-96-5
GLU-002
D-Glucosamine Sulfate Potassium Chloride; Glucosamine Sulfate Potassium Chloride; Glucosamine; Sulfate Potassium Chloride
D-GLUCOSAMINE SULFATE SODIUM CHLORIDE
CAS:38899-05-7
GLU-003
Sulfate sodium chloride; D-Glucosamine Sulfate Sodium Chloride; Glucosamine Sulfate Sodium Chloride; Glucosamine
D-RIBO-PHYTOSPHINGOSINE
CAS:388566-94-7
SPHZ-044
>99%
(2S, 3S, 4R)-2-amino-1,3,4-octadecanetriol; D-ribo-Phytosphingosine; 4-hydroxysphinganine (Saccharomyces Cerevisiae); 388566-94-7
D-RIBO-PHYTOSPHINGOSINE(C17 BASE)
CAS:40289-37-0
SPHZ-042
>99%
(2S, 3S, 4R)-2-amino-1,3,4-heptadecanetriol; D-ribo-phytosphingosine(C17 base); 4-hydroxysphinganine (C17 base); 40289-37-0
D-RIBO-PHYTOSPHINGOSINE-1-PHOSPHATE
CAS:383908-62-1
SPHZ-043
>99%
Phytosphingosine 2S, 3S, 4R-1-Phosphate (Saccharomyces Cerevisiae); (2S, 3S, 4R)-2-amino-1,3,4-octadecanetriol-1-phosphate; D-ribo-Phytosphingosine-1-Phosphate; 4-hydroxysphinganine-1-phosphate (Saccharomyces Cerevisiae); 383908-62-1
D-THREO-PPMP
CAS:139889-53-5
SPHZ-019
>99%
PPMP; D-threo-PPMP; 1R,2R-(+)-1-phenyl-2-palmitoylamino-3-N-morpholine-1-propanol; 139889-53-5
DCHEMSPC
CAS:1155878-69-5
PHOZ-029
>99%
DCholPC; 1,2-Dicholesterylhemisuccinoyl-sn-glycero-3-phosphocholine; DChemsPC; 1155878-69-5
DGDG
CAS:63142-69-8
FLBZ-002
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 1,2-diacyl-3-O-(a-D-galactosyl1-6)--D-galactosyl-sn-glycerol; DGDG; 63142-69-8; Digalactosyldiacylglycerol (Plant)
DGTS
CAS:1607456-57-4
FLBZ-017
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; DGTS; 1607456-57-4; 1,2-Dipalmitoyl-sn-glycero-3-O-4-(N,N,N-trimethyl)-homoserine
DHEA SULFATE
CAS:651-48-9
STEZ-078
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; DHEA sulfate; Dehydroepiandrosterone sulfate (sodium salt); DHEA sulfateDHEASDHEA-S3-hydroxy-5-androsten-17-one 3-sulfate (sodium salt)5-androsten-3-ol-17-one sulfate (sodium salt)Prasterone sulfate (sodium salt); 651-48-9
DIHYDROLANOSTEROL
CAS:911660-54-3
STEZ-029
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; dihydrolanosterol; 24,25-dihydrolanosterol; LanostenolLanost-8-en-3b-ol5a-Lanost-8-en-3b-olDHL; 911660-54-3
DILYSO HEART CA
CAS:383907-65-1
NSMZ-004
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 383907-65-1; Dilyso Heart CA; Dilysocardiolipin (Heart, Bovine) (sodium salt)
DIMETHYL SPHINGANINE (D18:0)
CAS:17267-46-8
SPHZ-153
>99%
sphinganine 2S, 3R; N,N-dimethylamineN,N-dimethyl-D-erythro-sphinganine; (2S.3R)-2-aminooctadecane-1,3-diol; (2S,3R)-2-amino-1,3-octadecanediol; Dimethyl Sphinganine (d18:0); N,N-dimethyl-D-erythro-dihydrosphingosine; 17267-46-8
DIMETHYL SPHINGANINE-1-PHOSPHATE (D18:0)
CAS:474943-85-6
SPHZ-154
>99%
Dimethyl Sphinganine-1-Phosphate (d18:0); N,N-dimethyl-D-erythro-dihydrosphingosine-1-phosphate (ammonium salt); 474943-85-6
DIMETHYL SPHINGOSINE (D17:1)
CAS:474943-92-5
SPHZ-152
>99%
N,N-dimethylsphingosine (d17:1); Dimethyl Sphingosine (d17:1); N,N-dimethyl-D-erythro-sphingosine (C17 base); 474943-92-5
DIMETHYL SPHINGOSINE-1-PHOSPHATE (D18:1)
CAS:474943-83-4
SPHZ-155
>99%
dimethyl S-1-P (d18:1); sphingosine d18 D erythro 2S,3R,4(E) 1-phosphate-N,N-dimethyl (ammonium salt); Dimethyl Sphingosine-1-Phosphate (d18:1); N,N-dimethyl-D-erythro-sphingosine-1-phosphate (ammonium salt); 474943-83-4
DMHCA
CAS:79066-03-8
STEZ-070
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; DMHCA; N,N-dimethyl-3?-hydroxycholenamide; 79066-03-8
DOBAQ
CAS:1360461-69-3
NSMZ-091
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 1360461-69-3; DOBAQ; N-(4-carboxybenzyl)-N,N-dimethyl-2,3-bis(oleoyloxy)propan-1-aminium
DOCP
CAS:1360461-57-9
PHOZ-033
>99%
2-((2,3-Bis(oleoyloxy)propyl)dimethylammonio)ethyl hydrogen phosphate; DOCP; 1360461-57-9
DOCPE
CAS:1360461-58-0
PHOZ-034
>99%
2-((2,3-Bis(oleoyloxy)propyl)dimethylammonio)ethyl ethyl phosphate; DOCPe; 1360461-58-0
DOLICHOL (13~21)
CAS:153857-77-3
NSMZ-045
>98%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 153857-77-3; Dolichol (13~21); Dolichol Mixture (13~21)
DONG QUAI EXTRACT
CAS:4431-01-0
EXTW-088
1% Ligustilide By HPLC, 5-10:1 By TLC
Dong Quai Extract; 4431-01-0; Angelic(sinensis (Oilv)Diels; plant extract
DOTMA
CAS:104872-42-6
PCNZ-055
>99%
DOTMA; 1,2-di-O-octadecenyl-3-trimethylammonium propane (chloride salt); 104872-42-6; Cationic Lipids; Transfection; lipid products; lipid
DSPE-PEG(2000) AMINE
CAS:474922-26-4
PCNZ-008
>99%
DSPE-PEG(2000) Amine; 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol)-2000] (ammonium salt); 474922-26-4; Polymers; Polymerizable Lipids; lipid products; lipid
DSPE-PEG(2000) BIOTIN
CAS:385437-57-0
PCNZ-007
>99%
DSPE-PEG(2000) Biotin; 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[biotinyl(polyethylene glycol)-2000] (ammonium salt); 385437-57-0; Polymers; Polymerizable Lipids; lipid products; lipid
DSPE-PEG(2000) CARBOXYLIC ACID
CAS:474922-20-8
PCNZ-010
>99%
DSPE-PEG(2000) Carboxylic Acid ; 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[carboxy(polyethylene glycol)-2000] (ammonium salt); 474922-20-8; Polymers; Polymerizable Lipids; lipid products; lipid
DSPE-PEG(2000) CYANUR
CAS:1246304-74-4
PCNZ-013
>99%
DSPE-PEG(2000) Cyanur; 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[cyanur(polyethylene glycol)-2000] (ammonium salt); 1246304-74-4; Cyanur-PEG2000-DSPE; Polymers; Polymerizable Lipids; lipid products; lipid
DSPE-PEG(2000) FOLATE
CAS:1236288-25-7
PCNZ-011
The product will be 80-85% gamma conjugated and co
DSPE-PEG(2000) Folate; 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[folate(polyethylene glycol)-2000] (ammonium salt); 1236288-25-7; Polymers; Polymerizable Lipids; lipid products; lipid
DSPE-PEG(2000) MALEIMIDE
CAS:474922-22-0
PCNZ-003
>99%
DSPE-PEG(2000) Maleimide; 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide(polyethylene glycol)-2000] (ammonium salt); 474922-22-0; Polymers; Polymerizable Lipids; lipid products; lipid
DSPE-PEG(2000) PDP
CAS:474922-24-2
PCNZ-009
>99%
DSPE-PEG(2000) PDP; 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[PDP(polyethylene glycol)-2000] (ammonium salt); 474922-24-2; Polymers; Polymerizable Lipids; lipid products; lipid
DSPE-PEG(5000) FOLATE
CAS:1236288-25-7
PCNZ-012
The product will be 80-85% gamma conjugated and co
DSPE-PEG(5000) Folate; 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[folate(polyethylene glycol)-5000] (ammonium salt); 1236288-25-7; Polymers; Polymerizable Lipids; lipid products; lipid
DTPA-BSA (GD)
CAS:186796-30-5
NSMZ-065
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 186796-30-5; DTPA-BSA (Gd); (diethylenetriaminepentaacetic acid)-bis(stearylamide) (gadolinium salt); Gd-DTPA-BSA; DTPA-bis(stearylamide) (gadolinium s
E. COLI CA
CAS:796964-05-1
PHOZ-053
>99%
Cardiolipin (E. coli) (sodium salt); E. coli CA; 796964-05-1
E. COLI EXTRACT TOTAL
CAS:1240502-50-4
NSMZ-046
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 1240502-50-4; E. coli Extract Total; E.?coli Total Lipid Extract
E. COLI PE
CAS:94581-14-3
PHOZ-171
>99%
L-a-phosphatidylethanolamine (E. coli) DIV; E. coli PE; 94581-14-3
E. COLI PG
CAS:796963-92-3
PHOZ-119
>99%
L-a-phosphatidylglycerol (E. coli) (sodium salt)DIV; E. coli PG; 796963-92-3
EGG LISS RHOD PE
CAS:383906-59-0
FLBZ-128
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; Egg Liss Rhod PE; 383906-59-0; L-a-Phosphatidylethanolamine-N-(lissamine rhodamine B sulfonyl) (Ammonium Salt) (Egg-Transphosphatidylated, Chicken)
EGG LYSO PC
CAS:97281-36-2
PHOZ-208
>99% LPC; may contain up to 10% of the 2-LPC isome
L-a-lysophosphatidylcholine (Egg, Chicken); Egg Lyso PC; 97281-36-2
EGG LYSO PE
CAS:97281-40-8
PHOZ-164
>99% LPE; may contain up to 10% of the 2-LPE isome
L-a-lysophosphatidylethanolamine (Egg, Chicken); Egg Lyso PE; 97281-40-8
EGG NBD PE
CAS:477225-98-2
FLBZ-119
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; Egg NBD PE; 477225-98-2; L-a-Phosphatidylethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (Ammonium Salt) (Egg-Transphosphatidylated, Chicken)
EGG PA
CAS:383907-53-7
PHOZ-207
>99%
L-a-phosphatidic acid (Egg, Chicken) (sodium salt); Egg PA; 383907-53-7
EGG PE
CAS:97281-40-8
PHOZ-166
>99%
L-a-phosphatidylethanolamine (Egg, Chicken); Egg PE; 97281-40-8
EGG PG
CAS:383907-64-0
PHOZ-117
>99%
L-a-phosphatidylglycerol (Egg, Chicken) (sodium salt); Egg PG; 383907-64-0
EGG SPHINGOSINE
CAS:475662-41-0
SPHZ-172
>99%
Sphingosine 2S, 3R; D-erythro-sphingosine; (2S,3R,4E)-2-aminooctadec-4-ene-1,3-diol; (2S,3R,4E)-2-amino-1,3-octadec-4-enediol; Egg Sphingosine; D-erythro-Sphingosine (Egg, Chicken); 475662-41-0
EGG TRANS PE
CAS:383907-63-9
PHOZ-172
>99%
L-alpha-Phosphatidylethanolamine Transphosphatidylated (prepared from Egg PC); L-a-phosphatidylethanolamine, transphosphatidylated (Egg, Chicken); Egg Trans PE; 383907-63-9
ELEUTHEROSIDE B
CAS:118-34-3
ELSB-001
4-[(1E)-3-Hydroxy-1-propen-1-yl]-2,6-dimethoxyphenyl--D-glucopyranoside; Eleutheroside B; Ilexanthin A; Ligustrin; Lilacin; Magnolenin; Methoxyconiferine; NSC 287441; Sinapyl alcohol 4-O-glucoside; Siringin; Syringoside; 118-34-3
ELEUTHEROSIDE E
CAS:39432-56-9
ELSE-001
Eleutheroside E; 39432-56-9
ENDOTOXIN STANDARD BRP
CAS:67924-63-4
LIGC-003
Endotoxin standard; Endotoxin
EVODIAMINE (INGREDIENTS)
CAS:518-7-2
EXTW-002
98.0% Evodiamine HPLC
Evodiamine (Ingredients); 518-7-2; C19H17N3O
F7-5?,6?-EPOXY CHOLESTANOL
CAS:240129-24-2
STEZ-013
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; F7-5?,6?-Epoxy Cholestanol; 25,26,26,26,27,27,27-heptafluoro-5?,6?-epoxycholestanol; 240129-24-2
F7-5A,6A-EPOXY CHOLESTANOL
CAS:240129-21-9
STEZ-014
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; F7-5a,6a-Epoxy Cholestanol; 25,26,26,26,27,27,27-heptafluoro-5a,6a-epoxycholestanol; 240129-21-9
F7-7-KETOCHOLESTEROL
CAS:215094-37-4
STEZ-015
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; F7-7-ketocholesterol; 25,26,26,26,27,27,27-heptafluoro-7-ketocholesterol; 215094-37-4
F7-7?-OH CHOLESTEROL
CAS:240129-42-4
STEZ-011
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; F7-7?-OH Cholesterol; 25,26,26,26,27,27,27-heptafluoro-7?-hydroxycholesterol; 240129-42-4
F7-7A-OH CHOLESTEROL
CAS:240129-40-2
STEZ-012
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; F7-7a-OH cholesterol; 25,26,26,26,27,27,27-heptafluoro-7a-hydrosycholesterol; 240129-40-2
F7-CHOLESTEROL
CAS:153463-21-9
STEZ-016
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; F7-Cholesterol; 25,26,26,26,27,27,27-heptafluorocholesterol; 153463-21-9
FF-MAS
CAS:64284-64-6
STEZ-054
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; FF-MAS; 14-demethyl-14-dehydrolanosterol; 4,4-dimethyl-5a-cholesta-8,14,24-trien-3?-olfollicular fluid meiosis-activating sterol; 64284-64-6
FLUORESCENT DOTAP
CAS:1010076-97-7
FLBZ-214
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 18:1-06:0 NBD DOTAP; Fluorescent DOTAP; 1010076-97-7; 1-Oleoyl-2-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-3-trimethylammonium propane (chloride salt)
FSL 1
CAS:322455-70-9
LIGC-005
FSL 1
GANGLIOSIDE GD3 (BOVINE MILK)
CAS:1246353-20-7
NSMZ-001
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 1246353-20-7; Ganglioside GD3 (Bovine Milk); GD3 Ganglioside (Milk, Bovine-Ammonium Salt)
GANGLIOSIDE GM3 (BOVINE MILK)
CAS:1246353-19-4
NSMZ-002
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 1246353-19-4; Ganglioside GM3 (Bovine Milk); GM3 Ganglioside (Milk, Bovine-Ammonium Salt)
GANGLIOSIDE-TOTAL
CAS:383907-71-9
SPHZ-085
>99%
Ganglioside-Total; Total Ganglioside Extract (Brain, Porcine-Ammonium Salt); 383907-71-9
GARDENIA EXTRACT
CAS:24512-63-8
EXTW-138
50% Geniposide by HPLC, 5-10:1 by TLC
Gardenia Extract; 24512-63-8; Gardenia florida L.; plant extract
GARDENIA YELLOW
CAS:94238-00-3
EXTW-115
Gardenia Yellow; 94238-00-3; Gardenia jasminoides L.; plant extract
GIANT KNOTWEED EXTRACT (STANDARD)
CAS:501-36-0
EXTW-011
50.0%, 98.0% Resveratrol HPLC
Giant Knotweed Extract (Standard); 501-36-0; C14H12O3
GLUCOSYLCERAMIDE (SOY)
CAS:497155-61-0
SPHZ-084
>99%
Cerebroside (Soy); GlcCer(d18:2/16:0); Glucosylceramide (Soy); Glucocerebrosides (Soy, 98%); 497155-61-0
GLYCYRRHIZA GLABRA EXTRACT (STANDARD)
CAS:517-43-1
EXTW-207
98%, HPLC
Glycyrrhiza Glabra Extract (Standard); 517-43-1; plant extract
GOLDEN ROD EXTRACT
CAS:90045-39-9
EXTW-132
4-10:1 by TLC
Golden Rod Extract; 90045-39-9; Solidago virgaurea L.; plant extract
GRIFFONIA SEEDS EXTRACT (STANDARD)
CAS:4350-9-8
EXTW-003
20.0~50.0%5-HTP HPLC
Griffonia Seeds Extract (Standard); 4350-09-8; C11H12N2O3
GT-11
CAS:649767-83-9
SPHZ-021
>99%
GT-11 dihydroceramide desaturase inhibitor; GT-11; N-[(1R,2S)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl]octanamide; 649767-83-9
GYMNEMA EXTRACT (STANDARD)
CAS:122168-40-5
EXTW-004
25.0% 75.0% Gymnemic acid HPLC
Gymnema Extract (Standard); 122168-40-5; C43H66O14
GYMNEMA SYLVESTRE EXTRACT
CAS:1399-64-0
EXTW-098
25%, 75% Gymnemic Acid By UV
Gymnema Sylvestre Extract; 1399-64-0; Gymnema sylvestre (Retz.) Schult.; plant extract
HAWTHORN LEAF EXTRACT (STANDARD)
CAS:84603-61-2
EXTW-016
1.8% Vitexin-2-0-R HPLC
Hawthorn Leaf Extract (Standard); 84603-61-2; C27H30O14
HEART CA
CAS:383907-10-6
PHOZ-052
>99%
Cardiolipin (Heart, Bovine) (sodium salt); Heart CA; 383907-10-6
HEART EXTRACT POLAR
CAS:86088-90-6
NSMZ-043
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 86088-90-6; Heart Extract Polar; Heart Polar Lipid Extract (Bovine)
HEART PE
CAS:477241-93-3
PHOZ-169
>99%
L-a-phosphatidylethanolamine (Heart, Bovine); Heart PE; 477241-93-3
HOPS FLOWER EXTRACT (STANDARD)
CAS:6754-58-1
EXTW-018
4.0% Flavones UV
Hops Flower Extract (Standard); 6754-58-1; C21H22O5
HORSE CHESTNUT EXTRACT (STANDARD)
CAS:6805-41-0
EXTW-009
20.0% Aescins UV/HPLC
Horse Chestnut Extract (Standard); 6805-41-0; C55H86O24
HUPERZIA SERRATA EXTRACT (STANDARD)
CAS:120786-18-7
EXTW-007
1.0%, 5.0% Huperzine A HPLC
Huperzia Serrata Extract (Standard); 120786-18-7; C15H18N2O
HYDRO SOY PC
CAS:97281-48-6
PHOZ-248
>99%
HSPC; L-a-phosphatidylcholine, hydrogenated (Soy); Hydro Soy PC; 97281-48-6
IMIQUIMOD
CAS:99011-02-6
LIGC-006
>95 %
Aldara; Beselna; R-837; TMX 101; Zyclara
IP3(1,3,4)
CAS:1246355-66-7
PHOZ-093
>97% (contains 3% IP3 with phosphorus migration)
D-Myo-inositol-1,3,4-trisphosphate (ammonium salt); IP3(1,3,4); 1246355-66-7
IP3(1,3,5)
CAS:1246355-67-8
PHOZ-094
>99%
D-Myo-inositol-1,3,5-triphosphate (ammonium salt); IP3(1,3,5); 1246355-67-8
IP3(1,4,5)
CAS:345958-55-6
PHOZ-095
>99%
D-Myo-inositol-1,4,5-triphosphate (ammonium salt); IP3(1,4,5); 345958-55-6
IP4(1,3,4,5)
CAS:1246355-68-9
PHOZ-096
>99%
D-Myo-inositol-1,3,4,5-tetraphosphate (ammonium salt); IP4(1,3,4,5); 1246355-68-9
KDO2-LIPID A (KLA)
CAS:1246298-62-3
FLBZ-003
>95%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; KLA; Kdo2-Lipid A (KLA); 1246298-62-3; Di[3-deoxy-D-manno-octulosonyl]-lipid A (ammonium salt)
LANOSTEROL-D6
CAS:28290-39-4
STEZ-023
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; lanosterol-d6; 26,26,26,27,27,27-hexadeuteriolanosta-8,24-dien-3?-ol; 28290-39-4
LIGUSTRUM LUCIDUM EXTRACT
CAS:77-52-1
EXTW-087
10:1 By TLC, 25% Ursolic Acid By HPLC
Ligustrum Lucidum Extract; 77-52-1; Fructus Ligustri Lucidi; plant extract
LIVER EXTRACT TOTAL
CAS:86088-91-7
NSMZ-042
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 86088-91-7; Liver Extract Total; Liver Total Lipid Extract (Bovine)
LIVER LYSO PI
CAS:796963-93-4
PHOZ-059
>99% LPI; may contain up to 10% of the 2-LPI isome
L-a-lysophosphatidylinositol (Liver, Bovine) (sodium salt); Liver Lyso PI; 796963-93-4
LIVER PC
CAS:475662-36-3
PHOZ-250
>99%
L-a-phosphatidylcholine (Liver, Bovine); Liver PC; 475662-36-3
LIVER PE
CAS:383907-31-1
PHOZ-170
>99%
L-a-phosphatidylethanolamine (Liver, Bovine); Liver PE; 383907-31-1
LIVER PI
CAS:383907-33-3
PHOZ-055
>99%
L-a-phosphatidylinositol (Liver, Bovine) (sodium salt); Liver PI; 383907-33-3
LUTEOLIN (INGREDIENTS)
CAS:497-70-3
EXTW-001
98.0% Luteolin HPLC
Luteolin (Ingredients); 497-70-3; C15H10O6
LYCOPENE (STANDARD)
CAS:502-65-8
EXTW-012
5.0%,10.0% Lycopene HPLC
Lycopene (Standard); 502-65-8; C40H56
LYSO PA
CAS:1246355-62-3
FLBZ-216
>99% LPA; may contain up to 10% of the 2-LPA isome
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; Lyso PA; 1246355-62-3; 1-{12-[4-(Dipyrrometheneboron difluoride)butanoyl]amino}dodecanoyl-2-hydroxy-sn-glycero-3-phosphate (ammonium salt)
LYSO SM (D17:1)
CAS:118540-32-2
SPHZ-088
>99%
D-erythro-sphingosine phosphocholine (C17 base); Lyso SM (d17:1); Sphingosylphosphorylcholine (C17 base); 118540-32-2
LYSO SM (DIHYDRO) (D18:0)
CAS:21658-11-7
SPHZ-089
>99%
Sphinganine PC (d18:0); D-erythro-sphinganine phosphocholine; Lyso SM (dihydro) (d18:0); Sphinganine Phosphorylcholine; 21658-11-7
MAGNOLIA OFFICINALIS
CAS:528-43-8
EXTW-204
90%, HPLC
Magnolia officinalis; 528-43-8; plant extract
MARSHMALLOW ROOT EXTRACT
CAS:97676-24-9
EXTW-140
4-10:1 by TLC
Marshmallow Root Extract; 97676-24-9; Althaea officinalis L.; plant extract
MGLC-DAG
CAS:1246303-08-1
PCNZ-088
>99%
MGlc-DAG; 1,2-diacyl-3-O-(a-D-glucopyranosyl)-sn-glycerol (E. coli); 1246303-08-1; Monoglucosyl Diacylglycerol (E. coli); MGlcDG; neutral Lipids; lipid products; lipid
MILK SM
CAS:475662-40-9
SPHZ-087
>99%
23:0 SM; N-(tricosanoyl)-sphing-4-enine-1-phosphocholine; Milk SM; Sphingomyelin (Milk, Bovine); 475662-40-9
MONOMETHYL SPHINGOSINE (D18:1)
CAS:2700-62-1
SPHZ-151
>99%
sphingosine 2S, 3R, N-methylamine; Monomethyl Sphingosine (d18:1); N-methyl-D-erythro-sphingosine; 2700-62-1
MURAMYL DIPEPTIDE (MDP)
CAS:53678-77-6
LIGC-009
N-Acetylmuramyl-L-Alanyl-D-Isoglutamine (L-D isoform); Muramyldipeptide (L-D isomer, active); Muramyl dipeptide; MDP
MVL5
CAS:464926-03-2
PCNZ-054
>99%
MVL5; N1-[2-((1S)-1-[(3-aminopropyl)amino]-4-[di(3-amino-propyl)amino]butylcarboxamido)ethyl]-3,4-di[oleyloxy]-benzamide; 464926-03-2; N1,N1,N4-tris(3-ammoniopropyl)-5-((2-(3,4-bis((Z)-octadec-9-en-1-yloxy)benzamido)ethyl)amino)-5-oxopentane-1,4-diaminium chloride; Cationic Lipids; Transfection; lipid products; lipid
N-02:0 PHYTOSPHINGOSINE
CAS:475995-69-8
SPHZ-037
>99%
N-acetoyl 4-hydroxysphinganine; N-acetyl (2S, 3S, 4R)-2-amino-1,3,4 -octadecanetriol; N-02:0 Phytosphingosine; N-acetoyl 4-hydroxysphinganine (Saccharomyces Cerevisiae); 475995-69-8
N-08:0 PHYTOSPHINGOSINE
CAS:475995-74-5
SPHZ-036
>99%
N-octanoyl 4-hydroxysphinganine; N-octanoyl (2S, 3S, 4R)-2-amino-1,3,4 -octadecanetriol; N-08:0 Phytosphingosine; N-octanoyl 4-hydroxysphinganine (Saccharomyces Cerevisiae); 475995-74-5
N-16:0 L-SERINE MEESTER
CAS:79876-27-0
FLBZ-100
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 1-hexadecanoyl-L-serine methyl ester; (S)-methyl-3-hydroxy-2-hexadecanamidopropanoate; (S)-methyl-3-hydroxy-2-palmitamidopropanoate; N-16:0 L-Serine MeEster; 79876-27-0; N-palmitoyl L-serine methyl ester
N-16:0 PHYTOSPHINGOSINE
CAS:111149-09-8
SPHZ-046
>99%
N-hexadecanoyl 4-hydroxysphinganine; Cer(NP); Cer3(C16); N-16:0 Phytosphingosine; N-palmitoyl-phytosphingosine (Saccharomyces Cerevisiae); 111149-09-8
N-18:0 PHYTOSPHINGOSINE
CAS:475995-75-6
SPHZ-035
>99%
N-octadecanoyl 4-hydroxysphinganine; N-octadecanoyl (2S, 3S, 4R)-2-amino-1,3,4 -octadecanetriol; N-18:0 Phytosphingosine; N-stearoyl 4-hydroxysphinganine (Saccharomyces Cerevisiae); 475995-75-6
N-18:1 L-SERINE
CAS:1246302-99-7
FLBZ-095
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 1-(9Z-octadecenoyl)-L-serine; (S)-3-hydroxy-2-(9Z)-octadecenamidopropanoate; (S)-3-hydroxy-2-oleoamidopropanoate; N-18:1 L-Serine; 1246302-99-7; N-oleoyl L-serine
N-18:1 L-SERINE MEESTER
CAS:1246302-98-6
FLBZ-092
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 1-(9Z-octadecenoyl)-L-serine methyl ester; (S)-methyl-3-hydroxy-2-(9Z)-octadecenamidopropanoate; (S)-methyl-3-hydroxy-2-oleamidopropanoate; N-18:1 L-Serine MeEster; 1246302-98-6; N-oleoyl L-serine methyl ester
N-20:4 L-SERINE (ARA-S)
CAS:1246355-55-4
FLBZ-091
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; ARA-S; 1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-L-serine; (S)-3-hydroxy-2-(5Z,8Z,11Z,14Z)-eicosatetraenamidopropanoate; (S)-3-hydroxy-2-arachidonamidopropanoate; N-20:4 L-Serine (ARA-S); 1246355-55-4; N-arachidonoyl L-serine
N-20:4 L-SERINE MEESTER
CAS:288262-62-4
FLBZ-086
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-L-serine methyl ester; (S)-methyl-3-hydroxy-2-(5Z,8Z,11Z,14Z)-eicosatetraenamidopropanoate; (S)-methyl-3-hydroxy-2-arachidonamidopropanoate; N-20:4 L-Serine MeEster; 288262-62-4; N-arachidonoyl L-serine
N-24:0 PHYTOSPHINGOSINE
CAS:34437-74-6
SPHZ-045
>99%
N-tetracosanoyl 4-hydroxysphinganine; CER(NP); CER3(C24); N-24:0 Phytosphingosine; N-lignoceroyl-phytosphingosine (Saccharomyces Cerevisiae); 34437-74-6
N-C12-DEOXYSPHINGANINE
CAS:1246298-40-7
SPHZ-018
>99%
N-dodecanoyl-1-deoxysphinganine (m18:0/12:0); N-C12-1-deoxyDHCer; N-C12-deoxysphinganine; N-lauroyl-1-deoxysphinganine (m18:0/12:0); 1246298-40-7
N-C12-DEOXYSPHINGOSINE
CAS:1246298-54-3
SPHZ-007
>99%
N-dodecanoyl-1-deoxysphing-4-enine (m18:1/12:0); N-C12-1-deoxyCer; N-C12-deoxysphingosine; N-lauroyl-1-deoxysphingosine (m18:1/12:0); 1246298-54-3
N-C12-DESOXYMETHYLSPHINGANINE
CAS:1246298-41-8
SPHZ-017
>99%
N-dodecanoyl-1-desoxymethylsphinganine (m17:0/12:0); N-C12-1-desoxyMeDHCer; N-C12-desoxymethylsphinganine; N-lauroyl-1-desoxymethylsphinganine (m17:0/12:0); 1246298-41-8
N-C12-DESOXYMETHYLSPHINGOSINE
CAS:1246298-55-4
SPHZ-011
>99%
N-dodecanoyl-1-desoxymethylsphing-3-enine (m17:1/12:0); N-C12-1-desoxyMeCer; N-C12-desoxymethylsphingosine; N-lauroyl-1-desoxymethylsphingosine (m17:1/12:0); 1246298-55-4
N-C16-DEOXYSPHINGANINE
CAS:378755-69-2
SPHZ-015
>99%
N-hexadecanoyl-1-deoxysphinganine (m18:0/16:0); N-C16-1-deoxyDHCer; N-C16-deoxysphinganine; N-palmitoyl-1-deoxysphinganine (m18:0/16:0); 378755-69-2
N-C16-DEOXYSPHINGOSINE
CAS:1246298-56-5
SPHZ-006
>99%
N-hexadecanoyl-1-deoxysphing-4-enine (m18:1/16:0); N-C16-1-deoxyCer; N-C16-deoxysphingosine; N-palmitoyl-1-deoxysphingosine (m18:1/16:0); 1246298-56-5
N-C16-DESOXYMETHYLSPHINGANINE
CAS:1246298-42-9
SPHZ-014
>99%
N-hexadecanoyl-1-desoxymethylsphinganine (m17:0/16:0); N-C16-1-desoxyMeDHCer; N-C16-desoxymethylsphinganine; N-palmitoyl-1-desoxymethylsphinganine (m17:0/16:0); 1246298-42-9
N-C16-DESOXYMETHYLSPHINGOSINE
CAS:1246298-57-6
SPHZ-010
>99%
N-hexadecanoyl-1-desoxymethylsphing-3-enine (m17:1/16:0); N-C16-1-desoxyMeCer; N-C16-desoxymethylsphingosine; N-palmitoyl-1-desoxymethylsphingosine (m17:1/16:0); 1246298-57-6
N-C24:1-DEOXYSPHINGANINE
CAS:1246298-60-1
SPHZ-013
>99%
N-(15Z-tetracosenoyl)-1-deoxysphinganine (m18:0/24:1); N-C24:1-1-deoxyDHCer; N-C24:1-deoxysphinganine; N-nervonoyl-1-deoxysphinganine (m18:0/24:1); 1246298-60-1
N-C24:1-DEOXYSPHINGOSINE
CAS:1246298-58-7
SPHZ-008
>99%
N-(15Z-tetracosenoyl)-1-deoxysphing-4-enine (m18:1/24:1); N-C24:1-1-deoxyCer; N-C24:1-deoxysphingosine; N-nervonoyl-1-deoxysphingosine (m18:1/24:1); 1246298-58-7
N-C24:1-DESOXYMETHYLSPHINGANINE
CAS:1246298-61-2
SPHZ-012
>99%
N-(15Z-tetracosenoyl)-1-desoxymethylsphinganine (m17:0/24:1); N-C24:1-1-desoxyMeDHCer; N-C24:1-desoxymethylsphinganine; N-nervonoyl-1-desoxymethylsphinganine (m17:0/24:1); 1246298-61-2
N-C24:1-DESOXYMETHYLSPHINGOSINE
CAS:1246298-59-8
SPHZ-009
>99%
N-(15Z-tetracosenoyl)-1-desoxymethylsphing-3-enine (m17:1/24:1); N-C24:1-1-desoxyMeCer; N-C24:1-desoxymethylsphingosine; N-nervonoyl-1-desoxymethylsphingosine (m17:1/24:1); 1246298-59-8
N-P SERINE PA
CAS:799268-44-3
PHOZ-173
0.99
N-palmitoyl-serine phosphoric acid (ammonium salt); N-P Serine PA; 799268-44-3
N-P TYROSINE PA
CAS:799268-45-4
PHOZ-174
0.99
N-palmitoyl-tyrosine phosphoric acid (ammonium salt); N-P Tyrosine PA; 799268-45-4
N-PALMITOYL HOMOCYSTEINE (PHC)
CAS:474942-73-9
NSMZ-109
>99%
Avanti Polar Lipids; lipid products; natural lipids; natural; synthetic lipid; synthetic; modified lipids; headgroup modified lipids; fatty acid modified lipids; singnal transduction; cell pathways; 474942-73-9; N-palmitoyl homocysteine (PHC); PHCPamHcy; N-palmitoyl homocysteine (ammonium salt)
NARINGIN
CAS:10236-47-2
EXTW-206
98%, HPLC
Naringin; 10236-47-2; plant extract
NATIVE BOVINE APROTININ
CAS:9087-70-1
PHAM-235
aprotinin; Trasylol; bovine pancreatic trypsin inhibitor BPTI; 9087-70-1
NATIVE BOVINE FIBRINOGEN
CAS:9001-32-5
NATE-1595
Factor I; 9001-32-5; Fibrinogen; bovine plasma Fibrinogen; bovine Fibrinogen;
NATIVE CHICKEN EGG WHITE AVIDIN
CAS:1405-69-2
NATE-0949
Highly Purified
Avidin
NATIVE EQUINE PREGNANT MARE SERUM GONADOTROPIN
CAS:9002-70-4
NATE-0969
Pregnant Mare Serum Gonadotropin; PMSG; Equine chorionic gonadotropin; Ecg
NBD 18:0 CERAMIDE
CAS:1246303-04-7
FLBZ-202
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; NBD 18:0 Ceramide; 1246303-04-7; Omega(7-nitro-2-1,3-benzoxadiazol-4-yl)-N-stearoyl-D-erythro-sphingosine
NBD LYSO SM
CAS:1246303-02-5
FLBZ-227
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; NBD Lyso SM; 1246303-02-5; Omega(7-nitro-2-1,3-benzoxadiazol-4-yl)-D-erythro-sphingosine-1-phosphocholine
NBD SPHINGANINE
CAS:1246303-03-6
FLBZ-243
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; D-erythro-sphinganine-N-NBDNBD-dihydrosphingosine; NBD Sphinganine; 1246303-03-6; Omega(7-nitro-2-1,3-benzoxadiazol-4-yl)(2S,3R)-2-aminooctadecane-1,3-diol
NBD SPHINGOSINE
CAS:799268-47-6
FLBZ-244
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; D-erythro-Sphingosine-N-NBD; NBD Sphingosine; 799268-47-6; Omega(7-nitro-2-1,3-benzoxadiazol-4-yl)(2S,3R,4E)-2-aminooctadec-4-ene-1,3-diol
NBD SPHINGOSINE-1-PHOSPHATE
CAS:799268-48-7
FLBZ-238
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; NBD Sphingosine-1-Phosphate; 799268-48-7; Omega(7-nitro-2-1,3-benzoxadiazol-4-yl)-D-erythro-sphingosine-1-phosphate
NBD-12 CHOLESTEROL
CAS:1246303-05-8
STEZ-004
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; NBD-12 Cholesterol; 5-cholesten-3?-ol 12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoate; 1246303-05-8
NBD-6 CHOLESTEROL
CAS:201731-19-3
FLBZ-221
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; NBD-6 Cholesterol; 201731-19-3; 5-Cholesten-3?-ol 6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]caproate
OCHEMSPC
CAS:155401-41-5
PHOZ-031
>99%
1-Oleoyl-2-cholesterylhemisuccinoyl-sn-glycero-3-phosphocholine; OChemsPC; 155401-41-5
PAM3CSK4
CAS:112208-00-1
LIGC-001
Pam3CSK4
PAPRIKA EXTRACT
CAS:465-42-9
EXTW-120
95% Capsanthin By HPLC
Paprika Extract; 465-42-9; ; plant extract
PAZEPC
CAS:117746-89-1
PHOZ-015
>99%
PAzPC; 1-Palmitoyl-2-azelaoyl-sn-glycero-3-phosphocholine; PAzePC; 117746-89-1
PC
CAS:1246355-63-4
FLBZ-162
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; 1-palmitoyl-2-(dipyrrometheneboron difluoride)undecanoyl-sn-glycero-3-phosphocholine; PC; 1246355-63-4; 1-Palmitoyl-2-(dipyrrometheneboron difluoride)undecanoyl-sn-glycero-3-phosphocholine
PCHCPC
CAS:1085528-78-4
PHOZ-030
>99%
1-Palmitoyl-2-cholesterylcarbonoyl-sn-glycero-3-phosphocholine; PChcPC; 1085528-78-4
PCHEMSPC
CAS:155401-40-4
PHOZ-032
>99%
PCholPC; 1-Palmitoyl-2-cholesterylhemisuccinoyl-sn-glycero-3-phosphocholine; PChemsPC; 155401-40-4
PE
CAS:1246355-64-5
FLBZ-173
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; PE; 1246355-64-5; 1-Palmitoyl-2-(Dipyrrometheneboron difluoride)undecanoyl-sn-glycero-3-phosphoethanolamine
PHYTOSPHINGOSINE PHOSPHOCHOLINE
CAS:475995-43-8
SPHZ-041
>99%
(2S, 3S, 4R)-2-amino-1,3,4-octadecanetriol-1-phosphocholine; Phytosphingosine Phosphocholine; 4-hydroxysphinganine-1-phosphocholine (Saccharomyces Cerevisiae); 475995-43-8
PHYTOSPHINGOSINE-N,N,N-TRIMETHYL
CAS:497156-28-2
SPHZ-038
>99%
(2S, 3S, 4R)-2-amino-1,3,4-octadecanetriol-N,N,N-trimethyl (methyl sulfate salt); Phytosphingosine-N,N,N-Trimethyl; 4-hydroxysphinganine-N,N,N-trimethyl (methyl sulfate salt) (Saccharomyces cerevisiae); 497156-28-2
PHYTOSPHINGOSINE-N,N-DIMETHYL
CAS:475995-68-7
SPHZ-040
>99%
(2S, 3S, 4R)-2-amino-1,3,4 -octadecanetriol-N,N-dimethyl; Phytosphingosine-N,N-Dimethyl; 4-hydroxysphinganine-N,N-dimethyl (Saccharomyces Cerevisiae); 475995-68-7
PHYTOSPHINGOSINE-N,N-DIMETHYL-1-PHOSPHATE
CAS:477243-08-6
SPHZ-039
>99%
(2S, 3S, 4R)-2-amino-1,3,4 -octadecanetriol-N,N-dimethyl-1-phosphate (ammonium salt); Phytosphingosine-N,N-Dimethyl-1-Phosphate; 4-hydroxysphinganine-N,N-dimethyl-1-phosphate (ammonium salt) (Saccharomyces Cerevisiae); 477243-08-6
PI(4,5)P2
CAS:1246355-57-6
FLBZ-136
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; PI(4,5)P2; 1246355-57-6; 1-Oleoyl-2-{6-[4-(Dipyrrometheneboron difluoride)butanoyl]amino}hexanoyl-sn-glycero-3-phosphoinositol-4,5-bisphosphate (ammonium salt)
POLY I: C
CAS:24939-03-5
LIGC-002
Polyinosinic-polycytidylic acid sodium salt; Polyinosinic acid, homopolymer, complex with polycytidylic acid, homopolymer (1:1); Poly(C).poly(I); Poly(C:I); Poly(I)-poly(C); Poly(I).poly(C); Poly(I).poly(C) Complex; Poly(cytidylic acid)-poly(inosinic acid); Poly(rI)-poly(rC); Poly(rI).poly(rC); Poly(rI):poly(rC); Poly(rI:rC); Polycytidylic-polyinos
POLYPRENAL (13~21)
CAS:1246745-16-3
PCNZ-078
Polyprenal (13~21); Polyprenal mixture (13~21); 1246745-16-3; neutral Lipids; lipid products; lipid
POLYPRENOL (13~21)
CAS:153857-77-3
PCNZ-079
Polyprenol (13~21); Polyprenol mixture (13~21); 153857-77-3; neutral Lipids; lipid products; lipid
POVPC
CAS:121324-31-0
PHOZ-012
>99%
POVPC; 1-Palmitoyl-2-(5'-oxo-valeroyl)-sn-glycero-3-phosphocholine; POVPC; 121324-31-0
PS
CAS:1246355-65-6
FLBZ-159
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; PS; 1246355-65-6; 1-Palmitoyl-2-(dipyrrometheneboron difluoride)undecanoyl-sn-glycero-3-phospho-L-serine (ammonium salt)
PURPLE CONEFLOWER EXTRACT
CAS:90028-20-9
EXTW-185
4% Total Polyphenol
Purple Coneflower Extract; 90028-20-9; Echinacea purpurea; plant extract
PYGEUM BARK EXTRACT
CAS:949109-75-5
EXTW-079
5%-15% Total Phytosterol by HPLC
Pygeum Bark Extract; 949109-75-5; Pygeum africanum L.; plant extract
PYRGPC
CAS:920494-89-9
PHOZ-016
>99%
1-(10-Pyrenedecanoyl)-2-glutaroyl-sn-glycero-3-phosphocholine; PyrGPC; 920494-89-9
PYROVPC (DMA)
CAS:920494-91-3
PHOZ-017
>99%
1-(10-Pyrenedecanoyl)-2-(5,5-dimethoxyvaleroyl)-sn-glycero-3-phosphocholine; PyrOVPC (DMA); 920494-91-3
RIBONUCLEIC ACID (RNA) POWDER
CAS:63231-63-0
RNAC-001
> 90%
RNA Powder; RNA; Ribonucleic acid; Ribonucleic Acid (RNA) Powder; Ribonucleic Acid Powder
SAFFRON EXTRACT
CAS:84604-17-1
EXTW-114
0.3% Saffranol By HPLC
Saffron Extract; 84604-17-1; Crocus sativus L.; plant extract
SITOINDOSIDE II
CAS:53657-29-7
STEZ-001
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; Sitoindoside II; 6-O-oleoyl-sitosteryl-?-D-glucose; 3-O-[(6-O-oleoyl)-?-D-glucopyranosyl] sitosterol; 18:1 sitosteryl glucose; 53657-29-7
SNOWPARSLEY EXTRACT
CAS:484-12-8
EXTW-097
10%-98% Osthole By HPLC, 10:1 By TLC
Snowparsley Extract; 484-12-8; Fructus Cnidii; plant extract
SOY LYSO PC
CAS:97281-38-4
PHOZ-251
>99% LPC; may contain up to 10% of the 2-LPC isome
L-a-lysophosphatidylcholine (Soy); Soy Lyso PC; 97281-38-4
SOY LYSO PI
CAS:796963-91-2
PHOZ-058
>99% LPI; may contain up to 10% of the 2-LPI isome
L-a-lysophosphatidylinositol (Soy) (sodium salt); Soy Lyso PI; 796963-91-2
SOY PA
CAS:475995-54-1
PHOZ-206
>99%
L-a-phosphatidic acid (Soy) (sodium salt); Soy PA; 475995-54-1
SOY PE
CAS:97281-51-1
PHOZ-168
>99%
L-a-phosphatidylethanolamine (Soy); Soy PE; 97281-51-1
SOY PG
CAS:322647-44-9
PHOZ-118
>99%
L-a-phosphatidylglycerol (Soy) (sodium salt); Soy PG; 322647-44-9
SOY PS
CAS:383908-63-2
PHOZ-115
>99%
L-a-phosphatidylserine (Soy, 99%) (sodium salt); Soy PS; 383908-63-2
SPEARMINT EXTRACT
CAS:84696-51-5
EXTW-183
4-10:1 by TLC
Spearmint Extract; 84696-51-5; Menthaspicata L; plant extract
SPHINGANINE (D17:0)
CAS:32164-02-6
SPHZ-164
>99%
dihydrosphingosine (C17 base); sphinganine (d17:0); D-erythro-sphinganine (C17 base); 32164-02-6
SPHINGANINE (D20:0)
CAS:24006-62-0
SPHZ-165
>99%
dihydrosphingosine (C20 base); Sphinganine (d20:0); D-erythro-sphinganine (C20 base); 24006-62-0
SPHINGANINE-1-PHOSPHATE (D17:0)
CAS:474923-29-0
SPHZ-159
>99%
dihydro-D-erythro-sphingosine-1-phosphate (C17 base); sphinganine-1-phosphate (C17 base); sphinganine-1-phosphate (d17:0); D-erythro-sphinganine-1-phosphate (C17 base); 474923-29-0
SPHINGANINE-1-PHOSPHATE (D20:0)
CAS:436846-91-2
SPHZ-162
>99%
dihydro-D-erythro-sphingosine-1-phosphate (C20 base); sphinganine-1-phosphate (C20 base); Sphinganine-1-Phosphate (d20:0); D-erythro-sphinganine-1-phosphate (C20 base); 436846-91-2
SPHINGOSINE (D20:1)
CAS:6918-49-6
SPHZ-167
>99%
Sphingosine (d20:1); D-erythro-sphingosine (C20 base); 6918-49-6
SPHINGOSINE-1-PHOSPHATE (D17:1)
CAS:474923-27-8
SPHZ-160
>99%
Sphingosine-1-Phosphate (d17:1); D-erythro-sphingosine-1-phosphate (C17 base); 474923-27-8
SPHINGOSINE-1-PHOSPHATE (D20:1)
CAS:799812-75-2
SPHZ-163
>99%
Sphingosine-1-Phosphate (d20:1); D-erythro-sphingosine-1-phosphate (C20 base); 799812-75-2
SPHINGOSINE-1-PHOSPHATE (DMA ADDUCT)
CAS:474943-63-0
SPHZ-161
>99%
sphingosine d18 D erythro 2S,3R,4(E) 1-phosphate (dimethylamine salt); (2S,3R,4E)-2-aminooctadec-4-ene-1,3-diol-1-phosphate (dimethylamine adduct); (2S,3R,4E)-2-amino-1,3-octadec-4-enediol-1-phosphate (dimethylamine adduct); Sphingosine-1-Phosphate (DMA Adduct); D-erythro-sphingosine-1-phosphate (DMA Adduct); 474943-63-0
SPHINGOSYL PE (D18:1)
CAS:90850-31-0
SPHZ-048
>99%
Sphingosyl Phosphoethanolamine; Sphingosyl PE (d18:1); D-erythro-sphingosyl phosphoethanolamine; 90850-31-0
SPHINGOSYL PI (D18:1)
CAS:799812-72-9
SPHZ-047
>99%
Sphingosyl Phosphoinositol; Sphingosyl PI (d18:1); D-erythro-sphingosyl phosphoinositol; 799812-72-9
SQDG
CAS:123036-44-2
FLBZ-001
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; SQDG; 123036-44-2; Sulfoquinovosyldiacylglycerol
ST. JOHNS WORT EXTRACT (STANDARD)
CAS:118-34-3
EXTW-015
0.3% Hypericins UV/ HPLC
St. Johns Wort Extract (Standard); 118-34-3; C30H16O8
TRIMETHYL SPHINGANINE (D18:0)
CAS:474943-87-8
SPHZ-157
>99%
sphinganine 2S, 3R N,N,N-trimethylamine (chloride salt); N,N,N-trimethyl-D-erythro-sphinganine (chloride salt); Trimethyl Sphinganine (d18:0); N,N,N-trimethyl-D-erythro-dihydrosphingosine (chloride salt); 474943-87-8
TRIMETHYL SPHINGOSINE (D17:1)
CAS:474943-94-7
SPHZ-156
>99%
Trimethyl Sphingosine (d17:1); N,N,N-trimethyl-D-erythro-sphingosine (C17 base) (methyl sulfate salt); 474943-94-7
TRIMETHYL SPHINGOSINE (D18:1)
CAS:133561-52-1
SPHZ-158
>99%
sphingosine 2S, 3R, N,N,N-trimethylamine (methyl sulfate salt); Trimethyl Sphingosine (d18:1); N,N,N-trimethyl-D-erythro-sphingosine (methyl sulfate salt); 133561-52-1
VALERIAN ROOT EXTRACT
CAS:8057-49-6
EXTW-157
0.3%, 0.8%Valeric Acids
Valerian Root Extract; 8057-49-6; Valeriana officinalis; plant extract
VPC 12249 (S)
CAS:799268-73-8
PHOZ-176
>99%
(S)-phosphoric acid mono-[3-(4-benzyloxy-phenyl)-2-octadec-9-enoylamino-propyl] ester (ammonium salt); VPC 12249 (S); 799268-73-8
VPC 23153
CAS:787582-98-3
SPHZ-034
>99%
VPC 23153; (R)-phosphoric acid mono-[2-amino-2-(6-octyl-1H-benzoimiazol-2-yl)-ethyl] ester; 787582-98-3
VPC 24191
CAS:799268-83-0
SPHZ-033
>99%
VPC 24191; (S)-phosphoric acid mono-[2-amino-3-(4-octyl-phenylamino)-propyl] ester; 799268-83-0
VPC 31143 (R)
CAS:799268-80-7
PHOZ-179
>99%
N-{(1R)-2-hydroxy-1-[(phosphonooxy)methyl]ethyl}(9Z)octadec-9-enamide (ammonium salt); VPC 31143 (R); 799268-80-7
VPC 32179 (R)
CAS:799268-76-1
PHOZ-177
>99%
(R)-phosphoric acid mono-{2-octadec-9-enoylamino-3-[4-(pyridin-2-ylmethoxy)-phenyl]-propyl} ester (ammonium salt); VPC 32179 (R); 799268-76-1
VPC 32183 (S)
CAS:799268-75-0
PHOZ-175
>99%
(S)-phosphoric acid mono-{2-octadec-9-enoylamino-3-[4-(pyridin-2-ylmethoxy)-phenyl]-propyl} ester (ammonium salt); VPC 32183 (S); 799268-75-0
VPC 44116
CAS:925978-30-9
SPHZ-029
>99%
VPC 44116; (R)-(3-amino-4-((3-octylphenyl)amino)-4-oxobutyl) phosphonic acid; 925978-30-9
VU0155056
CAS:1130067-18-3
FLBZ-081
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; VU0155056; 1130067-18-3; N-(2-{4-[2-oxo-2,3-dihydro-1H-benzo(d)imidazol-1-yl]piperidin-1-yl}ethyl)-2-naphthamide
VU0285655-1
CAS:1158347-73-9
FLBZ-071
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; APVVU0285655-1; VU0285655-1; 1158347-73-9; N-{2-[4-oxo-1-phenyl-1,3,8-triazaspiro(4.5)decan-8-yl]ethyl}quinoline-3-carboxamide
VU0359595
CAS:1246303-14-9
FLBZ-048
>99%
Avanti Polar Lipids; lipid products; bioactive lipids; fluorescent lipids; singnal transduction; cell pathways; EVJVU0359595; VU0359595; 1246303-14-9; (1R,2R)-N-([S]-1-{4-[5-bromo-2-oxo-2,3-dihydro-1H-benzo(d)imidazol-1-yl]piperidin-1-yl}propan-2-yl)-2-phenylcyclopropanecarboxamide
W140
CAS:909725-64-0
SPHZ-031
>99%
S1P1 Control Molecule; W140; (S)-3-amino-4-(3-hexylphenylamino)-4-oxobutylphosphonic acid (TFA salt); 909725-64-0
W146
CAS:909725-62-8
SPHZ-030
>99%
S1P1 Antagonist; W146; (R)-3-Amino-(3-hexylphenylamino)-4-oxobutylphosphonic acid (TFA salt); 909725-62-8
WHITE PEONY EXTRACT
CAS:23180-57-6
EXTW-096
5%-12% Paeoniflorin By HPLC
White Peony Extract; 23180-57-6; Paeonia lactiflora Pall.; plant extract
WHITE WILLOW EXTRACT (STANDARD)
CAS:138-52-3
EXTW-019
15.0% 50.0% Salicin HPLC
White Willow Extract (Standard); 138-52-3; C13H18O7
WORMWOOD EXTRACT
CAS:977032-37-3
EXTW-130
4-10:1 by TLC
Wormwood Extract; 977032-37-3; Artemisia princes orientalis L.; plant extract
YOHIMBE EXTRACT
CAS:65-19-0
EXTW-077
8% Yohimbine by HPLC
Yohimbe Extract; 65-19-0; Corynante Yohimbe; plant extract
YUCCA EXTRACT
CAS:90147-57-2
EXTW-131
30%-60% Saponins by UV
Yucca Extract; 90147-57-2; Yucca filamentosa L.; plant extract
ZYMOSAN A FROM SACCHAROMYCES CEREVISIAE
CAS:58856-93-2
LIGC-008
Zymosan A
ZYMOSTEROL
CAS:128-33-6
STEZ-082
>98%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; zymosterol; 5a-cholesta-8,24-dien-3?-ol; 128-33-6
ZYMOSTEROL-D5
CAS:1246298-29-2
STEZ-079
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; zymosterol-d5; (2,2,3,4,4-d5)-zymosterol; (2,2,3,4,4-D5)-5a-cholesta-8,24-dien-3?-ol; 1246298-29-2
ZYMOSTERONE
CAS:27192-37-6
STEZ-083
>99%
Avanti Polar Lipids; lipid products; sterols; sterols products; singnal transduction; cell pathways; zymosterone; cholesta-8(9),24-dien-3-one; 27192-37-6


Inhibitors

(+)-JQ1
CAS:1268524-70-4
CEI-1018
>95%
BRD2; RING3 protein; bromodomain containing 2; FLJ31942; RING3; FSH; KIAA9001; OTTHUMP00000029350; FSRG1; OTTHUMP00000178757; D6S113E; OTTHUMP00000178758; NAT; OTTHUMP00000178759; bromodomain-containing 2; RNF3; Really interesting new gene 3 protein; bromodomain-containing protein 2; O27.1.1; female sterile homeotic-related gene 1; DKFZp686N0336; H
(-)-EPIGALLOCATECHIN GALLATE
CAS:989-51-5
CEI-0676
>98% by HPLC
(-)-Epigallocatechin gallate, EGCG; (2R, 3R)-2-(3, 4, 5-Trihydroxyphenyl)-3, 4-dihydro-1[2H]-benzopyran-3, 5, 7-triol 3-(3, 4, 5-trihydroxybenzoate), 989-51-5, telomerase, DNA methyltransferase (DNMT), C??H??O??, DNMT1
(-)-HUPERZINE A
CAS:102518-79-6
CEI-0211
>99%
(-)-Huperzine A, 102518-79-6, C15H18N2O, 4-(5-p-tolyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,
(-)-JQ1
CAS:1268524-71-5
CEI-1028
>98%
DNER; delta/notch-like EGF repeat containing; delta-notch-like EGF repeat-containing transmembrane; unq26; NP_001116263; NM_001122791; WUGSC:H_NH0150O02.1; UNQ26; delta and Notch-like epidermal growth factor-related receptor; bet; H_NH0150O02.1; BET; OTTHUMP00000204223; HGNC: 24456; Entrez Gene: 92737; Ensembl: ENSG00000187957; OMIM: 607299; UniPro
(3R,4S)-TOFACITINIB
CAS:1092578-46-5
CEI-1184
0.98
(3R,4S)-Tofacitinib; 1092578-46-5; JAK; C16H20N6O
(3S,4R)-TOFACITINIB
CAS:1092578-48-7
CEI-1185
0.98
(3S,4R)-Tofacitinib; 1092578-48-7; JAK; C16H20N6O
(3S,4S)-TOFACITINIB
CAS:1092578-47-6
CEI-1186
0.98
(3S,4S)-Tofacitinib; 1092578-47-6; JAK; C16H20N6O
(R)-(-)-IBUPROFEN
CAS:51146-57-7
CEI-1187
0.98
(R)-(-)-Ibuprofen; 51146-57-7; COX; C13H18O2
(R)-BACLOFEN
CAS:69308-37-8
CEI-1188
0.98
(R)-baclofen; 69308-37-8; GABAB receptor; C10H12ClNO2
(R)-MG132
CAS:1211877-36-9
CEI-1002
>98%
ChTL, TLa, PGPH, (R)-MG132, 1211877-36-9, C26H41N3O5
(S)-(+)-IBUPROFEN
CAS:51146-56-6
CEI-1189
0.98
(S)-(+)-Ibuprofen; 51146-56-6; COX; C13H18O2
(S)-HDAC-42
CAS:935881-37-1
CEI-0998
>95%
HDACs, (S)-HDAC-42, 935881-37-1, C17H21NO2S
1,5-ISOQUINOLINEDIOL
CAS:5154-2-9
CEI-1006
PARP1; poly (ADP-ribose) polymerase 1; poly [ADP-ribose] polymerase 1; PARP-1; ADPRT 1; poly[ADP-ribose] synthase 1; poly[ADP-ribose] synthetase 1; NAD(+) ADP-ribosyltransferase 1; parp; ppol; adprt1; padprt-1; MGC131214; NP_001081571; NM_001088102; EC 2.4.2.30; PARP; ADPRT1; ADPRT; OTTHUMP00000035663; PPOL; ADP-ribosyltransferase NAD(+); ADP-ribos
10058-F4
CAS:403811-55-2
CEI-0895
10058-F4, 403811-55-2, C12H11NOS2, 4-Thiazolidinone, 5-[(4-ethylphenyl)methylene]-2-thioxo,
1400W DIHYDROCHLORIDE
CAS:214358-33-5
CEI-0541
>95%
1400W dihydrochloride, N-(3-(Aminomethyl)benzyl)acetamidine . 2HCl, 214358-33-5, iNOS, C 10 H 15 N 3 . 2HCl, NOS2
17-AAG
CAS:75747-14-7
CEI-0534
>97% by TLC
17-AAG, Telatinib; 17-(Allylamino)-17-demethoxygeldanamycin; 17-(Allylamino)geldanamycin; Tanespimycin, 75747-14-7, Hsp90, C??H??N?O?, HSP90
17-AAG, HSP90 INHIBITOR
CAS:747412-49-3
CEI-0984
>99%
17-AAG, Hsp90 inhibitor
17-DMAG HYDROCHLORIDE
CAS:467214-21-7
CEI-0535
>95% by HPLC
17-DMAG hydrochloride, 17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin Hydrochloride; Alvespimycin, 467214-21-7, Hsp90, C??H??N?O??HCl, HSP90
2-METHOXYESTRADIOL
CAS:362-07-2
CEI-0257
>99%
2-Methoxyestradiol, 2-ME2, 362-07-2, C19H2603, (8R, 9S, 13S, 14S, 17S)-2-methoxy-13-methyl-7, 8, 9, 11, 12, 13, 14, 15, 16, 17-decahydro-6H-cyclopenta[a]phenanthrene-3, 17-diol,
23-EPI-26-DEOXYACTEIN
CAS:501938-01-8
CEI-1602
(3,12,16,23S,24R,25R)-12-(Acetyloxy)-16,23:23,26:24,25-triepoxy-9,19-cyclolanostan-3-yl-D-Xylopyranoside; 26-Deoxyactein; 27-Deoxyactein; 23-epi-26-Deoxyactein
27-DEOXYACTEIN
CAS:264624-38-6
CEI-1603
(3,12,16,23S,24R,25R)-12-(Acetyloxy)-16,23:23,26:24,25-triepoxy-9,19-cyclolanostan-3-yl-D-Xylopyranoside; 26-Deoxyactein; 27-Deoxyactein; 23-epi-26-Deoxyactein
3-BROMO-7-NITROINDAZOLE
CAS:74209-34-0
CEI-0642
>95% by HPLC
BEC, S-?(2-?boronoethyl)-?L-?cysteine, 63107-40-4, rat liver arginase, human arginase II, C 5 H 12 BNO 4 S, Arg1, ARG2
3-DEAZANEPLANOCIN
CAS:102052-95-9
CEI-0477
>99%
3-Deazaneplanocin, DZNep; NSC 617989; 5R-?(4-?amino-?1H-?imidazo[4, ?5-?c]pyridin-?1-?yl)-?3-?(hydroxymethyl)-?3-?cyclopentene-?1S, ?2R-?diol, 102052-95-9, EZH2, C12H24N4O3, EZH2
3-DEAZANEPLANOCIN A (DZNEP) HYDROCHLORIDE
CAS:120964-45-6
CEI-1191
0.98
3-Deazaneplanocin A (DZNep) hydrochloride; 120964-45-6; NSC 617989 hydrochloride,DZNep,3-Deazaneplanocin A; SAHH; ENZ2; C12H14N4O3.HCl
3-DEAZANEPLANOCIN A (HYDROCHLORIDE)
CAS:120964-45-6
CEI-1011
EZH2; enhancer of zeste homolog 2; histone-lysine N-methyltransferase EZH2; Polycomb protein EZH2; xez; enx1; ezh1; kmt6; enx-1; NP_001017293; NM_001017293; enhancer of zeste homolog 2 (Drosophila); OTTHUMP00000213774; ENX-1; OTTHUMP00000213776; KMT6; OTTHUMP00000213778; EZH1; OTTHUMP00000213779; KMT6A; OTTHUMP00000213780; Lysine N-methyltransferas
3-METHYLADENINE
CAS:5142-23-4
CEI-0099
>99%
3-Methyladenine, 3-MA, 5142-23-4, C6H7N5, 3-methyl-3H-purin-6-amine,
3-NITROPROPIONIC ACID
CAS:504-88-1
CEI-0674
>95% by TLC
3-Nitropropionic acid, 3-NP, 504-88-1, succinate dehydrogenase, C 3 H 5 NO 4, SDHB
360A
CAS:794458-56-3
CEI-1190
360A; 794458-56-3; 360 A; G-quadruplex structures; C27H23N5O2+2
4-HYDROXYNONENAL
CAS:75899-68-2
CEI-0655
>97% by TLC
4-Hydroxynonenal, 4-HNE, 75899-68-2, Sirtuin 3 (SIRT3), C9H16 O2, SIRT3
4-IODO-SAHA
CAS:1219807-87-0
CEI-0996
> 98%
HDAC1, HDAC6, 4-iodo-SAHA, 1219807-87-0, C14H19IN2O3
4-METHYLUMBELLIFERONE
CAS:90-33-5
CEI-0375
>99%
4-Methylumbelliferone, 4-MU, 90-33-5, C10H8O3, 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid,
5'-O-TRITYLINOSINE
CAS:4152-77-6
CEI-1600
>98%
KIN-59; 5'-O-Tritylinosine; Tpase inhibitor
5-IODOTUBERCIDIN
CAS:24386-93-4
CEI-1192
0.9826
5-Iodotubercidin; 24386-93-4; NSC 113939; 5-ITu; Adenosine kinase; C11H13IN4O4
5-R-RIVAROXABAN
CAS:865479-71-6
CEI-1193
0.9972
5-R-Rivaroxaban; 865479-71-6; Xarelto; BAY 59-7939; Fxa; C19H18ClN3O5S
680C91
CAS:163239-22-3
CEI-0687
>98% by HPLC
680C91, 6-Fluoro-3-[(1E)-2-(3-pyridinyl)ethenyl]-1H-indole, 163239-22-3, tryptophan 2, 3-dioxygenase (TDO), C 15 H 11 FN 2, TDO2
6BIO
CAS:667463-62-9
CEI-0951
98% (TLC: 5% CH3OH3 in CH2Cl2, Rf=0.43); NMR (Conf
(2'Z, 3'E)-6-Bromoindirubin-3'-oxime, GSK3, 667463-62-9, C16H10BrN3O2, 6BIO
7-NITROINDAZOLE
CAS:2942-42-9
CEI-0643
>97% by TLC
7-Nitroindazole, 7-?nitro-?1H-?indazole; 7-NI, 2942-42-9, rat nNOS, bovine eNOS, rat iNOS, C7H5N3O2, Nos1, NOS3, Nos2
A 922500
CAS:959122-11-3
CEI-0246
>99%
A 922500, 959122-11-3, C26H24N2O4, Cyclopentanecarboxylic acid, 2-[[4-[[(phenylamino)carbonyl]amino][1, 1-biphenyl]-4-yl]carbonyl]-, (1R, 2R)-,
A-443654
CAS:552325-16-3
CEI-1194
0.98
A-443654; 552325-16-3; A 443654; A443654; Akt; C24H23N5O
A-674563
CAS:552325-73-2
CEI-0105
>99%
A-674563, 552325-73-2, Akt1, C22H22N4O, AKT1
A-769662
CAS:844499-71-4
CEI-0133
>99%
A-769662, 844499-71-4, AMP, AMPK alpha-1, AMPK beta-1, AMPK gamma-1, C20H12N2O3S, Thieno[2, 3-b]pyridine-5-carbonitrile, 6, 7-dihydro-4-hydroxy-3-(2-hydroxy[1, 1-biphenyl]-4-yl)-6-oxo-, APRT, PRKAA1, PRKAB1, PRKAG1
A-966492
CAS:934162-61-5
CEI-0324
>99%
A-966492, 934162-61-5, PARP1, C18H17FN4O, 2-(2-fluoro-4-((S)-pyrrolidin-2-yl)phenyl)-3H-benzo[d]imidazole-4-carboxamide, PARP1
A-BUNGAROTOXIN
CAS:11032-79-4
CEI-1182
>99%
a-BTX, a-Bgt
A66
CAS:1166227-08-2
CEI-0127
>99%
A66, 1166227-08-2, p110-alpha, C17H23N5O2S2, (2S)-N1-(5-(2-tert-butylthiazol-4-yl)-4-methylthiazol-2-yl)pyrrolidine-1, 2-dicarboxamide, PIK3CA
A83-01
CAS:909910-43-6
CEI-0952
>98% (TLC); NMR (Conforms)
ALK; anaplastic lymphoma receptor tyrosine kinase; anaplastic lymphoma kinase (Ki 1); ALK tyrosine kinase receptor; CD246; CD246 antigen; mutant anaplastic lymphoma kinase; NBLST3; NP_004295; NM_004304; Q9UM73; anaplastic lymphoma kinase (Ki-1); OTTHUMP00000201048; EC 2.7.10.1; Anaplastic lymphoma kinase; HGNC: 427; Entrez Gene: 238; Ensembl: ENSG0
A939572
CAS:1032229-33-6
CEI-1195
A939572; 1032229-33-6; SCD1; C20H22ClN3O3
AAL-993
CAS:269390-77-4
CEI-0953
>98% (TLC); NMR (Conforms)
VEGFA; vascular endothelial growth factor A; vascular endothelial growth factor, VEGF; VEGF A; VPF; vascular permeability factor; VEGF; MVCD1; MGC70609; NP_001020537; NM_001025366; P15692;
ABC294640
CAS:915385-81-8
CEI-1196
0.98
ABC294640; 915385-81-8; Sphingosine kinase 2; C23H25ClN2O
ABIRATERONE
CAS:154229-19-3
CEI-1197
0.9819
Abiraterone; 154229-19-3; CB 7598,16-dien-3-ol,CB7598; CYP17; C24H31NO
ABIRATERONE ACETATE (CB7630)
CAS:154229-18-2
CEI-0228
>99%
Abiraterone Acetate (CB7630), CB 7630, CB-7630, 154229-18-2, cytochrome P45017alpha, C26H33NO2, Cyp17a1
ABITREXATE(METHOTREXATE)
CAS:1959-5-2
CEI-0325
>99%
Abitrexate(Methotrexate), Methotrexate, Rheumatrex, Trexall, 21672, C20H22N8O5
ABT-046
CAS:1031336-60-3
CEI-1198
ABT-046; 1031336-60-3; DGAT-1 inhibitor; ABT 046; ABT046; DGAT-1; C20H22N4O2
ABT-263 (NAVITOCLAX)
CAS:923564-51-6
CEI-0941
ABT-263 (Navitoclax), 923564-51-6, Bcl-xL, Bcl-2, Bcl-w, C47H55ClF3N5O6S3, BCL2L1, BCL2, BCL2L2
ABT-737
CAS:852808-04-09
CEI-1079
> 95%
BCL2,
ABT-888
CAS:912445-05-7
CEI-0636
>98% by TLC
Emetine dihydrochloride, 2S, 3R, 11bS)-2-{[(1R)-6, 7-Dimethoxy-1, 2, 3, 4-tetrahydroisoquinolin-1-yl]methyl}-3-ethyl-9, 10-dimethoxy-2, 3, 4, 6, 7, 11b-hexahydro-1H-pyrido[2, 1-a]isoquinoline, 316-42-7, Protein Synthesis, C??H??N?O?2HCl, Protein Synthesis
ABT-888 (VELIPARIB)
CAS:912444-00-9
CEI-0316
>99%
ABT-888 (Veliparib), 912444-00-9, PARP1, PARP2, C13H16N4O, (R)-2-(2-methylpyrrolidin-2-yl)-1H-benzo[d]imidazole-4-carboxamide, PARP1, PARP2
AC220 (QUIZARTINIB)
CAS:950769-58-1
CEI-0055
>99%
AC220 (Quizartinib), 950769-58-1, Flt3(ITD), Flt3(WT), C29H32N6O4S, Urea, N-[5-(1, 1-dimethylethyl)-3-isoxazolyl]-N-[4-[7-[2-(4-morpholinyl)ethoxy]imidazo[2, 1-b]benzothiazol-2-yl]phenyl]-, FLT3
ACADESINE
CAS:2627-69-2
CEI-0888
Acadesine, AICAR, AICA-riboside, 2627-69-2, AMPK, C9H14N4O5, 5-amino-1-((2R, 3R, 4S, 5R)-3, 4-dihydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-1H-imidazole-4-carboxamide, PRKAA1
ACLACINOMYCIN A
CAS:57576-44-0
CEI-0624
>95% by HPLC
Aclacinomycin A, Aclarubicin, 57576-44-0, proteasome, C 42 H 53 NO 15, proteasome
ACTINOMYCIN D
CAS:50-76-0
CEI-1044
>99%
Transcription inhibitor, Actinomycin D, 50-76-0, C62H86N12O16
ACYCLOVIR
CAS:59277-89-3
CEI-0376
>99%
Acyclovir, Aciclovir, Acycloguanosine, Zovirax, 59277-89-3, C8H11N5O3
ADEFOVIR DIPIVOXIL(PREVEON, HEPSERA)
CAS:142340-99-6
CEI-0249
>99%
Adefovir Dipivoxil(Preveon, Hepsera), Bis-POM PMEA, Preveon, Hepsera, 142340-99-6, C20H32N5O8P
ADENYLYL CYCLASE TYPE V INHIBITOR, NKY80
CAS:299442-43-6
CEI-0722
Adenylyl Cyclase Type V Inhibitor, NKY80, NKY80, 2-Amino-7-(furan-2-yl)-7, 8-dihydroquinazolin-5(6H)-one, 299442-43-6, Adenylyl Cyclase, C12H11N3O2, ADCY
ADRIAMYCIN (DOXORUBICIN)
CAS:25316-40-9
CEI-0290
>99%
Adriamycin (Doxorubicin), 25316-40-9, topoisomerase II, C27H29NO11.HCl, (8S, 10S)-10-((2R, 4S, 5S, 6S)-4-amino-5-hydroxy-6-methyl-tetrahydro-2H-pyran-2-yloxy)-6, 8, 11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7, 8, 9, 10-tetrahydrotetracene-5, 12-dione hydrochloride, TOP2A
AEBSF.HCL
CAS:30827-99-7
CEI-0646
>95% by HPLC
AEBSF.HCl, 4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride, 30827-99-7, serine protease, C??H??N?O, F2
AEE788 (NVP-AEE788)
CAS:497839-62-0
CEI-0036
>99%
AEE788 (NVP-AEE788), 497839-62-0, EGFR, C27H32N6, EGFR
AFATINIB (BIBW2992)
CAS:439081-18-2
CEI-0048
>99%
Afatinib (BIBW2992), Tomtovok, 439081-18-2, EGFR(WT), EGFR(L858R), EGFR(L858R/T790M), HER2, C24H25CLFN5O3, (S, E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide, EGFR, ERBB2
AG 18 (TYRPHOSTIN 23, RG-50810)
CAS:118409-57-7
CEI-0848
AG 18 (Tyrphostin 23, RG-50810), RG-50810, 118409-57-7, EGFR, C10H6N2O2, Propanedinitrile, 2-[(3, 4-dihydroxyphenyl)methylene]-, EGFR
AG-1024 (TYRPHOSTIN)
CAS:65678-07-1
CEI-0035
>99%
AG-1024 (Tyrphostin), 65678-07-1, IGF-1R, C14H13BrN2O, IGF1R
AG-1296
CAS:146535-11-7
CEI-0954
>98% (TLC); NMR (Conforms)
PDGFRB; platelet-derived growth factor receptor, beta polypeptide; PDGFR; platelet-derived growth factor receptor beta; CD140b; JTK12; PDGFR1; PDGFR-beta; PDGF-R-beta; CD140 antigen-like family member B; platelet-derived growth factor receptor 1; beta-type platelet-derived growth factor receptor; CD140B; PDGFR-1; NP_002600; NM_002609; P09619; OTTHU
AG-14361
CAS:328543-09-5
CEI-1200
0.98
AG-14361; 328543-09-5; PARP1; C19H20N4O
AG-1478
CAS:175178-82-2
CEI-0955
>98% (TLC); NMR (Conforms)
EGFR; epidermal growth factor receptor; epidermal growth factor receptor (avian erythroblastic leukemia viral (v erb b) oncogene homolog), ERBB; ERBB1; erythroblastic leukemia viral (v erb b) oncogene homolog (avian); proto-oncogene c-ErbB-1; cell growth inhibiting protein 40; cell proliferation-inducing protein 61; receptor tyrosine-protein kinase
AG-1478 (TYRPHOSTIN AG-1478)
CAS:153436-53-4
CEI-0068
>99%
AG-1478 (Tyrphostin AG-1478), 153436-53-4, EGFR, C16H14ClN3O2, N-(3-chlorophenyl)-6, 7-dimethoxyquinazolin-4-amine, EGFR
AG-490
CAS:133550-30-8
CEI-0007
>99%
AG-490, 133550-30-8, EGFR, ErbB2, JAK2, C17H14N2O3, (E)-N-benzyl-2-cyano-3-(3, 4-dihydroxyphenyl)acrylamide, EGFR, ERBB2, JAK2
AG-879
CAS:148741-30-4
CEI-0956
>99% (TLC); NMR (Conforms)
NGFR; nerve growth factor receptor; nerve growth factor receptor (TNFR superfamily, member 16); tumor necrosis factor receptor superfamily member 16; CD271; low affinity nerve growth factor receptor; p75NTR; TNFR superfamily; member 16; TNFRSF16; p75 ICD; NGF receptor; TNFR superfamily, member 16; low affinity neurotrophin receptor p75NTR; low-affi
AG13958
CAS:319460-94-1
CEI-1080
> 95%
KDR,
AGI-5198
CAS:1355326-35-0
CEI-0995
> 95%
IDH1; isocitrate dehydrogenase (NAD+) subunit 1 Idh1; EC 1.1.1.41; NP_594397; NM_001019820; isocitrate dehydrogenase 1 (NADP+), soluble; IDPC; Oxalosuccinate decarboxylase; OTTHUMP00000163870; IDH; OTTHUMP00000206464; IDP; OTTHUMP00000206466; PICD; isocitrate dehydrogenase [NADP] cytoplasmic; NADP(+)-specific ICDH; NADP-dependent isocitrate dehydro
AICAR
CAS:2627-69-2
CEI-0988
>99%
Acetyl Carboxylase, AICAR
AIM-100
CAS:873305-35-2
CEI-1201
0.98
AIM-100; 873305-35-2; AIM 100; AIM100; Ack1; C23H21N3O2
AKT INHIBITOR VIII
CAS:612847-09-3
CEI-1202
0.98
AKT inhibitor VIII; 612847-09-3; Akt1; Akt2; Akt3; C34H29N7O
AKT INHIBITOR X
CAS:925681-41-0
CEI-0724
Akt Inhibitor X, 2-Chloro-10-[4-(diethylamino)butyl]phenoxazine hydrochloride4-(2-Chloro-10H-phenoxazin-10-yl)-N, N-diethylbutan-1-amine hydrochloride, 925681-41-0, Akt, C20H25ClN2O.HCl, AKT1
AKT KINASE INHIBITOR
CAS:842148-40-7
CEI-1203
0.98
AKT Kinase Inhibitor; 842148-40-7; AKT Kinase; C16H19N7O3
AKT-I-1
CAS:473382-39-7
CEI-1081
> 95%
AKT1, AKT1; v-akt murine thymoma viral oncogene homolog 1; RAC-alpha serine/threonine-protein kinase; AKT; PKB; PRKBA; RAC; PKB alpha; RAC-PK-alpha; proto-oncogene c-Akt; protein kinase B alpha; rac protein kinase alpha; PKB-ALPHA; RAC-ALPHA; MGC99656; NP_001014431; NM_001014431; P31749; EC 2.7.11.1; Protein kinase B; Proto-oncogene c-Akt; EC 2.7.1
AKT-I-1,2
CAS:473382-48-8
CEI-1082
> 95%
AKT1, AKT2, AKT1; v-akt murine thymoma viral oncogene homolog 1; RAC-alpha serine/threonine-protein kinase; AKT; PKB; PRKBA; RAC; PKB alpha; RAC-PK-alpha; proto-oncogene c-Akt; protein kinase B alpha; rac protein kinase alpha; PKB-ALPHA; RAC-ALPHA; MGC99656; NP_001014431; NM_001014431; P31749; EC 2.7.11.1; Protein kinase B; Proto-oncogene c-Akt; EC
ALENDRONATE
CAS:121268-17-5
CEI-0362
>99%
Alendronate, Fosamax, 121268-17-5, C4H13NO7P2.3H2O.Na
ALFACALCIDOL
CAS:41294-56-8
CEI-1204
0.9988
Alfacalcidol; 41294-56-8; Bone; C27H44O2
ALISKIREN HEMIFUMARATE
CAS:173334-58-2
CEI-0352
>99%
Aliskiren hemifumarate, 173334-58-2, C30H53N3O6.1/2C4H4O4, (2S, 4S, 5S, 7S)-7-(4-methoxy-3-(3-methoxypropoxy)benzyl)-5-amino-N-(3-amino-2, 2-dimethyl-3-oxopropyl)-4-hydroxy-2-isopropyl-8-methylnonanamide hemifumarate,
ALK INHIBITOR 1
CAS:761436-81-1
CEI-1205
0.98
ALK inhibitor 1; 761436-81-1; ALK; C23H28BrN7O3S
ALK INHIBITOR 2
CAS:761438-38-4
CEI-1206
0.98
ALK inhibitor 2; 761438-38-4; ALK; C23H28ClN7O3S
ALOGLIPTIN BENZOATE
CAS:850649-62-6
CEI-1207
0.98
Alogliptin Benzoate; 850649-62-6; SYR322, SYR-322,Nesina; DPP-4; C25H27N5O4
ALPROSTADIL
CAS:745-65-3
CEI-1178
> 95%
PTGER3, PTGER4,
ALSTERPAULLONE
CAS:237430-03-4
CEI-0957
>96% (TLC); NMR (Conforms)
GSK3B; glycogen synthase kinase 3 beta; glycogen synthase kinase-3 beta; GSK-3 beta; GSK3beta isoform; serine/threonine-protein kinase GSK3B; NP_001139628; NM_001146156; P49841; OTTHUMP00000165240; EC 2.7.11.26; OTTHUMP00000165239; EC 2.7.11; HGNC: 4617; Entrez Gene: 2932; Ensembl: ENSG00000082701; OMIM: 605004; UniProtKB: P49841; GSK3B_HUMAN;
ALVESPIMYCIN
CAS:467214-20-6
CEI-1208
0.98
Alvespimycin; 467214-20-6; 17-DMAG,KOS-1022,NSC707545; Hsp90; C32H48N4O8
ALVOCIDIB
CAS:146426-40-6
CEI-0990
>99%
CDK, CTPB
ALW-II-41-27
CAS:1186206-79-0
CEI-1209
ALW-II-41-27; 1186206-79-0; Eph receptor tyrosine kinase inhibitor; Eph receptor;
AM-1241
CAS:444912-48-5
CEI-0331
>99%
AM-1241, 444912-48-5, CB2 receptor, C22H22IN3O3, CNR2
AM679
CAS:1206880-66-1
CEI-1210
0.98
AM679; 1206880-66-1; AM-679; AM 679; FLAP; C40H44N4O5S
AMG 900
CAS:945595-80-2
CEI-0948
AMG 900, 945595-80-2, Aurora A, Aurora B, Aurora C, p38a, C28H21N7OS, N-(4-(3-(2-aminopyrimidin-4-yl)pyridin-2-yloxy)phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine, AURKA, AURKB, Aurora C, MAPK14
AMG-1
CAS:913376-84-8
CEI-1135
> 95%
MET, MST1R,
AMG-208
CAS:1002304-34-8
CEI-0034
>99%
AMG-208, 1002304-34-8, c-Met, C22H17N5O2, MET
AMG-25
CAS:1003311-62-3
CEI-1128
> 95%
KIT,
AMG-47A
CAS:882663-88-9
CEI-1083
> 95%
LCK, LCK; lymphocyte-specific protein tyrosine kinase; tyrosine-protein kinase Lck; leukocyte C-terminal Src kinase; p56(LSTRA) protein-tyrosine kinase; t cell-specific protein-tyrosine kinase; proto-oncogene tyrosine-protein kinase LCK; lymphocyte cell-specific protein-tyrosine kinase; T-lymphocyte specific protein tyrosine kinase p56lck; LSK; YT1
AMG-51
CAS:890019-63-3
CEI-1119
> 95%
MET, KDR; kinase insert domain receptor (a type III receptor tyrosine kinase); vascular endothelial growth factor receptor 2; CD309; FLK1; VEGFR; VEGFR2; soluble VEGFR2; fetal liver kinase 1; fetal liver kinase-1; protein-tyrosine kinase receptor Flk-1; tyrosine kinase growth factor receptor; NP_002244; NM_002253; P35968;
AMG-TIE2-1
CAS:870223-96-4
CEI-1084
> 95%
TEK,
AMG458
CAS:913376-83-7
CEI-0032
>99%
AMG458, 913376-83-7, human c-Met, C30H29N5O5, MET
AMI-1
CAS:134-47-4
CEI-0619
>98% by HPLC
AMI-1, Arginine N-methyltransferase inhibitor-1, PRMT1, HIV-1 RT polymerase, C??H??N?O?S?Na?, PRMT1
AMI-5
CAS:17372-87-1
CEI-0559
>97% by HPLC
AMI-5, 2', 4', 5', 7'-Tetrabromofluorescein disodium salt, Acid Red 87, Bromo acid J. TS, XL, or XX, Bromofluorescein, Bronze Bromo ES, Eosin yellowish, 17372-87-1, metalloprotease (MMP), C20H6Br4Na2O5, MMP
AMIDEPSINE A, HUMCOLA SP.
CAS:169181-28-6
CEI-0457
>97% by HPLC
Amidepsine A, Humcola sp., N-[4-[[4-[(2, 4-Dimethoxy-6-methylbenzoyl)oxy]-2-hydroxy-6-methylbenzoyl]oxy]-2-hydroxy-6-methylbenzoyl]-L-alanine, 169181-28-6, diacylglycerol acyltransferase (DGAT), C 29 H 29 NO 11, DGAT1
AMIDEPSINE D, HUMCOLA SP.
CAS:79786-34-8
CEI-0458
>95% by HPLC
Amidepsine D, Humcola sp., N-[4-[[4-[(2, 4-Dimethoxy-6-methylbenzoyl)oxy]-2-hydroxy-6-methylbenzoyl]oxy]-2-hydroxy-6-methylbenzoic acid, 79786-34-8, diacylglycerol acyltransferase (DGAT), C 26 H 24 NO 10, DGAT1
AMONAFIDE
CAS:69408-81-7
CEI-0284
>99%
Amonafide, AS1413, Xanafide, Quinamed, 69408-81-7, topoisomerase II, C16H17N3O2, TOP2A
AMPRENAVIR (AGENERASE)
CAS:161814-49-9
CEI-1211
0.9684
Amprenavir (agenerase); 161814-49-9; HIV-1 protease; C25H35N3O6S
AMUVATINIB (MP-470)
CAS:850879-09-3
CEI-0020
>99%
Amuvatinib (MP-470), 850879-09-3, c-Kit, C23H21N5O3S, KIT
AN-2728
CAS:906673-24-3
CEI-1212
0.9918
AN-2728; 906673-24-3; AN2728; AN 2728; PDE4; C14H10BNO3
ANACARDIC ACID
CAS:16611-84-0
CEI-0597
>97% by HPLC
Anacardic Acid, 2-Hydroxy-6-pentadecylbenzoic acid, 6-Pentadecylsalicylic acid; AA, 16611-84-0, p300 and PCAF histone acetyltransferase, C??H??O?, EP300, KAT2B
ANACETRAPIB (MK-0859)
CAS:875446-37-0
CEI-1213
0.9959
Anacetrapib (MK-0859); 875446-37-0; MK 0859, MK0859; rhCETP; mutant CETP(C13S); C30H25F10NO3
ANASTROZOLE
CAS:120511-73-1
CEI-0349
>99%
Anastrozole, Arimidex, 120511-73-1, C17H19N5
ANDARINE
CAS:401900-40-1
CEI-1214
0.98
Andarine; 401900-40-1; Androgen receptor; C19H18F3N3O6
ANDRASTIN A, ASPERGILLUS FUMIGATUS
CAS:174232-42-9
CEI-0479
>98% by HPLC
Andrastin A, Aspergillus fumigatus, Andrastin A, Aspergillus fumigatus, 174232-42-9, Farnesyl Protein Transferase (FPT), C 28 H 38 O 7, FPT
ANGIOTENSIN CONVERTING ENZYME INHIBITOR
CAS:35115-60-7
CEI-0725
Angiotensin Converting Enzyme Inhibitor, H-pGlu-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro-OH, 35115-60-7, Angiotensin Converting Enzyme, C53H76N14O12, ACE
ANGUIZOLE
CAS:442666-98-0
CEI-1215
0.98
Anguizole; 442666-98-0; 7-[chloro(difluoro)methyl]-5-(furan-2-yl)-N-(thiophen-2-ylmethyl)pyrazolo[1,5-a]pyrimidine-2-carboxamide; HCV; C17H11ClF2N4O2S
ANISOMYCIN
CAS:22862-76-6
CEI-0555
>95% (1H NMR)
Anisomycin, (2R, 3S, 4S)-2-(4-Methoxybenzyl)-3, 4-pyrrolidinediol-3-acetate, 2-[(4-Methoxyphenyl)methyl]-3, 4-pyrrolidinediol 3-acetate, Flagecidin, 22862-76-6, MAP kinase, C??H??NO?, MAPK
ANTIMYCIN A
CAS:1397-94-0
CEI-0573
>98% by HPLC
Antimycin A, Antipiricullin, Virosin, 1397-94-0, mitochondrial complex I, C 28 H 40 N 2 O 9, mitochondrial complex I
ANTIPAIN
CAS:37691-11-5
INBZ-001
Antipain; Antipain; arboxy-2-Phenylethyl]-Carbamoyl-L-Arg-L-Val-Arginal; 37691-11-5; inhibitor
ANTITHROMBIN III FROM HUMAN
CAS:90170-80-2
CEI-1597
>=95% by SDS-PAGE
ATIII; Antithrombin; AT; Factor Xa inhibitor; Heparin cofactor; Antithrombin III
AP26113
CAS:1197958-12-5
CEI-0851
AP26113, 1197958-12-5, ALK, FER, ROS/ROS1, FLT3, FES/FPS, C26H34ClN6O2P, 2, 4-Pyrimidinediamine, 5-chloro-N2-[4-[4-(dimethylamino)-1-piperidinyl]-2-methoxyphenyl]-N4-[2-(dimethylphosphinyl)phenyl]-, ALK, FER, ROS1, FLT3, FES
APATINIB (YN968D1)
CAS:811803-05-1
CEI-0028
>99%
Apatinib (YN968D1), 811803-05-1, VEGFR2, C25H27N5O4S, KDR
APICIDIN
CAS:183506-66-3
CEI-0495
>98% by ?1V-NMR
Apicidin, cyclo-L-(2-Amino-8-oxodecanoyl)-L-(N-methoxy-tryptophan)-L-isoleucyl-D-pipecolinyl]Suberoylanilide hydroxamic acid, 183506-66-3, HDAC, C??H??N?O?, HDAC
APIGENIN
CAS:520-36-5
CEI-0235
>99%
Apigenin, 520-36-5, C15H10O5
APIXABAN
CAS:503612-47-3
CEI-0241
>99%
Apixaban, 503612-47-3, Factor Xa, C25H25N5O4, 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4, 5, 6, 7-tetrahydro-1H-pyrazolo[3, 4-c]pyridine-3-carboxamide, F10
APOGOSSYPOLONE (APOG2)
CAS:886578-07-0
CEI-0937
Apogossypolone (ApoG2), 886578-07-0, Bcl-2, Bcl-XL, Mcl-1, C28H26O8, [2, 2'-Binaphthalene]-1, 1', 4, 4'-tetrone, 6, 6', 7, 7'-tetrahydroxy-3, 3'-dimethyl-5, 5'-bis(1-methylethyl)-, BCL2, BCL2L1, MCL1
APOPTOSIS ACTIVATOR 2
CAS:79183-19-0
CEI-0922
Apoptosis Activator 2, 79183-19-0, caspases, C15H9Cl2NO2, 1H-Indole-2, 3-dione, 1-[(3, 4-dichlorophenyl)methyl]-, caspases
APOPTOSIS INHIBITOR II, NS3694
CAS:426834-38-0
CEI-0726
Apoptosis Inhibitor II, Ns3694, 4-Chloro-2-(3-[3-(trifluoromethyl)phenyl]ureido)benzoic acid, 426834-38-0, Apoptosis, C15H10ClF3N2O3, Apoptosis
APREMILAST
CAS:608141-41-9
CEI-0616
>95% by TLC
Apremilast, N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1, 3-dioxo-2, 3-dihydro-1H-isoindol-4-yl}acetamide, 608141-41-9, phosphodiesterase (PDE), C 22 H 24 N 2 O 7 S, PDE1a, PDE2A, PDE3A, PDE4A, PDE5A
APREPITANT(MK-0869)
CAS:170729-80-3
CEI-0371
>99%
Aprepitant(MK-0869), MK-869, L-754030, Emend, 170729-80-3, C23H21F7N4O3
APROTININ FROM BOVINE, RECOMBINANT
CAS:9087-70-1
NATE-1892
> 95%
Trypsin Inhibitor; 9087-70-1; aprotinin; Trasylol
AR-C155858
CAS:496791-37-8
CEI-1216
0.98
AR-C155858; 496791-37-8; AR C155858; MCT1; MCT2; C21H27N5O5S
ARN-509
CAS:956104-40-8
CEI-1217
0.98
ARN-509; 956104-40-8; ARN 509; ARN509; Androgen Receptor; GABAA receptor; C21H15F4N5O2S
ARQ 197 (TIVANTINIB)
CAS:905854-02-6
CEI-0006
>99%
ARQ 197 (Tivantinib), 905854-02-6, c-Met, C23H19N3O2, (3R, 4R)-3-(2, 3-dihydro-1H-pyrrolo[3, 2, 1-ij]quinolin-6-yl)-4-(1H-indol-3-yl)pyrrolidine-2, 5-dione, AG-490, 133550-30-8, EGFR, ErbB2, JAK2, C17H14N2O3, (E)-N-benzyl-2-cyano-3-(3, 4-dihydroxyphenyl)acrylamide, EGFR, ERBB2, JAK2
ARRY 520 TRIFLUOROACETATE
CAS:885060-09-3
CEI-1218
0.98
ARRY 520 trifluoroacetate; 885060-09-3; KSP; C20H22F2N4O2S. CF3CO2H
ARRY-380
CAS:937265-83-3
CEI-0031
>99%
Arry-380, 937265-83-3, HER2, C29H27N7O4S, ERBB2
ARRY334543 (VARLITINIB)
CAS:845272-21-1
CEI-0927
ARRY334543 (Varlitinib), 845272-21-1, ErbB2, ErbB1, C22H19ClN6O2S, (R)-N4-(3-chloro-4-(thiazol-2-ylmethoxy)phenyl)-N6-(4-methyl-4, 5-dihydrooxazol-2-yl)quinazoline-4, 6-diamine, ERBB2, EGFR
AS-041164
CAS:6318-41-8
CEI-0958
>98% (TLC); NMR (Conforms)
PIK3CG; phosphoinositide-3-kinase, catalytic, gamma polypeptide; phosphatidylinositol-4, 5-bisphosphate 3-kinase catalytic subunit gamma isoform; p110gamma; p120-PI3K; PI3K-gamma; p110-gamma; PI3-kinase subunit gamma; ptdIns-3-kinase subunit gamma; 1-phosphatidylinositol 3-kinase; ptdIns-3-kinase subunit p110-gamma; serine/threonine protein kinase
AS-252424
CAS:900515-16-4
CEI-0088
>99%
AS-252424, 900515-16-4, PI3K-gamma, C14H8FNO4S, (Z)-5-((5-(4-fluoro-2-hydroxyphenyl)furan-2-yl)methylene)thiazolidine-2, 4-dione, PIK3CG
AS-602801
CAS:848344-36-5
CEI-1137
> 95%
JNK-1,
AS-604850
CAS:648449-76-7
CEI-0100
>99%
AS-604850, 648449-76-7, PI3K-gamma, C11H5F2NO4S, PIK3CG
AS-605240
CAS:648450-29-7
CEI-0080
>99%
AS-605240, 648450-29-7, PI3K-gamma, C12H7N3O2S, (Z)-5-(quinoxalin-6-ylmethylene)thiazolidine-2, 4-dione, PIK3CG
AS703026
CAS:1236699-92-5
CEI-0153
>99%
AS703026, MSC1936369B, 1236699-92-5, MEK1/2, C15H15FIN3O3, (S)-N-(2, 3-dihydroxypropyl)-3-(2-fluoro-4-iodophenylamino)isonicotinamide, Dsor1
ASP3026
CAS:1097917-15-1
CEI-1219
0.9802
ASP3026; 1097917-15-1; ASP 3026; ASP-3026; ALK; C29H40N8O3S
AST 487
CAS:630124-46-8
CEI-1220
0.98
AST 487; 630124-46-8; NVP-AST 487; RET kinase; C26H30F3N7O2
AST-1306
CAS:1050500-29-2
CEI-0001
>99%
AST-1306, 1050500-29-2, EGFR, ErbB2, C24H18ClFN4O2, C7H8O3S, 2-Propenamide, N-[4-[[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-, 4-methylbenzenesulfonate (1:1), Ki8751, 228559-41-9, VEGFR2, C24H18F3N3O4, ZM-323881, 193000-39-4, VEGFR2, C22H18FN3O2.HCl, 4-fluoro-2-methyl-5-[(7-phenylmethoxyquinazolin-4-yl)amino]phenol, ZM-30641
ASUNAPREVIR (BMS-650032)
CAS:630420-16-5
CEI-1222
0.98
Asunaprevir (BMS-650032); 630420-16-5; BMS-650032; BMS 650032; BMS650032,Asunaprevir; NS3 protease; C35H46ClN5O9S
AT-101
CAS:90141-22-3
CEI-1223
0.98
AT-101; 90141-22-3; (R)-(-)-Gossypol; R-(-)-gossypol acetic acid; AT 101; AT101; Bcl-2; Bcl-XL; Mcl-1; C30H30O8
AT-406
CAS:1071992-99-8
CEI-0179
>99%
AT-406, 1071992-99-8, XIAP, cIAP1, cIAP2, C32H43N5O4, (5S, 8S, 10aR)-N-benzhydryl-5-((S)-2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxo-decahydropyrrolo[1, 2-a][1, 5]diazocine-8-carboxamide, XIAP, BIRC2, BIRC3
AT-7519
CAS:902135-91-5
CEI-1085
> 95%
CDKs,
AT101
CAS:866541-93-7
CEI-0931
AT101, R-(-)-gossypol acetic acid, 866541-93-7, Bcl-2, C30H30O8.C2H4O2, [2, 2'-Binaphthalene]-8, 8'-dicarboxaldehyde, 1, 1', 6, 6', 7, 7'-hexahydroxy-3, 3'-dimethyl-5, 5'-bis(1-methylethyl)-, (2R)-, compd. with acetic acid (1:1), BCL2
AT13387
CAS:912999-49-6
CEI-0338
>99%
AT13387, 912999-49-6, HSP90, C24H31N3O3, Hsp90
AT7519
CAS:844442-38-2
CEI-0305
>99%
AT7519, 844442-38-2, CDK1, CDK2, CDK4, CDK5, CDK6, C16H17Cl2N5O2, 4-(2, 6-dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide, CDK1, CDK2, CDK4, CDK5, CDK6
AT7867
CAS:857531-00-1
CEI-0110
>99%
AT7867, 857531-00-1, Akt1, Akt2, Akt3, S6K, C20H20ClN3, 4-(4-(1H-pyrazol-4-yl)phenyl)-4-(4-chlorophenyl)piperidine, AKT1, AKT2, AKT3, RPS6KB1
AT9283
CAS:896466-04-9
CEI-0195
>99%
AT9283, 896466-04-9, Aurora A, Aurora B, JAK3, JAK2, Abl, C19H23N7O2, 1-cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea, AURKA, AURKB, JAK3, JAK2, ABL1
ATAZANAVIR
CAS:198904-31-3
CEI-1224
0.9801
Atazanavir; 198904-31-3; HIV protease; C38H52N6O7
ATAZANAVIR SULFATE
CAS:229975-97-7
CEI-0218
>99%
Atazanavir sulfate, BMS-232632, BMS-232632-05, Reyataz, 229975-97-7, C38H52N6O7.H2SO4
ATOMOXETINE HCL
CAS:82248-59-7
CEI-1225
0.98
Atomoxetine HCl; 82248-59-7; Norepinephrine transporter; C17H22ClNO
ATORVASTATIN
CAS:134523-00-5
CEI-0532
>98%
Atorvastatin, 2-?(4-?fluorophenyl)-?R, ?dR-?dihydroxy-?5-?(1-?methylethyl)-?3-?phenyl- ?4-?[(phenylamino)carbonyl]-?1H-?pyrrole-?1-?heptanoic acid, 134523-00-5, HMG-CoA reductase, C33H35FN2O5, HMG-CoA
ATORVASTATIN CALCIUM
CAS:134523-03-8
CEI-1163
> 95%
HMGCR,
ATPENIN A5 (SYNTHETIC)
CAS:119509-24-9
CEI-0572
>99%
Atpenin A5 (Synthetic), 3-[(2S, 4S, 5R)-5, 6-Dichloro-2, 4-dimethyl-1-oxohexyl]-4-hydroxy-5, 6-dimethoxy-2(1H)-pyridinone, 119509-24-9, mitochondrial complex I, C 15 H 21 Cl 2 NO 5, mitochondrial complex I
AURANOFIN
CAS:34031-32-8
CEI-0552
>98% by NMR
Auranofin, 1-Thio--D-glucopyranosatotriethylphosphine gold-2, 3, 4, 6-tetraacetate; SKF39162, 34031-32-8, Leukocyte activation pathways, C20H34AuO9PS, Leukocyte activation pathways
AURODOX
CAS:12704-90-4
CEI-0471
>98% by HPLC
Aurodox, 1-Methylmocimycin; Antibiotic X 5108; Goldinodox; Goldinomycin; NSC 233989; Benzamide; CYT11387, 12704-90-4, elongation factor Tu (EF-Tu), C 44 H 62 N 2 O 12, EEF1A1
AURORA A INHIBITOR I
CAS:1158838-45-9
CEI-0846
Aurora A Inhibitor I, 1158838-45-9, Aurora A, Aurora B, Aurora C, C31H31ClFN7O2, N-(2-chlorophenyl)-4-(2-(4-(2-(4-ethylpiperazin-1-yl)-2-oxoethyl)phenylamino)-5-fluoropyrimidin-4-ylamino)benzamide, AURKA, AURKB, Aurora C
AV-412
CAS:451492-95-8
CEI-1086
> 95%
EGFR, ERBB2, EGFR; epidermal growth factor receptor; epidermal growth factor receptor (avian erythroblastic leukemia viral (v erb b) oncogene homolog), ERBB; ERBB1; erythroblastic leukemia viral (v erb b) oncogene homolog (avian); proto-oncogene c-ErbB-1; cell growth inhibiting protein 40; cell proliferation-inducing protein 61; receptor tyrosine-p
AVL-292
CAS:1202757-89-8
CEI-1226
0.9994
AVL-292; 1202757-89-8; AVL292; AVL 292; Btk; C22H22FN5O3
AXITINIB(AG 013736)
CAS:319460-85-0
CEI-0889
Axitinib(AG 013736), AG 013736, 319460-85-0, VEGFR1, VEGFR2, VEGFR3, PDGFR, c-Kit, C22H18N4OS, FLT1, KDR, FLT4, PDGFRB, KIT
AZ 3146
CAS:1124329-14-1
CEI-0337
>99%
AZ 3146, 1124329-14-1, MSP1, C24H32N6O3, MSP1
AZ 960
CAS:905586-69-8
CEI-0189
>99%
AZ 960, 905586-69-8, JAK2, C18H16F2N6, JAK2
AZ20
CAS:1233339-22-4
CEI-1227
0.9925
AZ20; 1233339-22-4; AZ-20; AZ 20; ATR; C21H24N4O3S
AZ628
CAS:878739-06-1
CEI-0154
>99%
AZ628, 878739-06-1, BRAF(V600E), c-raf(wild-type), C27H25N5O2, BRAF, RAF1
AZACITIDINE(VIDAZA)
CAS:320-67-2
CEI-0279
>99%
Azacitidine(Vidaza), 5-azacytidine, Mylosar, Ladakamycin, 320-67-2, C8H12N4O5
AZD-26
CAS:1357158-81-6
CEI-1144
> 95%
AKT1,
AZD-5438
CAS:602306-29-6
CEI-0289
>99%
AZD-5438, 602306-29-6, GSK3beta, cyclin E-cdk2, cyclin A-cdk2, cyclin B1-cdk1, cyclin B1-cdk1, C18H21N5O2S, 4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)-N-(4-(methylsulfonyl)phenyl)pyrimidin-2-amine, GSK3B, cdc2c, SKP1, CCNB1-CDK1
AZD1080
CAS:612487-72-6
CEI-1228
0.9991
AZD1080; 612487-72-6; GSK-3a; GSK-3; C19H18N4O2
AZD1152
CAS:722543-31-9
CEI-1229
0.98
AZD1152; 722543-31-9; Barasertib; AZD-1152; AZD 1152; Aurora B kinase; C26H31FN7O6P
AZD1480
CAS:935666-88-9
CEI-0191
>99%
AZD1480, 935666-88-9, JAK1, JAK2, C14H14ClFN8, (S)-5-chloro-N2-(1-(5-fluoropyrimidin-2-yl)ethyl)-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2, 4-diamine, JAK1, JAK2
AZD2014
CAS:1009298-59-2
CEI-0829
AZD2014, 1009298-59-2, mTOR, PI3Ka, PI3K, PI3Kd, PI3K?, C25H30N6O3, 3-(2, 4-bis((S)-3-methylmorpholino)pyrido[2, 3-d]pyrimidin-7-yl)-N-methylbenzamide, MTOR
AZD2461
CAS:1174043-16-3
CEI-1230
0.98
AZD2461; 1174043-16-3; PARP; C22H22FN3O3
AZD3463
CAS:1356962-20-3
CEI-0871
AZD3463, 1356962-20-3, ALK, C24H25ClN6O, 2-Pyrimidinamine, N-[4-(4-amino-1-piperidinyl)-2-methoxyphenyl]-5-chloro-4-(1H-indol-3-yl)-, ALK
AZD3514
CAS:1240299-33-5
CEI-1231
0.98
AZD3514; 1240299-33-5; androgen receptor; C25H32F3N7O2
AZD4547
CAS:1035270-39-3
CEI-0047
>99%
AZD4547, 1035270-39-3, FGFR1, FGFR2, FGFR3, C26H33N5O3, N-(5-(3, 5-dimethoxyphenethyl)-1H-pyrazol-3-yl)-4-((3S, 5R)-3, 5-dimethylpiperazin-1-yl)benzamide, FGFR1, FGFR2, FGFR3
AZD5363
CAS:1143532-39-1
CEI-0843
AZD5363, 1143532-39-1, Akt1, Akt2, Akt3, C21H25ClN6O2, 4-Piperidinecarboxamide, 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)-, AKT1, AKT2, AKT3
AZD6244(SELUMETINIB)
CAS:606143-52-6
CEI-0164
>99%
AZD6244(Selumetinib), ARRY-142886, 606143-52-6, MEK, C17H15BrClFN4O3, 6-(4-bromo-2-chlorophenylamino)-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-3H-benzo[d]imidazole-5-carboxamide, MAP2K1
AZD6482
CAS:1173900-33-8
CEI-0136
>99%
AZD6482, 1173900-33-8, PI3Kbeta, C22H24N4O4, (R)-2-(1-(7-methyl-2-morpholino-4-oxo-4H-pyrido[1, 2-a]pyrimidin-9-yl)ethylamino)benzoic acid, PIK3CB
AZD7687
CAS:1166827-44-6
CEI-1232
0.98
AZD7687; 1166827-44-6; AZD 7687; AZD-7687; DGAT; C21H25N3O3
AZD7762
CAS:860352-01-8
CEI-0293
>99%
AZD7762, 860352-01-8, CHK1, CHK2, C17H19FN4O2S, 1-(2-((S)-piperidin-3-ylcarbamoyl)-5-(3-fluorophenyl)thiophen-3-yl)urea, CHK1, CHK2
AZD8055
CAS:1009298-09-2
CEI-0118
>99%
AZD8055, 1009298-09-2, mTOR, C25H31N5O4, (5-(2, 4-bis((S)-3-methylmorpholino)pyrido[2, 3-d]pyrimidin-7-yl)-2-methoxyphenyl)methanol, MTOR
AZD8330
CAS:869357-68-6
CEI-0147
>99%
AZD8330, 869357-68-6, MEK1/2, C16H17FIN3O4, 2-(2-fluoro-4-iodophenylamino)-N-(2-hydroxyethoxy)-1, 5-dimethyl-6-oxo-1, 6-dihydropyridine-3-carboxamide, Dsor1
AZD8931
CAS:848942-61-0
CEI-0064
>99%
AZD8931, 848942-61-0, EGFR, Erbb2, C23H25ClFN5O3, 2-(4-(4-(3-chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)-N-methylacetamide, EGFR, ERBB2
AZITHROMYCIN
CAS:83905-01-5
CEI-1179
> 95%
parasite growth,
B-RAF INHIBITOR
CAS:1315330-11-0
CEI-1261
0.98
B-Raf inhibitor; 1315330-11-0; A B-Raf; C29H31F3N6O2
BAFETINIB (INNO-406)
CAS:859212-16-1
CEI-0272
>99%
Bafetinib (INNO-406), NS-187, 859212-16-1, Bcr-Abl, Lyn, C30H31F3N8O, ABL1, LYN
BAFILOMYCIN A1
CAS:88899-55-2
CEI-0697
>98%
Bafilomycin A1, 88899-55-2, vacuolar H+-ATPases (V-ATPases), C??H??O?, ATP6V0A4
BAICALEIN
CAS:491-67-8
CEI-0239
>99%
Baicalein, 491-67-8, C15H10O5
BAM7
CAS:331244-89-4
CEI-0890
BAM7, BAX Activator Molecule 7, 331244-89-4, BAX, C21H19N5O2S, 1H-Pyrazole-4, 5-dione, 3-methyl-1-(4-phenyl-2-thiazolyl)-, 4-[2-(2-ethoxyphenyl)hydrazone], BAX
BAN ORL 24
CAS:475150-69-7
CEI-1234
0.98
BAN ORL 24; 475150-69-7; BAN-ORL-24; BAN ORL-24; NOP receptor; C27H37Cl2N3O2
BARASERTIB (AZD1152-HQPA)
CAS:722544-51-6
CEI-0919
Barasertib (AZD1152-HQPA), AZD1152, 722544-51-6, Aurora B, C26H30FN7O3, 2-(5-(7-(3-(ethyl(2-hydroxyethyl)amino)propoxy)quinazolin-4-ylamino)-1H-pyrazol-3-yl)-N-(3-fluorophenyl)acetamide, AURKB
BARICITINIB (INCB28050,LY3009104)
CAS:1187594-09-7
CEI-0198
>99%
Baricitinib (INCB28050, LY3009104), INCB 28050, 1187594-09-7, JAK1, JAK2, C16H17N7O2S, 3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-, JAK1, JAK2
BARICITINIB PHOSPHATE SALT
CAS:1187595-84-1
CEI-1123
> 95%
JAK3,
BATIMASTAT (MMP INHIBITOR)
CAS:130370-60-4
CEI-0557
>97% by HPLC
Batimastat (MMP Inhibitor), BB-94, 130370-60-4, metalloprotease (MMP), C??H??N?O?S?, MMP
BAY 1000394
CAS:1223498-69-8
CEI-0858
BAY 1000394, 1223498-69-8, CDK1, CDK2, CDK4, CDK9, CDK7, C18H21F3N4O3S, 2-Butanol, 3-[[2-[[4-[[S(R)]-S-cyclopropylsulfonimidoyl]phenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]oxy]-, (2R, 3R)-, CDK1, CDK2, CDK4, CDK9, CDK7
BAY 11-7082
CAS:19542-67-7
CEI-0590
>95% by HPLC
BAY 11-7082, (E)-3-(4-Methylphenylsulfonyl)-2-propenenenitrile, 19542-67-7, NF-?B, C??H?NO?S, NFKB1
BAY 60-7550
CAS:439083-90-6
CEI-1235
0.98
Bay 60-7550; 439083-90-6; BAY 607550; Bay60-7550; Bay-60-7550; PDE2; C27H32N4O4
BAY 61-3606
CAS:732983-37-8
CEI-1236
BAY 61-3606; 732983-37-8; BAY61-3606; Syk; C20H18N6O3
BAY 65-1942 FREE BASE
CAS:600734-02-9
CEI-1237
Bay 65-1942 free base; 600734-02-9; IKK kinase; C22H25N3O4
BAY 65-1942 HCL SALT
CAS:600734-06-3
CEI-1238
0.98
Bay 65-1942 HCl salt; 600734-06-3; IKK kinase; C22H26ClN3O4
BAY 65-1942 R FORM
CAS:758683-21-5
CEI-1239
0.98
Bay 65-1942 R form; 758683-21-5; Bay 65-1942; Bay 65 1942; IKK; C22H25N3O4
BAY80-6946
CAS:1032568-63-0
CEI-0834
BAY80-6946, 1032568-63-0, PI3Ka, PI3K, C23H28N8O4, 5-Pyrimidinecarboxamide, 2-amino-N-[2, 3-dihydro-7-methoxy-8-[3-(4-morpholinyl)propoxy]imidazo[1, 2-c]quinazolin-5-yl]-, PIK3CA, PIK3CB
BAYER-18
CAS:1251752-12-1
CEI-1130
> 95%
TYK2, TYK2; tyrosine kinase 2; non-receptor tyrosine-protein kinase TYK2; JTK1; NP_003322; NM_003331; P29597; OTTHUMP00000232746; OTTHUMP00000232748; EC 2.7.10.2; OTTHUMP00000232745; EC 2.7.10; HGNC: 12440; Entrez Gene: 7297; Ensembl: ENSG00000105397; OMIM: 176941; UniProtKB: P29597; TYK2_HUMAN;
BC-11-38
CAS:686770-80-9
CEI-1051
98% (TLC); NMR (Conforms)
Pde11, BC-11-38, 686770-80-9, C15H16N2OS2
BCL-2 INHIBITOR
CAS:383860-03-5
CEI-0728
Bcl-2 Inhibitor, 2, 9-Dimethoxy-11, 12-dihydrodibenzo[c, g]1, 2]-diazocine 5, 6-dioxide5, 5-Dimethoxy-2, 2-dinitrosobenzyl, 383860-03-5, Bcl-2, C16H16N2O4, BCL2
BCL-2 INHIBITOR GX15-070
CAS:803712-67-6
CEI-0406
>98% by NMR
BCl-2 Inhibitor GX15-070, (Z)-2-(2-((3, 5-dimethyl-1H-pyrrol-2-yl)methylene)-3-methoxy-2H-pyrrol-5-yl)-1H-indole, 803712-67-6, Bcl-2, C 18 H 29 N 3 O, BCL2
BCL-2 INHIBITOR, ABT-199
CAS:1257044-40-8
CEI-0407
>99% by HPLC
BCl-2 Inhibitor, ABT-199, 2-((1H-Pyrrolo[2, 3-b]pyridin-5-yl)oxy)-4-(4-((4-chloro-5, 5-dimethyl-3, 4, 5, 6-tetrahydro-[1, 1-biphenyl]-2-yl)methyl)piperazin-1-yl)-N-((3-nitro-4-(((tetrahydro-2H-pyran-4-yl)methyl)amino)phenyl)sulfonyl)benzamide; GDC-0199, 1257044-40-8, BCl-2, C 45 H 50 ClN 7 O 7 S, BCL2
BCX 1470
CAS:217099-43-9
CEI-1240
0.98
BCX 1470; 217099-43-9; Thrombin inhibitor; BCX 1470; BCX-1470; Serine protease; C14H10N2O2S2
BCX 1470 METHANESULFONATE
CAS:217099-44-0
CEI-1241
0.98
BCX 1470 methanesulfonate; 217099-44-0; BCX 1470; BCX-1470; BCX1470; Serine protease; C15H14N2O5S3
BEC
CAS:63107-40-4
CEI-0641
>95%
NSC 23766, N6-[2-[[4-(Diethylamino)-1-methylbutyl]amino]-6-methyl-4-pyrimidinyl]-2-methyl-4, 6-quinolinediamine trihydrochloride, 733767-34-5, Rac1, C??H??N?.3HCl, RAC1
BELINOSTAT (PXD101)
CAS:414864-00-9
CEI-1242
0.991
Belinostat (PXD101); 414864-00-9; PXD-101, PXD 101, PX105684, PX-105684; HDAC; C15H14N2O4S
BESTATIN
CAS:65391-42-6
INBZ-002
90%
Bestatin; Amino-2-hydroxy-4-phenylbutanoyl]-L-leucine; 65391-42-6; inhibitor
BETA-ADRENERGIC RECEPTOR KINASE 1 INHIBITOR
CAS:24269-96-3
CEI-0723
beta-Adrenergic Receptor Kinase 1 Inhibitor, beta-ARK1 Inhibitor, GRK2 Inhibitor, 24269-96-3, beta-Adrenergic Receptor Kinase 1, C12H9NO6, ADRBK1
BETULIN
CAS:473-98-3
CEI-0668
>97% by HPLC
Betulin, Lup-20(29)-ene-3b, 28-diol, 473-98-3, SREBP (Sterol Regulatory Element-Binding Proteins), C??H??O?, SREBP
BEZ235 (NVP-BEZ235)
CAS:915019-65-7
CEI-0140
>99%
BEZ235 (NVP-BEZ235), 915019-65-7, Thr308-P-Akt, Ser473-P-Akt, mTOR, C30H23N5O, 2-methyl-2-(4-(3-methyl-2-oxo-8-(quinolin-3-yl)-2, 3-dihydroimidazo[4, 5-c]quinolin-1-yl)phenyl)propanenitrile, AKT1, MTOR
BGJ398 (NVP-BGJ398)
CAS:872511-34-7
CEI-0067
>99%
BGJ398 (NVP-BGJ398), 872511-34-7, FGFR1, FGFR2, FGFR3, C26H31Cl2N7O3, 3-(2, 6-dichloro-3, 5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)phenylamino)pyrimidin-4-yl)-1-methylurea, FGFR1, FGFR2, FGFR3
BI 2536
CAS:755038-02-9
CEI-0295
>99%
BI 2536, 755038-02-9, PLK1, C28H39N7O3, (R)-4-(8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5, 6, 7, 8-tetrahydropteridin-2-ylamino)-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide, PLK1
BI-D1870
CAS:501437-28-1
CEI-0902
BI-D1870, 501437-28-1, RSK1, RSK2, RSK3, RSK4, C19H23F2N5O2, 6(5H)-Pteridinone, 2-[(3, 5-difluoro-4-hydroxyphenyl)amino]-7, 8-dihydro-5, 7-dimethyl-8-(3-methylbutyl)-, RPS6KA1, RPS6KA3, RPS6KA2, RPS6KA6
BI6727 (VOLASERTIB)
CAS:755038-65-4
CEI-0306
>99%
BI6727 (Volasertib), 755038-65-4, PLK1, PLK2, PLK3, C34H50N8O3, N-((1r, 4r)-4-(4-(cyclopropylmethyl)piperazin-1-yl)cyclohexyl)-4-((R)-7-ethyl-8-isopropyl-5-methyl-6-oxo-5, 6, 7, 8-tetrahydropteridin-2-ylamino)-3-methoxybenzamide, PLK1, PLK2, PLK3
BIBF1120
CAS:928326-83-4
CEI-0698
>96% by TLC and LC-MS
BIBF1120, (Z)-?methyl 3-?(((4-?(N-?methyl-?2-?(4-?methylpiperazin-?1-? yl)acetamido)phenyl)amino)(phenyl)methylene)-?2-?oxoindoline-?6-? carboxylate, 928326-83-4, VEGFR, PDGFR, C 31 H 33 N 5 O 4, KDR, PDGFRB
BIBF1120 (VARGATEF)
CAS:656247-17-5
CEI-0070
>99%
BIBF1120 (Vargatef), 656247-17-5, VEGFR1/VEGFR2/VEGFR3, FGFR1/FGFR2/FGFR3/FGFR4, PDGFRalpha/PDGFRbeta, Flt3, Lck/Lyn/Src, C31H33N5O4, (Z)-methyl 3-((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenylamino)(phenyl)methylene)-2-oxoindoline-6-carboxylate, FLT1/KDR/FLT4, FGFR1/FGFR2/FGFR3/FGFR4, PDGFRA/PDGFRB, FLT3, LCK/LYN/SRC
BIBR 1532
CAS:321674-73-1
CEI-0304
>99%
BIBR 1532, 321674-73-1, telomerase, C21H17NO3, (E)-2-(3-(naphthalen-2-yl)but-2-enamido)benzoic acid, TERT
BIBR 953 (DABIGATRAN, PRADAXA)
CAS:211914-51-1
CEI-1243
0.98
BIBR 953 (Dabigatran, Pradaxa); 211914-51-1; Thrombin; C25H25N7O3
BIBR-1048 (DABIGATRAN)
CAS:211915-06-9
CEI-0391
>99%
BIBR-1048 (Dabigatran), 211915-06-9, C34H41N7O5
BIBW 2992 MALEATE
CAS:936631-70-8
CEI-0051
>99%
BIBW 2992 maleate, Tomtovok, 936631-70-8, EGFR(WT), C32H33ClFN5O11, (S, E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide, EGFR
BIBX 1382
CAS:196612-93-8
CEI-1244
BIBX 1382; 196612-93-8; Falnidamol; BIBX-1382; BIBX1382; EGFR; C18H19ClFN7
BIIB 021
CAS:848695-25-0
CEI-0536
>95% by HPLC
BIIB 021, 6-Chloro-9-[(4-methoxy-3, 5-dimethyl--2-pyridinyl)methyl]-9H-purin-2-amine; CNF2024, 848695-25-0, Hsp90, C 14 H 15 ClN 6 O, HSP90
BIIB021
CAS:848695-25-0
CEI-0987
>99%
HSP90AA1; heat shock protein 90kDa alpha (cytosolic), class A member 1; Renal carcinoma antigen NY-REN-38; HSP90A; HSP86; HSPC1; HSP 86; HSPCA; HSP89A; FLJ31884; HSPCAL4; HSP90N; LAP2; Hsp89; HSPCAL1; Hsp90; HSPN; heat shock 90kD protein 1, alpha; heat shock 90kD protein 1, alpha-like 4; heat shock 90kDa protein 1, alpha; heat shock 90kD protein, a
BIMATOPROST
CAS:155206-00-1
CEI-0387
>99%
Bimatoprost, Lumigan, 155206-00-1, C25H37NO4, (Z)-7-((1R, 2R, 3S, 5S)-3, 5-dihydroxy-2-((E)-3-hydroxy-5-phenylpent-1-enyl)cyclopentyl)-N-ethylhept-5-enamide,
BIRB 796 (DORAMAPIMOD)
CAS:285983-48-4
CEI-0169
>99%
BIRB 796 (Doramapimod), 285983-48-4, p38-alpha MAPK, C31H37N5O3, 1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea, MAPK14
BIRINAPANT (TL32711)
CAS:1260251-31-7
CEI-0866
Birinapant (TL32711), 1260251-31-7, XIAP, cIAP1, C42H56F2N8O6, Propanamide, N, N'-[(6, 6'-difluoro[2, 2'-bi-1H-indole]-3, 3'-diyl)bis[methylene[(2R, 4S)-4-hydroxy-2, 1-pyrrolidinediyl][(1S)-1-ethyl-2-oxo-2, 1-ethanediyl]]]bis[2-(methylamino)-, (2S, 2'S)-, XIAP, BIRC2
BISINDOYLMALEIMIDE X HCL
CAS:145317-11-9
CEI-1087
> 95%
DYT10,
BITOPERTIN
CAS:845614-11-1
CEI-1245
0.98
Bitopertin; 845614-11-1; RG1678; RO4917838; RG-1678; RG 1678; RO-4917838; RO 4917838; GlyT1; C21H20F7N3O4S